ethinyl estradiol has been researched along with levonorgestrel in 771 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 187 (24.25) | 18.7374 |
| 1990's | 144 (18.68) | 18.2507 |
| 2000's | 200 (25.94) | 29.6817 |
| 2010's | 204 (26.46) | 24.3611 |
| 2020's | 36 (4.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Bloch, B | 1 |
| Briggs, M; Briggs, MH | 2 |
| Balabaud, C; Bioulac-Sage, P; Deugnier, Y; Jouhanole, H; Le Bail, B; Pellegrin, JL; Salame, G; Saric, J | 1 |
| Hall, PE; Holck, S; Loke, DF; Ng, CS; Ratnam, SS | 1 |
| Bäckström, T; Cavalli-Björkman, B; Hansson-Malmström, Y; Lindhe, BA; Nordenström, S | 1 |
| Elstein, M; Russell, J; Webb, AM | 1 |
| al-Yacoub, G; Fuhrmeister, A; Kuhnz, W | 1 |
| Alvarez-Sanchez, F; Brache, V; Faundes, A; Jackanicz, T | 1 |
| Croxatto, HB; Noé, G; Pavez, M | 1 |
| Kauppinen-Mäkelin, R; Kuusi, T; Tikkanen, MJ; Ylikorkala, O | 1 |
| Chen, JK; Fan, BC; Fotherby, K; He, ML; Li, LM; Rekers, H; Song, S; Yang, PJ | 1 |
| Back, DJ; Ellis, A; Gilmore, IT; Grimmer, SF; Orme, ML; Tjia, JF | 1 |
| Abdalla, KA; Shabaan, MM; Stanczyk, FZ | 1 |
| Fakeye, O | 1 |
| Brandstädt, A; Carol, W; Jäger, R; Kasch, R; Klinger, G | 1 |
| Carlier, PG; Fradin, EA; Gilles, RG; Rorive, GL; Vaesen, F | 1 |
| Barja, P; Bocaz, JA; Bonnar, J; Carrol, A; Coutinho, E; Daly, L; Goncalves, M; Leck, I; Thomson, JM; Tsakok, M | 1 |
| al-Yacoub, G; Kuhnz, W | 1 |
| Balogh, A; Hempel, E; Hoffmann, A; Irmisch, E; Klinger, G; Letrari, S; Splinter, FK; Wolf, P | 1 |
| Atsma, WJ; Fioretti, P; Fruzzetti, F; Lammers, P; Melis, GB; Nicoletti, I; Ricci, C | 1 |
| Csemiczky, G; Landgren, BM | 1 |
| Cassidenti, DL; Lobo, RA; Paulson, RJ; Serafini, P; Stanczyk, FZ | 1 |
| Laine, M; Ojanotko-Harri, A; Pienihäkkinen, K; Tenovuo, J | 1 |
| Burton, R | 1 |
| Fotherby, K | 1 |
| Back, DJ; Mant, T; Martin, C; Millar, E; Morrison, P; Orme, M; Tjia, J | 1 |
| Otubu, JA; Towobola, OA; Uguru, VE | 1 |
| Chiang, ST; Lobo, RA; Stanczyk, FZ; Woutersz, TB | 1 |
| Bull, CA; Houghton, CR; Langlands, AO; McKay, MJ | 1 |
| Maree, J; Meyer, B; Müller, F; Wessels, P | 1 |
| Borggaard, B; Bremmelgaard, A; Kjaer, A; Lebech, AM; Refn, H; Schierup, L | 1 |
| Angel de Toro, LA; Lavarello, AC; Roncales Mateo, JM; Sagasta, CL; Salas Diaz, R; Wiemeyer, JC | 1 |
| Belhadj, H; Croxatto, HB; Díaz, S; Pavez, M; Sivin, I; Stern, J | 1 |
| Andersch, B; Milsom, I; Sundell, G | 1 |
| Holck, S; Loke, DF; Ng, CS; Ratnam, SS; Samsioe, G | 1 |
| Back, DJ; Chadwick, DJ; Crawford, P; Martin, C; Orme, M; Tjia, J | 1 |
| Pienaar, CA; Schall, R; Sohnius, U; van der Spuy, ZM | 1 |
| Kloosterboer, HJ; Rekers, H | 1 |
| Bauer, K; Jürgensen, R; Kaffarnik, H; Steinmetz, A | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Kamau, RK; Kigondu, C; Maina, FW; Mati, JK | 1 |
| Edén, S; Karlsson, R; von Schoultz, B | 1 |
| Burcher, E; Byrne, KB; Geraghty, DP; McPherson, GA | 1 |
| Kivinén, S; Palatsi, R; Reinilä, M | 1 |
| Apelo, R; Osteria, T; Ramos, R; Vilar, E | 1 |
| Goldzieher, JW | 2 |
| Chen, JK; Fotherby, K; He, ML; Song, S | 1 |
| Akerlund, M; Ekström, P; Juchnicka, E; Laudanski, T | 1 |
| Maltau, JM; Oian, P; Omsjø, IH; Osterud, B | 1 |
| Garcia-Bragado, F; Grilo, A; Iriarte, LM; Lozano, F; Rivera, JM; Salgado, V | 1 |
| Almer, S; Bodemar, G; Elfström, J; Franzén, L; Ihse, I; Resjö, M; Rydén, BO | 1 |
| Fitz, R; Grünberger, W; Vytiska-Binstorfer, E | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
| Daw, E; Paraskevaides, EC | 1 |
| Gaspard, UJ; Lepot, MR | 1 |
| Bonnar, J; Carroll, E; Daly, L | 1 |
| Harenberg, J; Kohlmeier, M; Rabe, T; Runnebaum, B; Weicker, H | 1 |
| Skouby, SO | 1 |
| Burcher, E; Byrne, KB; Coupar, IM; Stanton, BJ | 1 |
| Gahn, G; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
| Gahn, G; Gross, W; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
| Aleksandrovskaia, TN; Dubnitskaia, LV; Manuilova, IA; Shallaeva, VV | 1 |
| Ide, P; Wynants, P | 1 |
| Ayeni, O; Chalapati, S; Crawford, MA; Drury, PJ; Dusitsin, N; Gellen, JJ; Lenihan, T; Pinol, A; Sas, M; Tunkeyoon, M | 1 |
| Mall-Haefeli, M | 1 |
| Kloosterboer, HJ; van den Ende, A; van Wayjen, RG | 1 |
| Doornebos, CM; Hamerlynck, JV; Muntendam, P; Vollebregt, JA | 1 |
| Bonnar, J | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Balestreri, R; Bertolini, S; Cordera, R; Croce, S; De Cecco, L; Elicio, N; Gapitanio, GL; Montagna, G; Saturnino, M | 1 |
| Winzer, M; Wolff, HH | 1 |
| Erkkola, R; Grönroos, M; Järnström, S; Liukko, P; Näntö, V; Pakarinen, P | 1 |
| Bergink, EW; Erkkola, R; Liukko, P | 1 |
| Desager, JP; Gaspard, U; Harvengt, C; Lepot, M | 1 |
| Belsey, EM | 1 |
| Anderson, DC; Evans, A; Mamtora, H; Mavroudis, K; Robertson, WR | 1 |
| Chalmers, JS; Cowen, PJ; Fulli-Lemaire, I | 1 |
| Burcher, E; Geraghty, DP | 1 |
| Balslev, I; Christensen, M; Støckel, M | 1 |
| Rådberg, G; Svanvik, J | 1 |
| Back, DJ; Chadwick, D; Cleland, P; Cowie, A; Crawford, P; Orme, ML; Tjia, J | 1 |
| Back, DJ; Cowie, A; Gilmore, I; Grimmer, SF; Orme, ML; Tjia, J | 1 |
| Annus, J; Apró, G; Bartfai, G; Belsey, E; Bulpitt, C; Kovacs, L; Pinol, A | 1 |
| Joshi, JV; Joshi, UM; Sankolli, GM; Shah, RS | 1 |
| Liew, DF; Ng, CS; Ratnam, SS; Yong, YM | 1 |
| Amatayakul, K; Bamji, MS; Belsey, MA; Hall, P; Joshi, UM; Parker, RA; Prema, K; Singkamani, R; Virkar, KD; Whitehead, TP | 1 |
| Hale, R | 1 |
| Back, DJ; el-Raghy, I; Fathalla, M; Orme, ML; Osman, F | 1 |
| Back, DJ; el-Raghy, I; Fathalla, M; Makeram, M; Orme, ML; Osman, F; Salem, H | 1 |
| Chiang, S; Goebelsmann, U; Hoffman, D; Woutersz, T | 1 |
| Anderson, AE; Ayerst, RI; Curtis, MK; Ellsworth, HS; Harris, JW; Jones, TL; Stone, RA | 1 |
| Andersen, O; Kühl, C; Saurbrey, N; Skouby, SO | 1 |
| Ehnholm, C; Heikkinen, JE; Luoma, PV; Ylöstalo, PR | 1 |
| Ambrosecchia, R; Bagni, B; Bassi, P; Bergamini, CM; Cavallini, AR; Meduri, P; Pansini, F | 1 |
| Bertina, RM; Gevers Leuven, JA; Hessel, LW; Kluft, C | 1 |
| Dreisler, A; Kühl, C; Petersen, KR; Skouby, SO | 1 |
| Albus, C; Männchen, E | 1 |
| Back, DJ; Grimmer, SF; Orme, ML; Rogers, SM; Stevenson, PJ | 1 |
| Kung, AW; Lam, KS; Li, DF; Ma, HK; Ma, JT; Ng, MM; Wang, CC; Wong, VC; Young, RT | 1 |
| Back, DJ; Batten, JC; Grimmer, SF; Hodson, ME; Orme, ML; Rogers, SM; Stead, RJ | 1 |
| Gu, SJ; Weng, LJ | 1 |
| Betrabet, SS; Patel, D; Saxena, BN; Shikary, ZK; Toddywalla, SP; Toddywalla, VS | 1 |
| Friman, S; Rådberg, G; Samsioe, G; Svanvik, J | 1 |
| Gillmer, MD | 1 |
| Hale, RW | 1 |
| Back, DJ; Cohen, M; Elstein, M; Killick, SR; Shenoy, N; Stevenson, PJ | 1 |
| D'Ambrosio, R; Gardner, MJ; Jusko, WJ; Kanarkowski, R; Tornatore, KM | 1 |
| Destée, A; Leys, D; Petit, H; Warot, P | 1 |
| Akerlund, M; Forsling, ML; Hauksson, A; Kindahl, H | 1 |
| Back, DJ; Grimmer, SF; Orme, ML; Rogers, S; Stevenson, PJ | 1 |
| Almkvist, O; Larsson, B; Silber, M; Stock, S; Uvnäs-Moberg, K | 1 |
| Grond, AJ; Janssens, AR; Kreuning, J; Kroon, HM; Ruiter, DJ; van Erpecum, KJ | 1 |
| Ellingson, AB; Kotlik, A; Spellacy, WN; Tsibris, JC | 1 |
| Abdelhamid, AM; Tag-el-Den, TH | 1 |
| DeAngelis, NJ; Eickhoff, WM; Jackman, JK; Reif, VD | 1 |
| Demeter, J; Gáti, I; Gerö, G; Rákóczi, I | 1 |
| Buret, J; Gaspard, UJ; Gillain, D; Lambotte, R; Romus, MA | 1 |
| Crona, N; Samsioe, G; Silfverstolpe, G | 3 |
| von Schoultz, B | 1 |
| Maity, CR; Mandal, B | 2 |
| Tiltman, AJ | 1 |
| Christensen, MS; Kühl, C; Mølsted-Pedersen, L; Petersen, K; Skouby, SO | 1 |
| Iohan, F; Jackanicz, T; Monder, C | 1 |
| Farkas, E; Farkas, M; Sas, M | 1 |
| Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
| Hirvensalo, E; Liukko, P; Malmiharju, T; Mattila, L; Palatsi, R; Riihiluoma, P; Ylöstalo, P | 1 |
| Bergink, EW; Borglin, NE; Klottrup, P; Liukko, P | 1 |
| Samsioe, G | 1 |
| Baumgarten, S; Hammerstein, J; Römmler, A; Schwartz, U | 1 |
| Alapiessa, U; Lund, L; Nummi, S; Ruokonen, A; Viinikka, L | 1 |
| Andersen, NB; Andersen, RF; Bredesgaard, P; Cullberg, G; Ernerot, H; Fanøe, E; Fylling, P; Haack-Sørensen, PE; Klottrup, P; Pedersen, JH; Samsioe, G; Sandager, T | 1 |
| Cersosimo, L; Consalvo, F; Iannucci, D; Orgiu, G | 1 |
| Demey-Ponsart, E; Duvivier, J; Franchimont, P; Gaspard, UJ; Gillain, D; Romus, MA | 1 |
| Hammond, GL; Langley, MS; Lund, L; Nummi, S; Robinson, PA | 1 |
| Klove, KL; Lobo, RA; Roy, S | 1 |
| Bergink, EW; Kloosterboer, HJ; Lund, L; Nummi, S | 1 |
| Crona, N; Enk, L; Samsioe, G; Silfverstolpe, G | 1 |
| Ayeni, O; Chalapati, S; Dusitsin, N; Gellen, JJ; Gray, R; Koetsawang, S; Pinol, A; Saibiang, S; Sas, M; Tankeyoon, M | 1 |
| Adashi, EY | 1 |
| Acorn, T; Ling, WY; Popat, R; Wilson, E; Wrixon, W; Zayid, I | 1 |
| Christie, T | 1 |
| Guillebaud, J | 1 |
| Haspels, AA | 3 |
| Moggia, AV | 1 |
| Woutersz, TB | 1 |
| Casado, ME; Croxatto, HB; Díaz, S; Durán, E; Herreros, C; Juez, G; Miranda, P; Peralta, O; Salvatierra, AM | 3 |
| Deville, JL; Dubois, M; Gaspard, UJ | 1 |
| Bergqvist, A; Bergqvist, D; Tangen, O | 1 |
| Cekan, SZ; Diczfalusy, E; Johannisson, E; Landgren, BM; Toddyvalla, V | 1 |
| Allen, WL; Back, DJ; Breckenridge, AM; Grimmer, SF; Orme, M; Tjia, J | 1 |
| Guillebaud, J; Kubba, AA | 1 |
| Colau, JC; de Gennes, JL; Gheron, G; Taurelle, R | 1 |
| Dechavanne, M; Guichardant, M; Lagarde, M; Quincy, C; Sassolas, A | 1 |
| Dessole, S; Firinu, C; Milia, S; Piras, G | 1 |
| Andersen, O; Skouby, SO; Wagner, HH | 1 |
| Cerskus, I; Hedlin, AM; Kakis, G; Powell, MG; Prudham, D; Rosenrot, P | 1 |
| Aaserud, J; Bratt, H; Fylling, P; Lie, S; Schiefloe, A; Steier, A; Svendsen, E; Ulstein, M | 1 |
| Gil, J; Jiménez, JL; Otero González, A; Sánchez-Guisande, D; Santos, C; Temes Montes, XL | 1 |
| Dubois, M; Duvivier, J; Franchimont, P; Gaspard, UJ; Gillain, D | 1 |
| Diczfalusy, E; Landgren, BM | 1 |
| Göretzlehner, G; Köhler, G | 1 |
| Amatayakul, K; Ruckphaopunt, S; Singkamani, R; Uttaravichai, C | 1 |
| Dagan, I; Gross, V; Landau, H; Palti, Z; Rachmilewitz, EA; Spitz, IM | 1 |
| Back, DJ; Breckenridge, AM; Grimmer, SF; Orme, ML; Purba, HS | 1 |
| Cruickshank, J; McMaster, M; Weir, RJ; Wilson, ES | 1 |
| el-Kabsh, MY; Elwan, SI; Farghaly, SA; Shaaban, MM; Thabet, N | 1 |
| Briggs, MH; Thomson, SB; Tucker, DJ | 1 |
| Spasojević, M | 1 |
| Ahren, T; Akinla, O; Alvarez-Sanchez, F; Brache, V; Brenner, PF; Coutinho, E; Darze, E; Diaz, J; Diaz, S; Fasan, MO; Faundes, A; Gama daSilva, JC; Giwa-Osagie, OF; Jackanicz, TM; Mishell, DR; Nash, HA; Nielsen, NC; Pavez, M; Pyorala, T; Roy, S; Sivin, I; Stern, J; Victor, A; Zausner-Guelman, B | 3 |
| Brenner, PF; de Quattro, V; Dozono-Takano, R; Eide, I; Gray, G; Mishell, DR; Roy, S; Shaw, ST | 1 |
| Back, DJ; Bates, M; Breckenridge, AM; Ellis, A; Hall, JM; Maciver, M; Orme, ML; Rowe, PH | 1 |
| Lehtovirta, P; Ranta, T; Seppälä, M | 1 |
| Back, DJ; Bates, M; Breckenridge, AM; Hall, JM; MacIver, M; Orme, ML; Park, BK; Rowe, PH | 1 |
| Love, AH; Vir, SC | 1 |
| Briggs, M | 1 |
| Capel, ID; Donaldson, D; Jenner, M; Nath, A; Williams, DC | 1 |
| Obel, EB | 1 |
| Ahrén, T; Johansson, ED; Lithell, H; Victor, A | 1 |
| Ahrén, T; Johansson, ED; Lithell, H; Vessby, B; Victor, A | 1 |
| Mishell, DR; Roy, S; Wilkins, J | 1 |
| Heikkinen, J; Jänne, O; Mäentausta, O; Ylöstalo, P | 1 |
| Wynn, V | 2 |
| Kay, CR | 1 |
| Adatia, A; Andolsek, L; Ayeni, S; Belsey, MA; Hall, PE; Jain, U; Li Hoi Foo, C; Parker, RA; Patankar, S; Pinol, A; Pretnar-Darovec, A; Sharma, S; Sheth, A | 1 |
| Kühl, C; Mølsted-Pedersen, L; Skouby, SO | 1 |
| Wingrave, SJ | 1 |
| Fåhraeus, L; Larsson-Cohn, U; Wallentin, L; Zador, G | 1 |
| Myklebust, RU; Ulstein, M | 1 |
| Back, DJ; Breckenridge, AM; MacIver, M; Orme, M; Rowe, PH; Staiger, C; Thomas, E; Tjia, J | 1 |
| Hodsman, GP; Mackay, A; Robertson, JI; Semple, PF | 1 |
| Weir, RJ | 1 |
| Barbosa, IC; Coutinho, EJ; Coutinho, EM; Gonçalves, MT | 1 |
| Elamsson, K; Elmestedt, U; Johansson, ED | 1 |
| Burrows, GD; Dennerstein, L | 1 |
| Cameron, ED; Elstein, M; McCafferty, E; Nuttall, ID; Seth, J | 1 |
| Bolis, PF; Franchi, M; Marino, L; Paganelli, AM; Sampaolo, P | 1 |
| Bouffioux, R; Gaspard, U; Werbrouck-Navette, J | 1 |
| Jespersen, J; Kluft, C | 1 |
| Cekan, SZ; Diczfalusy, E; Landgren, BM; Shi, S; Wang, E | 1 |
| Adams, MR; Anthony, MS; Clarkson, TB; Kaplan, JR; Manuck, SB; Morgan, TM | 1 |
| Gurewich, V; Jick, H; Jick, SS; Myers, MW; Vasilakis, C | 1 |
| Hau, J; Nielsen, CH; Poulsen, HK; Teisner, B; Thorsen, P; Westergaard, JG | 1 |
| Coates, PE; Mesure, R | 1 |
| Abdel Aleem, H; Aboul-Oyoon, M; Barbosa, IC; Coutinho, EM; Gu, ZP; O'Dwyer, E; Shaaban, MM | 1 |
| Bielfeld, P; Conrad, M; Graf, M; Krüssel, JS; Rudolf, K | 1 |
| Kuhnz, W; Löfberg, B | 1 |
| Crook, D; Devenport, M; Godsland, IF; Wynn, V | 1 |
| Sudik, R | 1 |
| Jütting, G; Kuhnz, W; Staks, T | 1 |
| Berenson, AB; Wiemann, CM | 1 |
| Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF | 1 |
| Fuchs, W; Klotz, U; Sennewald, R | 1 |
| Bortolotto, LA; Pileggi, F; Silva, HB | 1 |
| Burcher, E; Byrne, KB; Geraghty, DP; Stewart, BJ | 1 |
| Kondrikov, NI; Nazarova, NM; Prilepskaia, VN | 1 |
| Doğan, P; Köse, K; Ozesmi, C | 3 |
| Arbini, A; Mannucci, PM; Martinelli, I; Moia, M; Tripodi, A | 1 |
| Hemal, AK; Hemal, U; Kriplani, A; Wadhwa, SN | 1 |
| Blode, H; Kuhnz, W; Mahler, M | 1 |
| Nordby, J; Paulsen, JE; Wiik, P | 1 |
| Furukawa, F; Imazawa, T; Mitsumori, K; Nishikawa, A; Sato, M; Takahashi, M; Yoshimura, H | 1 |
| Aguayo, EL; Calventi, V; de Silva, P; Dunson, TR; Gerais, AS; McLaurin, VL; Serani, RG | 1 |
| Taberner, D; Webb, A | 1 |
| Alvarez, F; Bassol, S; Brache, V; Coutinho, EM; da Silva, AR; de Acosta, OM; de Souza, JC; Garza Flores, J; Santo, R; Vasquez-Estrada, L | 1 |
| Webb, A | 1 |
| Ho, PC; Kwan, MS | 1 |
| Bounds, W; Guillebaud, J; Newman, B; Nichols, M; Robinson, G | 1 |
| Broome, M; Clayton, J; Fotherby, K | 1 |
| Dieben, TO; Geurts, TB; Hellstern, P; Weinges, KF; Wenzel, E | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Gaspard, UJ; Hendrick, JC; Nervo, P; van den Brûle, FA | 1 |
| Alvarez-Sanchez, F; Brache, V; Cochon, L; Faundes, A; Thevenin, F | 1 |
| Fjalland, B; Moller, BM; Moller, SE; Olesen, M | 1 |
| Bennink, HC; Dieben, T; Exalto, N; van der Does, J | 1 |
| Entezami, M; Heger-Mahn, D; Kuhnz, W; Lübbert, H; Richert, K; Schütt, B | 1 |
| Bygdeman, M; Johannisson, E; Swahn, ML; Westlund, P | 1 |
| Lippert, TH; Lorkowski, G; Mück, AO; Seeger, H; Teichmann, AT | 1 |
| Brill, K; Feichtinger, W; Kindermann, C; Spona, J; Wünsch, C | 1 |
| Balasch, J; Sánchez-Borrego, R | 1 |
| Archer, DF; Philput, CA; Weber, ME | 1 |
| Affandi, B; Lau, TM; Rogers, PA; Witjaksono, J | 1 |
| Mansmann, U; Roots, I; Rost, KL | 1 |
| Berzas, JJ; Castañeda, G; Rodríguez, J | 1 |
| Balasch, J; Creus, M; Fábregues, F; Vanrell, JA | 1 |
| Archer, DF; DelConte, A; Maheux, R; O'Brien, FB | 2 |
| Bartoli, A; Barzaghi, N; Cipolla, G; Fattore, C; Gatti, G; Mumford, J; Perucca, E; Veliz, G | 1 |
| Diffey, B; O'Dea, K; Piers, LS; Soares, MJ | 1 |
| Glasier, A | 2 |
| Abdel-Aziz, O; Nafea, S; Rahseed, K; Shaarawy, M; Sheiba, M | 1 |
| Ebert, A; Entezami, M; Halis, G; Heger-Mahn, D; Lübbert, H | 1 |
| Jayo, MJ; Jerome, CP; Register, TC | 1 |
| Albring, M; Bannemerschult, R; Brill, K; Fox, P; Hanker, JP; Wünsch, C | 1 |
| Engström, BE; Karlsson, FA; Wide, L | 1 |
| Baird, D; Glasier, A | 1 |
| Berlien, HP; Ismail, MS; Serour, GI; Torsten, U; Weitzel, H | 1 |
| Bordasch, C; Lorkowski, G; Martens, H; Petersen, G; Teichmann, A | 1 |
| Awni, WM; Dube, LM; O'Dea, RF; Wong, SL | 1 |
| Czekaj, P; Nowaczyk-Dura, G | 1 |
| Bigrigg, A; Blanchard, K; Ellertson, C; Haskell, S; Webb, A | 1 |
| Nightingale, SL | 1 |
| Rutter, T | 1 |
| McMullen, JP; Schooff, M | 1 |
| Dorea, JG; Myazaki, E | 1 |
| von Hertzen, H | 1 |
| Boerrigter, PJ; Dolker, M; Ellman, H | 1 |
| Dunn, S; Evans, MF; Lee, SM | 1 |
| Farmer, RD; Lawrenson, R; Leydon, GM; Todd, J; Williams, TJ | 1 |
| Bannemerschult, R; Brill, K; Fox-Kuchenbecker, P; Hite, RC; Turck, R | 1 |
| Armengol, J; Aura, M; Calaf, J; Cuberas, N; Espinós, JJ; Senosiain, R; Vanrell, C | 1 |
| Bernasconi, C; Cipolla, G; Fattore, C; Gatti, G; Limido, GL; Perucca, E; Sturm, Y | 1 |
| DelConte, A; Grubb, GS; Loffer, F | 1 |
| Chavez, A; DelConte, A | 1 |
| Bromham, DR; Kirkman, RJ; O'Connor, TP; Sahota, JE | 1 |
| Archer, DF | 1 |
| Gast, MJ; Martin, D; Reisman, H | 1 |
| Coney, P; DelConte, A | 1 |
| DelConte, A; Young, RL | 1 |
| Archer, DF; Grubb, GS; Mammen, EF | 1 |
| Bouma, BN; Büller, HR; Christella, M; Curvers, J; Meijers, JC; Middeldorp, S; Nicolaes, GA; Prins, MH; Rosing, J; Tans, G; Thomassen, LG | 1 |
| Aura, M; Calaf, J; Espinós, JJ; Gispert, M; Rodríguez-Espinosa, J; Senosiain, R; Vanrell, C; Vega, C | 1 |
| Ballagh, SA; Bradshaw, KD; Nichols, M; Stanczyk, FZ; Thorneycroft, IH; Weber, ME | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Diab, KM; Zaki, MM | 1 |
| Anziano, RJ; Harness, J; Holt, PR; Muirhead, GJ; Oliver, S | 1 |
| Amundsen, CL; McGuire, EJ; Westney, OL | 1 |
| Buicu, C; Gaspard, U; van den Brûle, F | 1 |
| Jain, JK; Mishell, DR; Ota, F | 1 |
| Adams, MR; Anthony, MS; Golden, DL; Manning, JM; Parks, JS | 1 |
| Kluft, C | 1 |
| Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; van den Ende, AE; van Enk, A | 1 |
| Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Tekelenburg, W; van den Ende, AE | 1 |
| Bouma, BN; Büller, HR; Curvers, J; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Thomassen, MC | 1 |
| Colau, JC | 1 |
| Busse, R; Herkert, O; Kuhl, H; Schini-Kerth, VB | 1 |
| Morris, BJ; Young, C | 1 |
| Dórea, JG | 1 |
| Bosch, T; Empen, K; Otto, C; Parhofer, KG; Schwandt, P | 1 |
| Alam, V; Fabres, C; MacKenna, A; Morales, V | 1 |
| Wertheimer, RE | 1 |
| Balogh, A; Gräser, G; Kauf, E; Klinger, G; Oettel, M; Vollanth, R | 1 |
| Bashir, MI; Laway, BA; Masoodi, SR; Salahuddin, M; Wani, AI; Zargar, AH | 1 |
| Gabriel, HH; Hilberg, T; Müller-Berghaus, G; Nowacki, PE | 1 |
| Aubény, E | 1 |
| Croxatto, HB; Devoto, L; Durand, M; Ezcurra, E; Larrea, F; Nagle, C; Ortiz, ME; Vantman, D; Vega, M; von Hertzen, H | 1 |
| Bounds, W; Furs , SA; Guillebaud, J; Johnson, J; Machin, SJ; Mackie, IJ; Piegsa, K | 1 |
| Avari, KM; Bhiwgade, DA; Borkar, MR | 1 |
| Archer, DF; Harrison, DD; Lemay, A; Roberts, J; Thiboutot, D; Washenik, K | 1 |
| Bannemerschult, R; Endrikat, J; Gerlinger, C; Hite, R; Schmidt, W | 1 |
| Bijaoui, S; Dupont, G; Foulon, T; Groslambert, P; Laporte, F; Payen, N; Roland, F | 1 |
| Falk, G; Falk, L; Hanson, U; Milsom, I | 1 |
| Brautigam, J; Brueckner, T; Michels, W; Schleussner, E | 1 |
| Coney, P; DiGiovanna, JJ; Harrison, DD; Langley, RG; Washenik, K | 1 |
| Grimes, D; Helmerhorst, F; Schulz, K; Van Vliet, H | 1 |
| Creasy, GW; Fisher, AC; Lenihan, JP; Meador, ML; Shangold, GA; Smallwood, GH | 1 |
| Algra, A; Cats, VM; Helmerhorst, FM; Kemmeren, JM; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y | 1 |
| Landgren, BM; Olsson, B | 1 |
| Abrams, LS; Lasseter, KC; Natarajan, J; Skee, DM; Wong, FA | 1 |
| Bremme, K; Hamsten, A; Silveira, A; van Rooijen, M; von Schoultz, B | 1 |
| Schwetz, BA | 1 |
| Mueck, AO; Petersen, G; Schulte-Wintrop, E; Seeger, H; Wallwiener, D | 1 |
| Algra, A; Bouma, BN; Grobbee, DE; Kemmeren, JM; Meijers, JC | 2 |
| Algra, A; Grobbee, DE; Kemmeren, JM | 1 |
| Bjarnadóttir, RI; Killick, SR; Tuppurainen, M | 1 |
| Alvarez, F; Brache, V; Cochon, L; Croxatto, HB; Faundes, A; Fuentealba, B; Massai, R; Salvatierra, AM | 1 |
| Cronin, M; Düsterberg, B; Endrikat, J; Gerlinger, C; Klipping, C; Ruebig, A; Schmidt, W | 1 |
| Bauer, HH; Gross, W; Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; von Hayn, C; Wiegratz, I; Winkler, UH | 1 |
| Dubey, RK; Jäger, AW; Keller, PJ; Merki-Feld, GS; Rosselli, M | 1 |
| Mueck, AO; Petersen, G; Schulte-Wintrop, E; Seeger, H; Teichmann, AT | 1 |
| Grimes, DA; Helmerhorst, FM; Schulz, KF; van Vliet, HA | 3 |
| Faghihzadeh, S; Lamyian, M; Rajaei, L; Ziaei, S | 1 |
| Ashok, PW; Flett, GM; Melvin, L; Stalder, C; Templeton, A; Wagaarachchi, PT | 1 |
| Janik, F; Levy, RH; Ragueneau-Majlessi, I | 1 |
| Schwartz, JL | 1 |
| Carr, BR; DelConte, A | 1 |
| Cotton, S; Rosenthal, SL; Succop, PA; Wanchick, AM; Wimberly, YH | 1 |
| Hasegawa, M; Inês, M; Kassab, NM; Kedor-Hackmann, ER; Santoro, RM | 1 |
| Hordinsky, M; Leyden, J; Shalita, A; Stanczyk, FZ; Swinyer, L; Weber, ME | 1 |
| Imthurn, B; Keller, PJ; Merki-Feld, GS | 1 |
| Blode, H; Endrikat, J; Gerlinger, C; Kuhnz, W; Rosenbaum, P | 1 |
| El-kabarity, H; El-zenieny, AH; Fikry, MF; Hafiz, MA | 1 |
| Blum, M; Gelernter, I; Werchow, M | 1 |
| Hoffmann, KO | 1 |
| Chen, JK | 1 |
| Haspels, AA; Van Santen, MR | 1 |
| Rozenbaum, H | 1 |
| Serfaty, D | 1 |
| Hahn, DW; Mcguire, JL; Philipps, A | 1 |
| Olsson, SE | 1 |
| Gonzalez-ansorena, R; Rubio-lotvin, B; Ruiz-moreno, JA | 1 |
| Keters, D | 1 |
| Karim, HA | 1 |
| Kirumbi, LW; Maina, FW; Mati, JK; Sekadde Kigondu, CB | 1 |
| Maclennan, AH | 1 |
| Ishak, R | 1 |
| Smith, M | 1 |
| Defoort, P; Martens, G; Merchiers, E; Parewijck, W; Thiery, M; Van Kets, H | 1 |
| Baharum, Y; Khalid, H; Roshidah, I | 1 |
| Creinin, MD; Eder, SE; Godwin, AJ; Lippman, JS; Olson, W | 1 |
| Becker, KA; Emans, SJ; Feldman, HA; Goodman, E; Gordon, CM; Grace, E; Gundberg, CM; LeBoff, MS; Rosen, CJ | 1 |
| Porter, C; Rees, MC | 1 |
| Lo, SS | 1 |
| Taneepanichskul, S; Tantbirojn, P | 1 |
| Edelman, A; Jensen, JT; Kwiecien, M; Nichols, MD | 1 |
| Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; Wiegratz, I; Winkler, UH | 2 |
| Andolsek-Jeras, L; Kocijancic, A; Marc, J; Pinter, B; Prezelj, J | 1 |
| Cotton, S; Potter, LS; Ready, JN; Rosenthal, SL; Succop, PA | 1 |
| Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK | 1 |
| de Vries, CS; Farmer, RD; Seaman, HE | 1 |
| Langley, RG; Lemay, A | 1 |
| Hughes, JP; Miller, L | 1 |
| Mikolajczyk, RT; Stanford, JB | 1 |
| Breitkopf, DM; Nagamani, M; Rosen, MP; Young, SL | 1 |
| Breitkopf, DM; Nagamani, M; Rosen, MP | 1 |
| Alexandersen, P; Christiansen, C; Haarbo, J; Jespersen, J; Skouby, SO; Zandberg, P | 1 |
| Goffin, V; Piérard, GE; Piérard-Franchimont, C | 1 |
| Casonato, A; Gavasso, S; Girolami, A; Pellati, D; Pontara, E; Saggiorato, G; Spiezia, L; Teresa Sartori, M | 1 |
| Anderson, FD; Hait, H | 1 |
| Laine, K; Lundgren, S; Palovaara, S; Pelkonen, O; Uusitalo, J | 1 |
| Algra, A; Bouma, BN; Curvers, J; Grobbee, DE; Kemmeren, JM; Meijers, JC; Rosing, J; Tans, G | 1 |
| Abraham, S; Luscombe, G; Soo, I | 1 |
| Dasaratha Dhanaraju, M; Jayakumar, R; Vamsadhara, C; Vema, K | 1 |
| Croxatto, HB; Müller, AL; Ortiz, ME | 1 |
| Ekerbicer, HC; Kiran, G; Kiran, H | 1 |
| Suthipongse, W; Taneepanichskul, S | 1 |
| März, W; Nauck, M; Petersen, G; Scharnagl, H; Teichmann, AT; Wieland, H | 1 |
| Bigrigg, A; Gallagher, J; Hesketh, C; Loftus-Granberg, B; Shochet, T; Tyrer, A; Webb, A | 1 |
| Bittar, RS; Cruz, OL; Lorenzi, MC; Marone, SA; Miniti, A | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Dieben, TO; Klimscheffskij, R; Tuppurainen, M; Venhola, M | 1 |
| Aldrighi, JM; Bahamondes, L; Caetano, ME; De Lima, GR; Martinez, TR; Petta, CA | 1 |
| Dienel, A; Klement, S; Müller, F | 1 |
| Cedars, MI; Hughes, HD; Lynch, AM; Schlaff, WD; Smith, DL | 1 |
| Cooper, C; Nelson, B; Pentel, PR; Wikelius, N | 1 |
| Bjarnadóttir, RI; Dieben, TO; Geirsson, RT; Gudmundsdóttir, BR; Magnusdóttir, EM; Magnusdóttir, SD; Onundarson, PT | 1 |
| Ferguson, H; Mulders, JA; Winkler, UH | 1 |
| Kuhl, H; Kutschera, E; Lee, JH; Wiegratz, I; Winkler, UH | 1 |
| Dieben, TO; Duijkers, IJ; Klipping, C; Verhoeven, CH | 2 |
| Ameen, VZ; Baidoo, CA; Campanella, C; Kersey, KE; Koch, K; Manzo, JA | 1 |
| Ashok, PW; Flett, GM; Hamoda, H; Templeton, A | 1 |
| Baerwald, AR; Olatunbosun, OA; Pierson, RA | 1 |
| Calis, KA; Pucino, F | 1 |
| Benedetto, C; de Melo, NR; Dieben, TO; Leifels-Fischer, B; Oddsson, K; Verhoeven, CH; Wiel-Masson, D | 1 |
| Bonny, A; Cromer, BA; Debanne, SM; Lazebnik, R; Rome, E; Stager, M; Ziegler, J | 1 |
| Sucato, GS | 1 |
| Bonny, A; Cromer, BA; Lazebnik, R; Rome, E; Secic, M; Stager, M; Ziegler, J | 1 |
| Latif, SA; Nessa, A; Uddin, M | 1 |
| Bigrigg, A; Dieben, TO; Duijkers, I; Killick, S | 1 |
| Abramowitz, W; Jakate, AS; Kapil, R; Patel, A; Persiani, S; Roy, P; Wangsa, J | 1 |
| Düsterberg, B; Endrikat, J; Gerlinger, C; Goldstein, H; Jespersen, J; Schmidt, W; Skouby, SO; Wessel, J | 1 |
| Hahn, PM; Kives, S; Reid, RL; Stanczyk, FZ; White, E | 1 |
| Breitkreutz, J; Gröning, R; Müller, RS | 1 |
| Eriksson, MJ; Hirschberg, AL; Rickenlund, A; Schenck-Gustafsson, K | 1 |
| Bettoni, L | 1 |
| Bouma, BN; Deguchi, H; Griffin, JH; Lee, YM; Middeldorp, S | 1 |
| Kives, S; Mor, E; Paulson, RJ; Reid, RL; Saadat, P; Stanczyk, FZ; White, E | 1 |
| Düsterberg, B; Endrikat, J; Gerlinger, C; Jespersen, J; Schmidt, W; Sidelmann, JJ; Skouby, SO; Wessel, J | 1 |
| Latif, SA; Nessa, A; Uddin, MM | 1 |
| Ahmed, MR; Dhanaraju, MD; Gopinath, D; Jayakumar, R; Vamsadhara, C | 1 |
| Curran, MP; Dando, TM | 1 |
| Krauwinkel, WJ; Kuipers, ME; Smulders, RA; Swart, PJ; Taekema-Roelvink, ME; Visser, N | 1 |
| Cravioto, MD; Jiménez-Santana, L; Lara-Reyes, P; Mestanza-Peralta, M; Sánchez-Guerrero, J; Seuc, AH; Uribe, AG | 1 |
| Job, S; Philipson, R; Sidhu, J; Singh, S | 1 |
| Ayano, E; Kanazawa, H; Kikuchi, A; Okada, Y; Okano, T; Sakamoto, C | 1 |
| Edelman, AB; Jensen, JT; Koontz, SL; Nichols, MD | 1 |
| Bassas, L; Calaf, J; Espinós-Gómez, JJ; Mata, A; Senosiain, R; Vanrell, C | 1 |
| Grimes, DA; Helmerhorst, FM; Lopez, LM; Schulz, KF; van Vliet, HA | 2 |
| Jordan, B; Trussell, J | 1 |
| Dhanaraju, MD; Jayakumar, R; Rajkannan, R; Selvaraj, D; Vamsadhara, C | 1 |
| Cagiano, R; Sabatini, R | 1 |
| Jain, JK; Ozel, B; Stanczyk, FZ; White, T | 1 |
| Gupta, N | 1 |
| Archer, DF; Borisute, H; Constantine, GD; Grubb, GS; Jensen, JT; Johnson, JV | 1 |
| Burrows, M; Peters, C | 1 |
| Constantine, GD; Grubb, GS; Johnson, JV | 1 |
| Huber, P; Schmale, GA; Seidel, K; Simonian, P; Tencer, A; Woodhouse, E | 1 |
| Dieterle, W; Mann, J | 1 |
| Bowen, CL; Licea-Perez, H; Wang, S; Yang, E | 1 |
| Kaplan, PF; Meendering, JR; Minson, CT; Torgrimson, BN | 1 |
| Kubán, V; Matejícek, D | 1 |
| Alvarez-Sabin, J; de Francisco, J; Garcia-Martinez, R; Horga, A; Quilez, A; Santamarina, E | 1 |
| Bhat, GS; Bhat, KM; Sumanth, S | 1 |
| Bäcklin, BM; Bredhult, C; Olovsson, M | 1 |
| García Ibarbia, C; Gutiérrez Santiago, M; Hernández Hernández, JL; Nan Nan, DN | 1 |
| Burggraaf, J; de Kam, ML; Kluft, C; Menard, J; Rad, M; Sitruk-Ware, RL; Sivin, I; Tokay, BA | 1 |
| Ikarashi, H; Matsushita, H; Takayanagi, T | 1 |
| Nau, JY | 1 |
| Constantine, GD; Davis, AR; Grubb, GS; Kroll, R; Soltes, B; Zhang, N | 1 |
| Cherchi, C; Concas, A; Follesa, P; Panzanelli, P; Perazzini, AZ; Porcu, P; Sassoè-Pognetto, M; Sogliano, C | 1 |
| Aiach, M; Borgel, D; Clauser, S; Crespin, M; Emmerich, J; Gaussem, P; Peyrard, S | 1 |
| Guardianelli, F; Lello, S; Melis, GB; Paoletti, AM; Sorge, R; Vittori, G | 1 |
| Chandra, NC; Das, C; Ramakrishnan, G; Rana, A | 1 |
| Hussain, MA; Latif, SA; Nessa, A; Uddin, MM | 1 |
| Tan, JK | 1 |
| Boonyarangkul, A; Taneepanichskul, S | 1 |
| Wagstaff, AJ | 1 |
| Ensom, MH; Fielding, DW; Levine, M; Marciante, KD; Meckley, LM; Soon, JA | 1 |
| Archer, DF; Jensen, JT | 1 |
| Richardson, MK | 1 |
| Bonny, AE; Camlin-Shingler, K; Cromer, BA; Lazebnik, R; Rome, E; Secic, M; Stager, M; Ziegler, J | 1 |
| Fisher, AC; Kluft, C; LaGuardia, KD; Meijer, P | 1 |
| Anderson, FD; Feldman, R; Reape, KZ | 1 |
| Coffee, A; Kuehl, TJ; Reape, KZ; Sulak, PJ; Vandever, MA; Wincek, TJ; Witt, I | 1 |
| Baracat, EC; Estevão, RA; Logullo, AF; Nazário, AC; Oshima, CT | 1 |
| Abel, S; Muirhead, GJ; Ridgway, CE; Russell, D; Whitlock, LA | 1 |
| Bell, ML; Cotter, JD; Rehrer, NJ; Sims, ST | 1 |
| Barnhart, K; Constantine, G; Grubb, G; Mirkin, S | 1 |
| Scheinfeld, N | 1 |
| Archer, DF; Bacon, J; Cullins, V; Levine, AS; Philput, CB; Stovall, TG; Weber, ME | 1 |
| Malek-Khosravi, S | 1 |
| Freeman, SB | 1 |
| Caballero, PE | 1 |
| González, EA; Molina, RC; Molina, TG; Montero, AV; Oyarzún, PG; Sandoval, JZ | 1 |
| Bhardwaj, SS; Bohjanen, KA; Weinberger, CH | 1 |
| Hait, H; Kaunitz, AM; Portman, DJ; Reape, KZ | 1 |
| Buono, MJ; Martin, JG | 1 |
| Tanchev, L | 1 |
| Endrikat, J; Fortier, M; Kunz, M; Lukkari-Lax, E; Schmidt, W; Shapiro, H | 1 |
| Amaliev, G | 1 |
| Dacheva, T | 1 |
| Fekete, J; Fekete, S; Ganzler, K | 1 |
| Cameron, JL; Carlson, NE; Cherala, G; Edelman, AB; Jensen, JT; Munar, MY; Stanczyk, FZ; Stouffer, RL | 1 |
| Archer, DF; Ballagh, SA; Grubb, GS; Kovalevsky, G | 1 |
| Andreas, JO; Braun, M; Elshoff, JP; Horstmann, R; Müller, LI | 1 |
| Ahrendt, HJ; Makalová, D; Mansour, D; Mellinger, U; Parke, S | 1 |
| Apter, D; Constantine, GD; Emerich, J; Greven, K; Grubb, GS; Klasa-Mazurkiewicz, D; Melis, GB; Spaczynski, M; Spielmann, D; Teichmann, A | 1 |
| Hagberg, KW; Hernandez, RK; Jick, SS; Kaye, JA | 1 |
| Kroll, R; Margolis, M; Reape, KZ | 1 |
| Altinkaya, SO; Gulerman, C; Gungor, T; Talas, BB | 1 |
| Edelman, A; Patel, S; Stanczyk, FZ; Steiner, AZ | 1 |
| Kashanian, M; Shahpourian, F; Zare, O | 1 |
| Bokaei, M; Enjezab, B; Farajkhoda, T; Karimi Zarchi, M; Khoshbin, A | 1 |
| Langston, A | 1 |
| Carter, R; Davies, E; Fearns, S; Gerlinger, C; Kelly, S; McKinnon, C; Smithers, A | 1 |
| Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
| Höschen, K; Röhm, P; Winkler, UH | 1 |
| Cartwright, B; Robinson, J; Rymer, J | 1 |
| Weisberg, E | 1 |
| Chen, CS; Lee, AW; Matti, AI | 1 |
| Mayeda, ER; Pike, MC; Stanczyk, FZ; Torgal, AH; Westhoff, CL | 1 |
| Güner, Z; Küçük, M; Odabaşi, AR; Sezer, SD; Yüksel, H | 1 |
| Davis, MG; Hait, H; Reape, KZ | 1 |
| Cunha, EP; Fernandes, CE; Ferreira, JA; Peixoto, S; Pompei, LM; Steiner, ML; Strufaldi, R | 1 |
| Assmann, A; Dinger, J; Minh, TD; Möhner, S | 1 |
| Benn, EKT; Lerner, JP; Mayeda, ER; Paik, M; Stanczyk, FZ; Torgal, AH; Westhoff, CL | 1 |
| Bodmeier, R; Fussnegger, B; Schulz, M | 2 |
| Constantine, GD; Fortier, MP; Grubb, GS; Mirkin, S; Reid, RL; Smith, L | 1 |
| Cherala, G; Edelman, A | 1 |
| El-Nashar, SA; Sayed, GH; Shaaban, MM; Zakherah, MS | 1 |
| Bulechowsky, M; Cameron, J; Edelman, A; Jensen, JT | 1 |
| DiLiberti, CE; Hendy, CH; Margolis, MB; O'Leary, CM; Waters, DH | 1 |
| Davis, AR; Stanczyk, FZ; Westhoff, CL | 1 |
| Sanam, M; Ziba, O | 1 |
| Aiach, M; Alhenc-Gelas, M; Ali, FD; Bachelot-Loza, C; Gaussem, P; Remones, V; Scarabin, PY; Thomas, JL | 1 |
| Hindsberger, C; Jacobsen, LV; Vouis, J; Zdravkovic, M | 1 |
| Burggraaf, J; Cohen, AF; Constantine, GD; de Kam, ML; Grubb, GS; Kluft, C; Meijer, P; Rad, M | 1 |
| Cecchini, R; Gold, MA; Land, SR; Murray, PJ; Sucato, GS | 1 |
| Güner, Z; Küçük, M; Odabaşi, AR; Serter, M; Sezer, SD; Yuksel, H | 1 |
| Bressler, B; Brophy, JM; Delaney, JA; Etminan, M | 1 |
| Cleuren, AC; Postmus, I; Reitsma, PH; van Vlijmen, BJ; Vos, HL | 1 |
| Duijkers, I; Junge, W; Klipping, C; Mellinger, U; Parke, S; Serrani, M | 1 |
| Butler, K; Teng, R | 1 |
| Friedrich, C; Giessmann, T; Graefe-Mody, U; Iovino, M; Port, A; Ring, A; Woerle, HJ | 1 |
| Junge, W; Mellinger, U; Parke, S; Serrani, M | 1 |
| Chaisri, U; Chaiwong, T; Kurahashi, H; Sanford, M; Sukontason, K; Sukontason, KL | 1 |
| Belcaro, G; Cesarone, MR; Finco, A | 1 |
| Chintedze, J; Cohen, MS; Corbett, A; Hosseinipour, M; Kashuba, AD; Kumwenda, W; Malunga, G; Mkandawire, N; Moses, A; Phiri, G; Stanczyk, FZ; Stuart, GS | 1 |
| Ågren, UM; Anttila, M; Mäenpää-Liukko, K; Mommers, E; Rantala, ML; Rautiainen, H; Sommer, WF | 2 |
| Petrie, KA; Torgal, AH; Westhoff, CL | 1 |
| Carlson, NE; Edelman, A; Forbes, MM; Jensen, J; Kaneshiro, B; Nichols, M | 1 |
| Hait, HI; Reape, KZ; Westhoff, CL | 1 |
| Bergeron, R; Cohen, LS; Constantine, GD; Freeman, EW; Grubb, GS; Halbreich, U; Mirkin, S; Rapkin, AJ; Smith, L | 1 |
| Helmerhorst, FM; Lopez, LM; Raps, M; Van Vliet, HA | 1 |
| Beasley, A; Estes, C; Guerrero, J; Westhoff, C | 1 |
| Mayeda, ER; Pike, MC; Shimoni, N; Stanczyk, FZ; Torgal, AT; Westhoff, CL | 1 |
| Voelker, R | 1 |
| Archer, DF; Foegh, M; Rubin, A; Stanczyk, FZ | 3 |
| Constantine, GD; Freeman, EW; Grubb, GS; Halbreich, U; Mirkin, S; Rapkin, AJ; Skouby, SO; Smith, L | 1 |
| Berg, E; Bremme, K; Hamad, RR; Stenflo, J; Strandberg, K | 1 |
| Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Liu, X; Pepe, SR | 1 |
| Fallah, S; Korani, M; Rabbani Chadegani, A; Sanjary Pour, M | 1 |
| Divasta, AD; Feldman, HA; Giancaterino, C; Gordon, CM; Leboff, MS; Rosen, CJ | 1 |
| Cherala, G; Edelman, A; Elman, MR; Koop, D; Munar, M | 1 |
| Helmerhorst, FM; Kaptein, AA; Lopez, LM | 1 |
| Kothare, PA; Linnebjerg, H; Mace, K; Mitchell, MI; Northrup, J; Seger, ME | 1 |
| Burggraaf, J; Cohen, AF; de Kam, ML; Kluft, C; Rad, M | 1 |
| Anzures-Cabrera, J; Derks, M; Young, A | 1 |
| Chong, CL; Davis, J; Langdon, G; Layton, G; Ndongo, MN; Vourvahis, M | 1 |
| Corthout, J; De Braekeleer, K; Vanheusden, V | 1 |
| Franceschini, SA; Fumagalli, HF; Martinez, EZ; Marzocchi-Machado, CM; Stocco, B; Toloi, MR | 1 |
| Berretti, R; Concas, A; Mostallino, MC; Porcu, P; Santoru, F; Sogliano, C | 1 |
| David, OJ; den Daas, I; Emotte, C; Jakab, A; Meiser, K; Ocwieja, M; Schmouder, R; Wemer, J | 1 |
| Grob, P; Sørdal, T; Verhoeven, C | 1 |
| Basha, M; Burrows, LJ; Goldstein, AT | 1 |
| Cremers, S; Petrie, KA; Westhoff, CL | 1 |
| Cahill, L; Ferree, NK; Wheeler, M | 1 |
| Archer, DF; Foegh, M; Mishell, DR; Rubin, A; Stanczyk, FZ | 1 |
| Ferriani, RA; França, JB; Franceschini, SA; Martins, WP; Vieira, CS | 1 |
| Cherala, G; Dubois, B; Edelman, AB; Jensen, JT; McInnis, M; Munar, MY; Stanczyk, FZ | 1 |
| Cerda, A; da Silva, E; Hirata, MH; Hirata, RD; Kunz, VC; Rebelo, AC; Silva de Sá, MF; Tamburus, NY; Verlengia, R | 1 |
| Cawello, W; Rosenkranz, B; Schmid, B; Wierich, W | 1 |
| Aggarwal, A; Bernardin, J; Burnett, M; Clark, V; Davis, V; Dempster, J; Dunn, S; Fisher, W; Guilbert, É; MacKinnon, K; Pellizzari, R; Polomeno, V; Rutherford, M; Sabourin, J; Senikas, V; Wagner, MS | 1 |
| Bateson, D; Briggs, P; McNamee, K | 1 |
| Cheng, L; Gemzell-Danielsson, K; Rabe, T | 1 |
| Broedl, UC; Macha, S; Mattheus, M; Pinnetti, S; Woerle, HJ | 1 |
| Graham, CA; Panicker, S; Shawe, J; Stephenson, J | 1 |
| Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Hartzema, AG | 1 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Akintomide, H; Brima, N; Copas, A; O'Brien, P; Panicker, S; Sauer, U; Shawe, J; Stephenson, J; Wilkinson, C | 1 |
| Hahn, A; Lewis, J; Perrett, DI; Sprengelmeyer, R | 1 |
| Asadi, B; Fatehi, F; Ghorbani, A; Heidarzadeh, Z; Saadatnia, M | 1 |
| Szarewski, A | 1 |
| Macìas, G; Mellinger, U; Merki-Feld, GS; Parke, S; Serrani, M | 1 |
| Coelingh Bennink, HJ; Ebes, F; Fauser, BC; Wouters, W; Zimmerman, Y | 1 |
| Bitzer, J; Davis, SR; Giraldi, A; Mellinger, U; Nappi, RE; Palacios, S; Parke, S; Serrani, M | 1 |
| Heger-Mahn, D; Junge, W; Merz, M; Trummer, D | 1 |
| Stephenson, J | 1 |
| Mayeda, ER; Torgal, AH; Westhoff, CL | 1 |
| Cuman, RK; de Almeida, KL; de Lyra-Júnior, DP; de Oliveira Baldoni, A; do Nascimento, JD; Girotto, E; Guidoni, CM; Kos, M; Marusic, S; Obreli-Neto, PR; Pazete, AC; Pereira, LR | 1 |
| Cherala, G; Edelman, A; Maslen, C; Pearson, J | 1 |
| Rolan, P; Stockis, A | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Rubin, A; Westhoff, CL | 1 |
| Clark, JW; Coffee, AL; Hansen, DJ; Hill, AJ; Kuehl, TJ; Sulak, PJ | 1 |
| Bourg, D; Bourg, L; Harrison, LI; Karara, AH; Melikian, AP; Morrison, D; Poola, N; Zurth, C | 1 |
| Howard, B; Hsieh, J; Kaunitz, AM; Portman, DJ; Ricciotti, N; Weiss, H | 1 |
| de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
| Bond, M; Darwish, M; Fiedler-Kelly, J; Grasela, T; Hsieh, J; Ricciotti, N | 1 |
| Ichida, K; Motoyama, S; Murakoshi, H; Okada, J; Yasuda, R; Yokoyama, N; Yoshida, S | 1 |
| Galloula, A; Gautier, V; Messas, E; Minozzi, C; Mirault, T; Rossi, A | 1 |
| Mellinger, U; Parke, S; Petraglia, F; Römer, T; Serrani, M | 1 |
| Berretti, R; Concas, A; Locci, A; Porcu, P; Santoru, F | 1 |
| LaGuardia, KD | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Westhoff, CL | 3 |
| Chiovato, L; Howard, B; Nappi, RE; Paoletti, AM; Ricciotti, N; Volpe, A; Weiss, H | 1 |
| Furuta, T; Kume, M; Kuroiwa, M; Shibasaki, H; Tsuboyama, S; Uchikura, S; Yokokawa, A | 1 |
| Bekhradi, R; Mohammad-Alizadeh-Charandabi, S; Mohebbi-Kian, E | 1 |
| Cherala, G; Edelman, AB; Jensen, JT; McInnis, M; Munar, MY; Stanczyk, FZ | 1 |
| Biswal, S; Derne, C; Golla, G; Legangneux, E; Muhsen, N; Veldandi, UK | 1 |
| Benjamin, E; Conway, GS; McGregor, D; Olaitan, A; Saridogan, E; Swamy, A | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR | 1 |
| Dienel, A; Heger-Mahn, D; Klipping, C; Pabst, G; Schläfke, S | 1 |
| Bernard, A; Devineni, D; Mamidi, RN; Manitpisitkul, P; Rothenberg, P; Sha, S; Skee, D; Stieltjes, H; Tian, H; Vaccaro, N; Weiner, S | 1 |
| Elgadi, M; Huang, F; Lang, B; Sabo, JP | 1 |
| Bangerter, K; Kroll, R; Lynen, R; Merz, M | 1 |
| Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
| Flint, A; Hartvig, H; Jensen, CB; Jensen, L; Kapitza, C; Nosek, L | 1 |
| Cremers, S; DiNapoli, MN; Pike, MC; Sull, M; Tang, R; Westhoff, CL | 1 |
| Howard, B; Kroll, R; Ricciotti, N; Seidman, L; Weiss, H | 1 |
| Butler, K; Dietz Ostergaard, S; Johnson, R; Kersh, EN; Lathrop, G; McNicholl, JM; Powell, N; Ritter, JM; Sanders, J; Zaki, SR | 1 |
| El-Haggar, SM; Mostafa, TM | 1 |
| Coriat, R; Loulergue, P; Mir, O | 1 |
| Collomp, K; Jaffré, C; Lasne, F; Rieth, N; Vibarel-Rebot, N | 1 |
| de Sá, MFS; Franceschini, SA; Fumagalli, HF; Martinez, EZ; Marzocchi-Machado, CM; Stocco, B; Toloi, MRT | 1 |
| Berg, C; Fick, J; Jansson, E; Säfholm, M | 1 |
| Bhansali, S; Chen, J; Majumdar, T; Meyers, C; Neelakantham, S; Rebello, S; Sunkara, G; Trusley, C | 1 |
| Howard, B; Hsieh, J; Kroll, R; Ricciotti, N; Seidman, L; Weiss, H | 1 |
| Nelson, AL | 2 |
| Chakraborty, A; Jakab, A; Legangneux, E; Mensinga, T; Neelakantham, S; Rouzade-Dominguez, ML; Sivasubramanian, R; Ufer, M; Woessner, R | 1 |
| Chabbert-Buffet, N; Jamin, C; Lello, S; Lete, I; Lobo, P; Nappi, RE; Pintiaux, A | 1 |
| Burness, CB | 1 |
| Ding, L; Geng, T; Liu, X; Sun, C; Wu, Y; Xin, X | 1 |
| Giljanovic, S; Howard, B; Lobo Abascal, P; Luzar-Stiffler, V; Trussell, J; Weiss, H | 1 |
| Archer, DF; Sriprasert, I; Stanczyk, FZ | 1 |
| Coelingh Bennink, HJ; Foidart, JM; Klipping, C; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
| Bannbers, E; Engman, J; Frick, A; Gingnell, M; Moby, L; Sundström-Poromaa, I; Wikström, J | 1 |
| Bhatti, DL; Bogue, EA; Day, LE; Farr, NA; Grossman, AM; Holmes, PV; Simone, J | 1 |
| Appels, N; Coelingh Bennink, HJ; Duijkers, IJ; Foidart, JM; Jost, M; Klipping, C; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
| Kowalska, B; Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Cremers, S; Eisenberger, A; Grossman, LV; Pike, MC; Tang, R; Westhoff, CL | 1 |
| Beresford, N; Kugathas, S; Margiotta-Casaluci, L; Runnalls, TJ; Scholze, M; Scott, AP; Sumpter, JP | 1 |
| King, OC; Leusch, FD; McDonald, JA; van de Merwe, JP | 1 |
| Dinger, J; Heinemann, K; Möhner, S | 1 |
| Leung, VW; Levine, M; Lynd, LD; Marra, CA; Soon, JA | 1 |
| Mbonile, L | 1 |
| Akahori, M; Dahlke, M; Gan, L; Jiang, X; Langenickel, T; Mendonza, A; Neelakantham, S; Nguyen, J; Pal, P; Rajman, I; Rebello, S; Reynolds, C; Sunkara, G; Swan, T; Zhou, W | 1 |
| Alvey, CW; Krishnaswami, S; Menon, S; Petit, W; Riese, R; Shi, H; Wang, R | 1 |
| Dahiya, K; Dahiya, P; Dalal, M; Jain, S; Silan, V; Yadav, A | 1 |
| Gersten, J; Hsieh, J; Ricciotti, NA; Weiss, H | 1 |
| Ganie, MA; Mattoo, T; Mudassar, S; Rashid, F; Shekhar, C; Yousuf, SD; Zargar, MA | 1 |
| Albert, A; Appels, N; Coelingh Bennink, HJT; Fauser, BCJM; Laan, E; Termeer, HMM; Thijssen, JHH; van Lunsen, RHW; Zimmerman, Y | 1 |
| Jusko, WJ | 2 |
| Aït-Aïssa, S; Bourgine, G; Brion, F; Garoche, C; Hinfray, N; Kah, O; Pakdel, F; Piccini, B; Tebby, C | 1 |
| Borgatta, L; Buhling, KJ; Rosen, K; Roth, K; Rybowski, S | 1 |
| Blomberg, L; Dreber, A; Hirschberg, AL; Johannesson, M; Labrie, F; Ranehill, E; von Schoultz, B; Zethraeus, N | 1 |
| Goel, N; Priya, K; Rajaram, S | 1 |
| Basaraba, CN; Cremers, S; Nandakumar, R; Pike, MC; Westhoff, CL | 1 |
| Buchanan, AM; Ford, SL; Gould, E; Huang, C; Lou, Y; Patel, P; Ritter, JM; Spreen, W; Trezza, C | 1 |
| Cremers, S; Eisenberger, A; Pike, MC; Rosing, J; Thomassen, S; Westhoff, CL | 1 |
| Butterton, JR; Caro, L; Feng, HP; Guo, Z; Huang, X; Ma, J; Mangin, E; Marshall, WL; O'Reilly, TE; Panebianco, D; Talaty, J; Yeh, WW | 1 |
| Aleknaviciute, J; Bergink, V; Bouwkamp, CG; De Rijke, YB; Hoogendijk, WJG; Kooiman, CG; Kushner, SA; Tiemeier, H; Timmermans, M; Tulen, JHM; van der Kroeg, M; van Rossum, EFC; Wester, VL | 1 |
| Adeyanju, OA; Areola, ED; Michael, OS; Olatunji, LA; Soladoye, AO | 1 |
| Abolarinwa, BA; Achile, CJ; Kim, IK; Olaniyi, KS; Olatunji, LA; Usman, TO | 1 |
| de Zegher, F; Del Río, L; Díaz, M; Ibáñez, L; López-Bermejo, A; Pozo, ÓJ; Sebastiani, G | 1 |
| Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
| Aguilera, J; Carrascosa, JM; Castillo, G; Ferrándiz, C; Fuente, MJ; Richarz, NA | 1 |
| Michael, OS; Olatunji, LA | 1 |
| Araujo Castro, M; Campos Del Portillo, R; Izquierdo Álvarez, C; Oliván Palacios, B; Prieto Coca, L | 1 |
| Buggio, L; Frattaruolo, MP; Ottolini, F; Roberto, A; Somigliana, E; Vercellini, P | 1 |
| Adeyanju, OA; Olatunji, LA; Soetan, OA; Soladoye, AO | 1 |
| Barra, F; Ferrero, S; Leone Roberti Maggiore, U; Scala, C; Venturini, PL | 1 |
| Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
| Pike, MC; Westhoff, CL | 2 |
| Bosinger, SE; Butler, K; Dietz Ostergaard, S; Ellis, S; Johnson, RL; Kersh, EN; McNicholl, JM; Patel, NB; Payne, TL; Tharp, GK; Vishwanathan, SA; Zhao, C | 1 |
| Edelman, AB; Hennebold, JD; Jensen, JT; McCrimmon, S; Messerle-Forbes, M; O'Donnell, A | 1 |
| Bar-Ilan, O; Dror, V; Elgart, A; Korver, T; Mimrod, D; Spiegelstein, O; Zur, AA | 1 |
| Olaniyi, KS; Olatunji, LA | 2 |
| Michael, OS; Olatunji, LA; Omolekulo, TE | 1 |
| Avram, S; Coricovac, D; Dehelean, CA; Dumitru, C; Farcas, C; Navolan, D; Nica, C; Pinzaru, I; Popovici, RA; Proks, M; Simu, S; Soica, C; Stoian, D | 1 |
| Feng, T; Friedman, A; Mohamed, MF; Othman, AA; Trueman, S | 1 |
| Bujanda, L; Cosme Jimenez, Á; Gonzalez Canalizo, V; Medina Del Valle, A; Ortega Rezola, P; Sarasqueta Eizaguirre, C; Segues Merino, NM; Torrente Iranzo, S; Wong Arteta, J | 1 |
| Edelman, AB; Jusko, WJ; Luo, D; Natavio, M; Stanczyk, FZ; Westhoff, CL | 1 |
| Badmus, OO; Olatunji, LA | 1 |
| Bang, UC; Ries, A; Stannov, SU | 1 |
| Shenava, Y; Thwaites, A | 1 |
| DiVasta, AD; Feldman, HA; Gordon, CM; Leonard, MB; Long, J; O'Donnell, JM | 1 |
| Amin, S; Bhat, IA; Fatima, Q; Ganie, MA; Jeelani, H; Kawa, IA; Manzoor, S; Rashid, F; Shah, ZA; Yousuf, SD | 1 |
| Campos, JM; Queiroz, SCN; Roston, DM | 1 |
| Adeyanju, OA; Olatunji, LA | 1 |
| Grimmbacher, S; Hadji, P; Neulen, J; Schaudig, K; Schwenkhagen, A; Wiegratz, I | 1 |
| Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F | 1 |
| Gossell-Williams, M; Ramnath, R | 1 |
| Llombart, B; Requena, C | 1 |
| Anoka, NA; Lawrence, OA; Olufunmilayo, OM; Olufunto, BO | 1 |
| Christmann, R; Naik, H; Tidemann-Miller, B; Versavel, M; Zhao, Y | 1 |
| Etminan, M; Guo, MY; Khosrow-Khavar, F; Sodhi, M | 1 |
| Cordoba, R; de Jong, J; Dlugosz-Danecka, M; Hellemans, P; Jiao, J; Jurczak, W; Mitselos, A; Ouellet, D; Panizo, C; Sukbuntherng, J; Wrobel, T | 1 |
| Ampaw, L; Anderson, K; Begley, R; Kearney, BP; Mathias, A; Qin, A; Watkins, TR; Weng, W | 1 |
| Chaturvedula, A; Cicali, B; Cristofoletti, R; Hoechel, J; Lingineni, K; Schmidt, S; Vozmediano, V; Wendl, T; Wiesinger, H | 1 |
| Bastidas, A; Duijkers, I; Foidart, JM; Jost, M; Klipping, C; Maillard, C; Mawet, M | 1 |
| Cercato, C; de Melo, ME; Mancini, MC; Moreira de Brito, C; Santo, MA | 1 |
| Nguyen, NY | 1 |
| Creinin, MD | 1 |
| Albayaty, M; Anderson, TW; Breitschaft, A; Bækdal, TA; Christiansen, E; Houshmand-Øregaard, A; Jordy, AB; Manigandan, E | 1 |
| Etminan, M; Ganjizadeh-Zavareh, S; Khosrow-Khavar, F; Sodhi, M | 1 |
| Coricovac, D; Dehelean, CA; Dobrescu, A; Draghici, GA; Malita, D; Marcovici, I; Navolan, D; Olaru, F; Simu, S | 1 |
| Centkowski, P; Edwards, S; Górnaś, M; Grechko, N; Habeck, J; Jasiówka, M; Jeziorski, KG; Láng, I; Lee, J; Liao, M; Nash, E; Ramlau, R; Skarbová, V; Tomaszewska-Kiecana, M; Xiao, JJ | 1 |
| Butcher, L; Greene, TJ; Halliday, F; Johnson, M; Joshi, SR; Lataillade, M; Min, S; Pene Dumitrescu, T; Pham, TT; Webster, L; Xu, J; Zimmerman, E | 1 |
| Bauerfeind, A; Becker, K; DiBello, J; Franke, C; Heinemann, K; Koro, C; Reed, S | 1 |
| Avis, M; Gahlemann, M; Guillén-Del-Castillo, A; Kreuter, M; Mack, SR; Marzin, K; Vonk, MC; Wind, S | 1 |
| Burchardt, NA; Eliassen, AH; Fortner, RT; Kaaks, R; Rosner, B; Shafrir, AL; Tamimi, RM; Tworoger, SS | 1 |
| Ankrom, W; Brimhall, D; Fillgrove, KL; Gravesande, KN; Iwamoto, MN; Jackson Rudd, D; Matthews, RP; Stoch, SA; Zhang, S | 1 |
| Cherala, G; Guo, Y; Mathur, A; Nelson, C; Othman, AA; Tarnowski, T | 1 |
| Cagnacci, A; Chabbert-Buffet, N; Douxfils, J; Foidart, JM; Gemzell-Danielsson, K; Kubba, A; Lete Lasa, LI; Mansour, D; Neulen, J; Neves, J; Palma, F; Römer, T; Spaczyński, R; Tóth, V | 1 |
| Haverinen, AH; Heikinheimo, O; Hiltunen, L; Kangasniemi, MH; Lassila, R; Luiro, KM; Piltonen, TT; Sainio, S; Szanto, T; Tapanainen, JS | 1 |
| Arffman, RK; Haverinen, A; Heikinheimo, O; Hustad, S; Kangasniemi, MH; Luiro, K; Piltonen, TT; Tapanainen, JS | 1 |
| Dogné, JM; Douxfils, J; Foidart, JM; Gaspard, U; Jost, M; Morimont, L | 1 |
| Evans, KL; Fleury, C; Hampson, E; Morley, EE | 1 |
| Boulos, V; Brake, WG; Fisher, C; Hamilton, S; Heron, M; Lacasse, JM; Mac Cionnaith, CE; Peronace, V; Tito, N | 1 |
| Arffman, RK; Haverinen, A; Heikinheimo, O; Joenväärä, S; Kangasniemi, MH; Luiro, K; Piltonen, TT; Renkonen, R; Tapanainen, JS; Tohmola, T | 1 |
| Charfi, H; Dingemanse, J; Juif, PE; Mueller, MS | 1 |
| Archer, DF; Korner, P; Lohmer, LRL; Pirone, J; Previtera, M; Stanczyk, FZ | 1 |
| Calixto, LA; da Silva, FA; Lourenço, FR | 1 |
45 review(s) available for ethinyl estradiol and levonorgestrel
| Article | Year |
|---|---|
Pharmacology of contraceptive steroids: a brief review.
Topics: Biological Availability; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Humans; Levonorgestrel; Norethindrone; Norgestrel | 1989 |
[What does the micropill bring?].
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Ovary; Progesterone Congeners; Risk | 1986 |
Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months.
Topics: Adolescent; Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel; Prospective Studies | 1988 |
Emergency contraception: a review.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Emergencies; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone | 1994 |
Consensus statement on emergency contraception.
Topics: Contraceptives, Oral; Contraceptives, Postcoital; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Italy; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; World Health Organization | 1995 |
Emergency postcoital contraception.
Topics: Contraception; Contraceptives, Postcoital; Danazol; Embryo Implantation; Emergencies; Ethinyl Estradiol; Female; Fertilization; Humans; Intrauterine Devices; Levonorgestrel; Ovulation; Pregnancy; Pregnancy, Unwanted | 1997 |
Research on mifepristone and levonorgestrel in comparison with the Yuzpe regimen.
Topics: Abortifacient Agents, Steroidal; Clinical Trials as Topic; Contraceptives, Postcoital; Drug Therapy, Combination; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Mifepristone; Norgestrel; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; World Health Organization | 1998 |
Alesse: leading the shift to 20 microg.
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel | 1999 |
[New forms of hormonal contraception].
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnenes; Vinyl Compounds | 2000 |
[Contraception].
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds | 2000 |
Emergency postcoital contraception.
Topics: Abortifacient Agents; Adolescent; Adult; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Decision Making; Drug Administration Schedule; Drug Therapy, Combination; Emergency Treatment; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation-Inducing Agents; Mifepristone; Time Factors | 2000 |
Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature.
Topics: Animals; Contraceptives, Postcoital; Estrogens; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Levonorgestrel; Mifepristone; Pregnancy; Progestins | 2001 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Pregnancy; Randomized Controlled Trials as Topic | 2001 |
Emergency contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Health Services Accessibility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Risk Factors; Therapeutic Equivalency | 2002 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Progesterone Congeners; Randomized Controlled Trials as Topic | 2002 |
Release of progestin-only emergency contraception.
Topics: Contraception; Contraceptive Agents, Female; Drug Therapy, Combination; Ethinyl Estradiol; Female; Fertilization; Health Services Accessibility; Humans; Levonorgestrel; Nonprescription Drugs; Ovulation; Pregnancy | 2001 |
Bleeding problems and progestogen-only contraception.
Topics: Administration, Oral; Contraceptive Agents, Female; Counseling; Desogestrel; Drug Implants; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Levonorgestrel; Menstruation Disturbances; Progesterone Congeners | 2002 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Randomized Controlled Trials as Topic | 2003 |
Mechanisms of action of emergency contraception.
Topics: Animals; Contraception; Contraceptives, Postcoital; Embryo, Mammalian; Endometrium; Ethinyl Estradiol; Female; Fertilization; Haplorhini; Humans; Levonorgestrel; Male; Pregnancy; Rats; Sperm Motility; Spermatozoa; Steroids; Time Factors | 2003 |
Low-dose ethinylestradiol/levonorgestrel.
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 2005 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norethindrone; Randomized Controlled Trials as Topic | 2006 |
Triphasic versus monophasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norethindrone; Patient Compliance; Randomized Controlled Trials as Topic | 2006 |
Advances in hormonal contraception.
Topics: Administration, Cutaneous; Administration, Intravaginal; Contraceptive Agents, Female; Contraceptives, Postcoital; Delayed-Action Preparations; Drug Combinations; Ethinyl Estradiol; Female; Humans; Injections, Subcutaneous; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel | 2006 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
Continuous-use ethinylestradiol/levonorgestrel 20microg/90microg: as an oral contraceptive.
Topics: Amenorrhea; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 2007 |
Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms.
Topics: Animals; Chemistry, Pharmaceutical; Contraceptive Agents, Female; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Metrorrhagia | 2008 |
Continuous oral contraception. Strategies for managing breakthrough bleeding.
Topics: Aftercare; Contraceptives, Oral, Combined; Counseling; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Metrorrhagia; Nurse Practitioners; Patient Education as Topic; Primary Health Care | 2008 |
[Escapelle - a method of choice for emergency contraception ].
Topics: Clinical Trials as Topic; Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle | 2008 |
Emergency contraception: update and review.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Patient Education as Topic; Pregnancy; United States | 2010 |
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Triphasic versus monophasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norethindrone; Patient Compliance; Randomized Controlled Trials as Topic | 2011 |
Quadriphasic versus monophasic oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medication Adherence; Menstruation; Nandrolone; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2011 |
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.
Topics: Antidepressive Agents; Clinical Trials as Topic; Contraceptives, Oral, Combined; Depressive Disorder; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Placebo Effect; Premenstrual Syndrome | 2012 |
Oral contraceptives containing drospirenone for premenstrual syndrome.
Topics: Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Premenstrual Syndrome; Randomized Controlled Trials as Topic | 2012 |
The effects of hormonal contraceptives on female sexuality: a review.
Topics: Acne Vulgaris; Cervix Mucus; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; History, 20th Century; Humans; Levonorgestrel; Libido; Medroxyprogesterone Acetate; Progesterone Congeners; Sex Hormone-Binding Globulin; Sexuality; Vulva; Vulvodynia | 2012 |
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
[Portal vein thrombosis associated with an acute cytomegalovirus infection].
Topics: Acute Disease; Anticoagulants; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cytomegalovirus Infections; Ethinyl Estradiol; Female; Heparin, Low-Molecular-Weight; Hepatitis, Viral, Human; Humans; Levonorgestrel; Portal Vein; Venous Thrombosis; Warfarin; Young Adult | 2014 |
Transdermal contraception methods: today's patches and new options on the horizon.
Topics: Administration, Cutaneous; Animals; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 2015 |
Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Topics: Androstenes; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Megestrol; Nandrolone; Venous Thromboembolism | 2015 |
Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique(®)): A Review of Its Use as an Oral Contraceptive.
Topics: Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Humans; Levonorgestrel; Menstrual Cycle | 2015 |
Perspectives on variability in pharmacokinetics of an oral contraceptive product.
Topics: Area Under Curve; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Observer Variation; Sex Hormone-Binding Globulin | 2017 |
Clarification of contraceptive drug pharmacokinetics in obesity.
Topics: Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity | 2017 |
Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment.
Topics: Clinical Studies as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Humans; Levonorgestrel; Obesity | 2019 |
Oral Contraceptives in Dermatology.
Topics: Contraceptives, Oral; Dermatology; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Progesterone | 2020 |
A novel estetrol-containing combined oral contraceptive: European expert panel review.
Topics: Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Hemostatics; Humans; Levonorgestrel; Lipids; Progestins | 2022 |
324 trial(s) available for ethinyl estradiol and levonorgestrel
| Article | Year |
|---|---|
The effect of cyclical administration of levonorgestrel and ethinyloestradiol on blood pressure, body mass, blood glucose and serum triglycerides.
Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Time Factors; Triglycerides | 1979 |
Clinical and biochemical investigations of a variable-dose combined type oral contraceptive.
Topics: Blood Proteins; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hormones; Humans; Levonorgestrel; Lipids | 1977 |
Lipid and biochemical changes after low-dose oral contraception.
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Pressure; Blood Proteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Hematocrit; Hemoglobins; Humans; Intrauterine Devices; Levonorgestrel; Norethindrone; Parity; Time Factors; Triglycerides | 1992 |
Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations.
Topics: Adult; Analysis of Variance; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Premenstrual Syndrome | 1992 |
Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Danazol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Middle Aged; Mifepristone; Nausea; Pregnancy; Treatment Outcome; Vomiting | 1992 |
Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
Topics: Adult; Computer Simulation; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Liver; Pregnadienes; Serum Albumin; Sex Hormone-Binding Globulin; Time Factors | 1992 |
Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Estrogens; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Gonadal Steroid Hormones; Humans; Levonorgestrel; Lipoproteins; Menstrual Cycle; Menstruation; Norprogesterones; Progesterone; Radioimmunoassay | 1992 |
Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipase; Lipoproteins; Liver; Norpregnenes; Progesterone Congeners; Sex Hormone-Binding Globulin; Triglycerides | 1992 |
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Topics: Adult; Apolipoproteins; Blood Glucose; Ceruloplasmin; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Pancuronium; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1992 |
Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
Topics: Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Progestins; Radioimmunoassay; Sex Hormone-Binding Globulin; Time Factors; Vaginal Creams, Foams, and Jellies | 1992 |
A multicentre study of coagulation and haemostatic variables during oral contraception: variations with geographical location and ethnicity. Task Force on Oral Contraceptives--WHO Special Programme of Research, Development and Research Training in Human R
Topics: Adult; Blood Coagulation; Brazil; Chile; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Ethnicity; Female; Fibrinolysis; Hemostasis; Humans; Ireland; Levonorgestrel; Norethindrone; Norethindrone Acetate; Singapore | 1991 |
A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
Topics: Adult; Analysis of Variance; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation | 1991 |
The effect of follicular growth and luteal function of "missing the pill". A comparison between a monophasic and a triphasic combined oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Corpus Luteum; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Norgestrel; Norpregnenes; Ovarian Follicle; Ovary; Time Factors | 1991 |
Intrasubject variability in the pharmacokinetics of ethynyloestradiol.
Topics: Adult; Biological Availability; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Middle Aged; Norgestrel | 1991 |
The lack of interaction between temafloxacin and combined oral contraceptive steroids.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Fluoroquinolones; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Progesterone; Quinolones; Radioimmunoassay | 1991 |
Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Tablets | 1990 |
Metabolic changes during treatment with two different progestogens.
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Fertilization; Hormones; Humans; Levonorgestrel; Lipid Mobilization; Lipids; Menstrual Cycle; Norgestrel; Norpregnenes; Random Allocation; Reference Values | 1990 |
Multicentred clinical study of the metabolic effect of the monthly injectable contraceptive containing dihydroxyprogesterone acetophenide 150 mg + estradiol enanthate 10 mg.
Topics: Adult; Algestone; Algestone Acetophenide; Analysis of Variance; Ceruloplasmin; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Copper; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Injections; Levonorgestrel; Multicenter Studies as Topic; Norethindrone; Norgestrel; Sex Hormone-Binding Globulin; Testosterone; Transcortin; Triglycerides; White People | 1990 |
Clinical assessment of treatments for prolonged bleeding in users of Norplant implants.
Topics: Administration, Oral; Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral; Drug Implants; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Humans; Ibuprofen; Levonorgestrel; Menstruation; Norgestrel | 1990 |
A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
Topics: Adolescent; Adult; Analysis of Variance; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipoproteins; Norgestrel; Triglycerides | 1990 |
Low-dose oral contraceptives lower plasma levels of apolipoprotein E.
Topics: Adolescent; Adult; Apolipoproteins A; Apolipoproteins B; Apolipoproteins E; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Norpregnenes; Triglycerides | 1990 |
The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Topics: Adult; Contraceptive Agents, Female; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemia; Kenya; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel | 1990 |
Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Norpregnenes; Pituitary Gland; Prolactin; Sex Hormone-Binding Globulin; Testosterone | 1986 |
A comparative analysis of three different dose combinations of oral contraceptives.
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Nausea; Norethindrone; Norgestrel; Patient Compliance; Philippines; Pregnancy | 1989 |
The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: 1. Comparisons with IUD. Task Force on Oral Contraceptives. WHO Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hypertension; Intrauterine Devices; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Prospective Studies; Random Allocation; Time Factors; World Health Organization | 1989 |
The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: 2. Lack of effect of estrogen. Task Force on Oral Contraceptives. WHO Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Time Factors; World Health Organization | 1989 |
Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis.
Topics: Adult; Blood Coagulation; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 1989 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects. Report from a seven-centred study. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task force o
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Proteins; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Random Allocation; Serum Albumin; Triglycerides | 1985 |
Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
Clinical and metabolic effects of gestodene and levonorgestrel.
Topics: Adolescent; Adult; Blood Glucose; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Longitudinal Studies; Menstrual Cycle; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Stereoisomerism | 1987 |
Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Multicenter Studies as Topic; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Random Allocation; Testosterone | 1985 |
A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
Topics: Adult; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phospholipids; Random Allocation; Triglycerides | 1985 |
An investigation on the influence of steroidal contraceptives on milk lipid and fatty acids in Hungary and Thailand. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on oral contraceptives.
Topics: Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Double-Blind Method; Ethinyl Estradiol; Fatty Acids; Fatty Acids, Essential; Female; Humans; Hungary; Injections; Levonorgestrel; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Thailand | 1986 |
Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1986 |
Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Topics: Adolescent; Adult; Arteriosclerosis; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation | 1987 |
Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins.
Topics: Adult; Apolipoproteins; Cholesterol, HDL; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Norpregnenes; Prospective Studies | 1988 |
Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medical Records; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Norgestrel; Ovulation Detection; Research Design | 1988 |
The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy.
Topics: Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Ileostomy; Kinetics; Levonorgestrel; Norgestrel; Time Factors | 1986 |
The effect of the contraceptive pill on blood pressure: a randomized controlled trial of three progestogen-oestrogen combinations in Szeged, Hungary.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Structure-Activity Relationship; Time Factors | 1986 |
Impact of hormonal contraceptives vis-à-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task For
Topics: Adolescent; Adult; Avitaminosis; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Lactation; Levonorgestrel; Medroxyprogesterone; Norgestrel; Pregnancy; Social Class; Vitamins | 1986 |
Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Kinetics; Levonorgestrel; Norethindrone; Norgestrel; Random Allocation | 1986 |
The relative bioavailability of levonorgestrel and ethinyl estradiol administered as a low-dose combination oral contraceptive.
Topics: Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel | 1986 |
[Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel | 1987 |
ICMR Task Force Study on hormonal contraception. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Infant; Lactation; Levonorgestrel; Milk, Human; Norethindrone; Norgestrel; Pregnancy | 1987 |
The relative bioavailability of levonorgestrel and ethinylestradiol when administered in tablet and capsule form.
Topics: Adolescent; Adult; Biological Availability; Capsules; Clinical Trials as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Random Allocation; Tablets | 1987 |
Comparative pharmacokinetics of levonorgestrel and ethinyloestradiol following intravenous, oral and vaginal administration.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Biological Availability; Ethinyl Estradiol; Female; Half-Life; Humans; Injections, Intravenous; Levonorgestrel; Norgestrel | 1987 |
Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Time Factors; Triglycerides | 1985 |
Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1985 |
Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Progesterone Congeners; Sex Hormone-Binding Globulin; Stereoisomerism; Testosterone | 1984 |
Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins.
Topics: Adult; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes | 1982 |
Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers.
Topics: Adolescent; Adult; Body Weight; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phosphatidylcholines; Triglycerides | 1982 |
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
Topics: Adolescent; Adult; Blood Proteins; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Denmark; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Norway; Pregnancy; Sex Hormone-Binding Globulin; Sweden; Transcortin | 1982 |
The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Random Allocation | 1984 |
Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glycoproteins; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism; Triglycerides | 1984 |
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Child Development; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hungary; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Pregnancy; Thailand | 1984 |
Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Endometrium; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Levonorgestrel; Norgestrel; Ovary; Progesterone | 1983 |
The 150/30 formulation. Experience in the United Kingdom.
Topics: Adult; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Risk; Smoking; Stereoisomerism; United Kingdom | 1983 |
Clinical experience with a low-dose contraceptive agent. European studies.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy; Stereoisomerism | 1983 |
Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Digestive System; Dysmenorrhea; Ethinyl Estradiol; Female; Headache; Humans; Latin America; Levonorgestrel; Norgestrel; Pregnancy; Stereoisomerism | 1983 |
Fertility regulation in nursing women: III. Short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth.
Topics: Adult; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth.
Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
The influence of oral contraceptives on activated factor X inhibitor (XaI)-activity: a prospective study.
Topics: Adult; Antithrombin III; Contraceptives, Oral, Combined; Ethinyl Estradiol; Factor X; Factor Xa; Female; Humans; Levonorgestrel; Norgestrel; Prospective Studies | 1983 |
Effects of oral contraceptives on lipoprotein lipids: a prospective study.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Mestranol; Norgestrel; Triglycerides | 1984 |
Clinical experience with a triphasic oral contraceptive.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Uterine Hemorrhage | 1984 |
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Prospective Studies; Stereoisomerism | 1984 |
Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Topics: Adolescent; Adult; Alkaline Phosphatase; Angiotensin II; Antithrombin III; Aspartate Aminotransferases; Bilirubin; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Thromboembolism; Transcortin; Triglycerides | 1980 |
A randomized study of metabolic effects of four low-estrogen oral contraceptives: I. Results after 6 cycles.
Topics: Adult; Blood Proteins; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Lipids; Norethindrone; Norgestrel; Random Allocation; Stereoisomerism | 1981 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II-Subjective and objective measures of effects. An international comparative trial.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hemoglobins; Humans; Levonorgestrel; Norgestrel; Pregnancy; Vagina | 1981 |
A randomized, double-blind study of six combined oral contraceptives.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstruation; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Random Allocation | 1982 |
A randomized, double-blind study of two combined and two progestogen-only oral contraceptives.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstruation; Mestranol; Norethindrone; Norgestrel; Pregnancy; Random Allocation | 1982 |
Randomized prospective studies on metabolic effects of oral contraceptives.
Topics: Adult; Blood Coagulation Factors; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Levonorgestrel; Lipids; Norgestrel; Prospective Studies; Random Allocation; Renin-Angiotensin System | 1982 |
Progestogen effects and their relationship to lipoprotein changes. A report from the Oral Contraception Study of the Royal College of General Practitioners.
Topics: Breast Neoplasms; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Lipoproteins; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Prospective Studies; Thrombosis | 1982 |
Effects of the estrogenicity of levonorgestrel/ethinylestradiol combinations of the lipoprotein status.
Topics: Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Phospholipids; Random Allocation; Sex Hormone-Binding Globulin; Triglycerides | 1982 |
Does progestogen reduction in oral contraception parallel reduced lipid metabolic effects?
Topics: Adolescent; Adult; Cholesterol; Cholesterol Esters; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lynestrenol; Norgestrel; Progestins; Triglycerides | 1982 |
An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Topics: Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Indoles; Levonorgestrel; Oxindoles | 1995 |
Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route.
Topics: Administration, Intravaginal; Adolescent; Adult; Brazil; China; Contraceptive Agents, Female; Dosage Forms; Dose-Response Relationship, Drug; Drug Combinations; Egypt; Erythrocyte Count; Estradiol Congeners; Ethinyl Estradiol; Female; Hematocrit; Hemoglobins; Humans; International Cooperation; Levonorgestrel; Time Factors | 1995 |
[Regression of functional cysts: high dosage ovulation inhibitor and gestagen therapy has no added effect].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lynestrenol; Ovarian Cysts; Ovary; Progesterone Congeners; Prospective Studies; Remission, Spontaneous; Retrospective Studies; Treatment Outcome | 1995 |
Urinary excretion of 6 beta-hydroxycortisol in women during treatment with different oral contraceptive formulations.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Norpregnenes | 1995 |
Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels i
Topics: Administration, Oral; Adolescent; Adult; Blood Proteins; Computer Simulation; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein Binding; Radioimmunoassay; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1994 |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2 | 1995 |
Lansoprazole does not affect the bioavailability of oral contraceptives.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Biological Availability; Chromatography, High Pressure Liquid; Contraceptives, Oral; Cross-Over Studies; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Glucaric Acid; Humans; Hydrocortisone; Lansoprazole; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Omeprazole; Progesterone; Proton Pump Inhibitors; Sex Hormone-Binding Globulin; Therapeutic Equivalency | 1994 |
Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women.
Topics: Adolescent; Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel | 1994 |
Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives on serum lipids.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norethindrone; Reference Values; Single-Blind Method | 1993 |
A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
Topics: Adolescent; Adult; Chile; Contraceptives, Oral, Combined; Dominican Republic; Ecuador; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Sri Lanka; Sudan | 1993 |
Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Topics: Administration, Intravaginal; Adolescent; Adult; Desogestrel; Developing Countries; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Patient Acceptance of Health Care; Pregnancy; Random Allocation; Vagina | 1993 |
A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception.
Topics: Adolescent; Adult; Contraceptives, Postcoital; Drug Combinations; Ethinyl Estradiol; Female; Hong Kong; Humans; Levonorgestrel; Norgestrel; Pregnancy; Prospective Studies | 1993 |
Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norethindrone; Norpregnenes; Prospective Studies; Time Factors | 1993 |
The effects of two phasic oral contraceptives on hemostasis and platelet function.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Levonorgestrel | 1995 |
Hormonal treatment for bleeding irregularities in Norplant implant users.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Prospective Studies; Uterine Hemorrhage | 1996 |
Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Ovary; Progesterone; Progesterone Congeners; Ultrasonography | 1995 |
[Estrogenic effects after 14-days administration of 0.06 mg ethinyl estradiol in postmenopausal women].
Topics: Aged; Blood Flow Velocity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Endometrium; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Levonorgestrel; Middle Aged; Pulsatile Flow; Reference Values; Regional Blood Flow; Ultrasonography; Uterus; Vaginal Smears; Vascular Resistance | 1996 |
Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle.
Topics: Administration, Oral; Contraceptives, Postcoital, Hormonal; Contraceptives, Postcoital, Synthetic; Danazol; Drug Combinations; Endometrium; Estrone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstruation; Pregnancy; Pregnanediol | 1996 |
Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Ovarian Follicle; Ovulation; Progesterone; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone; Transcortin; Ultrasonography | 1996 |
Management of irregular uterine bleeding and spotting associated with Norplant.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Ibuprofen; Incidence; Levonorgestrel; Pilot Projects; Prospective Studies; Uterine Hemorrhage | 1996 |
Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Topics: Adult; Biopsy; Cohort Studies; Contraceptive Agents, Female; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Uterine Hemorrhage | 1996 |
Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Estradiol Congeners; Ethinyl Estradiol; Female; Glucaric Acid; Humans; Hydrocortisone; Lansoprazole; Levonorgestrel; Omeprazole; Placebos; Progesterone Congeners | 1997 |
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Headache; Humans; Incidence; Levonorgestrel; Life Tables; Menstruation; Metrorrhagia; Middle Aged; Patient Compliance; Patient Dropouts; Pregnancy; Pregnancy Rate; Safety; Uterine Cervical Neoplasms; Uterine Hemorrhage | 1997 |
A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers.
Topics: Adult; Anticonvulsants; Antipyrine; Aryl Hydrocarbon Hydroxylases; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Interactions; Enzyme Induction; Estradiol Congeners; Ethinyl Estradiol; Female; gamma-Aminobutyric Acid; gamma-Glutamyltransferase; Half-Life; Humans; Levonorgestrel; Microsomes, Liver; Oxidoreductases, N-Demethylating; Placebos; Vigabatrin | 1997 |
The cardiovascular safety of triphasic contraceptive steroids.
Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoprotein(a); Nitric Oxide; P-Selectin; Progesterone Congeners | 1997 |
Short-term treatment with levonorgestrel does not antagonize the ethinyl estradiol-induced increase of uterine blood flow in postmenopausal women.
Topics: Aged; Capillary Resistance; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Placebos; Postmenopause; Progesterone Congeners; Pulsatile Flow; Uterus | 1997 |
A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Patient Compliance; Pregnancy; Uterine Hemorrhage | 1997 |
The effects of self-administering emergency contraception.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Postcoital, Hormonal; Drug Prescriptions; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Self Administration | 1998 |
The effects of a new low-dose combined oral contraceptive containing levonorgestrel on ovarian activity.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Monitoring; Endometrium; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovary; Ovulation; Progesterone; Progesterone Congeners; Ultrasonography | 1996 |
Effects of ABT-761, a novel 5-lipoxygenase inhibitor, on the pharmacokinetics of a single dose of ethinyl estradiol and levonorgestrel in healthy female volunteers.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral; Drug Interactions; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydroxyurea; Levonorgestrel; Lipoxygenase Inhibitors | 1998 |
Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Double-Blind Method; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Nausea; Pregnancy; Pregnancy, Unwanted; Risk; Time Factors; Vomiting | 1998 |
An emergency contraceptive kit.
Topics: Contraception; Contraceptives, Postcoital; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Randomized Controlled Trials as Topic | 1998 |
Levonorgestrel versus the "Yuzpe" regimen. New choices in emergency contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Postcoital; Double-Blind Method; Estradiol Congeners; Ethinyl Estradiol; Family Practice; Female; Humans; Levonorgestrel | 1999 |
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women.
Topics: Adolescent; Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Double-Blind Method; Enzyme Induction; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Oxcarbazepine; Oxidoreductases, N-Demethylating; Placebos | 1999 |
Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. A multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 microgram
Topics: Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Hemorrhage; Humans; Levonorgestrel; Menstrual Cycle | 1999 |
A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.
Topics: Adolescent; Adult; Analysis of Variance; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Norethindrone; Uterine Hemorrhage | 1999 |
Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Implants; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Patient Satisfaction; Pregnancy; Prospective Studies; Treatment Outcome; United Kingdom | 1999 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).
Topics: Adolescent; Adult; Blood Pressure; Cervix Uteri; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Life Tables; Menstrual Cycle; Middle Aged; Safety; Treatment Outcome | 1999 |
A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
Topics: Adult; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone | 1999 |
The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Ovary; Progesterone; Ultrasonography | 1999 |
Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Longitudinal Studies | 1999 |
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Thromboembolism | 1999 |
Effect of low-dose oral contraceptives on androgenic markers and acne.
Topics: Acne Vulgaris; Adolescent; Adrenal Glands; Adult; Androgens; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Ovary; Sex Hormone-Binding Globulin; Testosterone; Weight Gain | 1999 |
Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A.
Topics: Adult; Blood Coagulation; Blood Glucose; Blood Pressure; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Implants; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Norpregnenes; Prospective Studies | 2000 |
Ziprasidone and the pharmacokinetics of a combined oral contraceptive.
Topics: Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Contraceptives, Oral, Synthetic; Cross-Over Studies; Double-Blind Method; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Piperazines; Prolactin; Thiazoles | 2000 |
Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Ovarian Follicle; Prospective Studies; Ultrasonography | 2000 |
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Levonorgestrel; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombin; Thrombophilia; Venous Thrombosis | 2000 |
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Topics: Adolescent; Adult; alpha-2-Antiplasmin; Biomarkers; Blood Proteins; Carboxypeptidase B2; Carboxypeptidases; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Factor XI; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Humans; Levonorgestrel; Netherlands; Peptide Fragments; Plasminogen; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Tissue Plasminogen Activator | 2000 |
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Topics: Activated Protein C Resistance; Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Biomarkers; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Partial Thromboplastin Time; Protein C; Protein C Inhibitor; Protein S; Thrombin; Thrombophilia | 2000 |
Oral contraceptives do not affect magnesium in breast milk.
Topics: Adult; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Family Characteristics; Female; Humans; Levonorgestrel; Magnesium; Maternal Age; Milk, Human; Norethindrone; Social Class; Time Factors | 2000 |
Clinical management of functional ovarian cysts: a prospective and randomized study.
Topics: Adult; Clomiphene; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Infertility; Levonorgestrel; Menotropins; Ovarian Cysts; Ovary; Ovulation Induction; Prospective Studies; Time Factors; Ultrasonography | 2000 |
Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH).
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Levonorgestrel; Linear Models; Nandrolone; Time Factors | 2000 |
Changes in blood coagulation and fibrinolysis associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives.
Topics: Adult; Analysis of Variance; Blood Coagulation; Conditioning, Psychological; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Exercise Test; Female; Fibrinolysis; Humans; Levonorgestrel; Physical Education and Training; Physical Exertion; Probability; Reference Values; Thrombophilia | 2000 |
A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Placebos; Surveys and Questionnaires | 2001 |
Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Treatment Outcome | 2001 |
Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins | 2001 |
Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Pregnancy | 2001 |
Efficacy and safety of a transdermal contraceptive system.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy | 2001 |
The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
Topics: Adult; Benzhydryl Compounds; Contraceptives, Oral, Combined; Cresols; Cross-Over Studies; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Muscarinic Antagonists; Ovulation; Phenylpropanolamine; Progesterone; Progesterone Congeners; Time Factors; Tolterodine Tartrate | 2001 |
Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Contraceptive Agents, Female; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Oximes; Time Factors | 2001 |
Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII.
Topics: Adult; Cholesterol, HDL; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Factor VII; Factor VIIa; Female; Humans; Levonorgestrel; Lipoproteins; Peptide Fragments; Prospective Studies; Prothrombin; Triglycerides | 2002 |
Effect of two oral contraceptives with different ethinyl estradiol and levonorgestrel concentrations on the urinary excretion of biochemical vasoactive markers.
Topics: Adult; Analysis of Variance; Atrial Natriuretic Factor; Biomarkers; Cardiovascular System; Contraceptives, Oral, Combined; Cyclic GMP; Double-Blind Method; Epoprostenol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Kidney; Levonorgestrel; Peptide Fragments; Serotonin; Thromboxanes; Water-Electrolyte Balance | 2001 |
Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor IX; Factor V; Factor VII; Female; Humans; Levonorgestrel; Peptide Fragments; Prothrombin; Thrombophilia | 2002 |
Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins, HDL; Point Mutation; Progesterone Congeners; Triglycerides | 2001 |
Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Menstrual Cycle; Uterine Hemorrhage | 2002 |
Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function.
Topics: Contraceptives, Postcoital; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Levonorgestrel; Luteinizing Hormone; Ovarian Follicle; Ovary; Ovulation; Placebos | 2002 |
An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables.
Topics: Adolescent; Adult; Carbohydrates; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipids; Netherlands; Prospective Studies; Statistics, Nonparametric | 2002 |
Effect of dienogest-containing oral contraceptives on lipid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Nandrolone; Statistics, Nonparametric | 2002 |
Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women.
Topics: Adult; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cross-Over Studies; Endothelin-1; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Nitric Oxide; Norpregnenes; Premenopause; Prospective Studies; Statistics, Nonparametric; Time Factors | 2002 |
Effect of two oral contraceptives containing ethinylestradiol and levonorgestrel on serum and urinary surrogate markers of endothelial function.
Topics: Adult; Arteriosclerosis; Biomarkers; Cell Adhesion Molecules; Contraceptives, Oral, Synthetic; Double-Blind Method; Endothelium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Urinalysis | 2002 |
Comparative study and evaluation of side effects of low-dose contraceptive pills administered by the oral and vaginal route.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Uterine Hemorrhage | 2002 |
A randomised study comparing a low dose of mifepristone and the Yuzpe regimen for emergency contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Postcoital, Synthetic; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Mifepristone; Ovulation; Patient Satisfaction; Pregnancy; Treatment Outcome | 2002 |
Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women.
Topics: Adult; Anticonvulsants; Contraceptives, Oral, Synthetic; Drug Interactions; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levetiracetam; Levonorgestrel; Piracetam | 2002 |
Using a low-dose contraceptive in women 35 years of age and over: 20 microg estradiol/100 microg levonorgestrel.
Topics: Adult; Age Factors; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Treatment Outcome | 2002 |
Attitudes and experiences with levonorgestrel 100 microg/ethinyl estradiol 20 microg among women during a 3-month trial.
Topics: Adult; Attitude; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Patient Satisfaction; Surveys and Questionnaires; Uterine Hemorrhage | 2002 |
Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Carboxypeptidase B2; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Thrombophilia | 2002 |
Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Safety; Treatment Outcome | 2002 |
Effects of two oral contraceptives on plasma levels of nitric oxide, homocysteine, and lipid metabolism.
Topics: Adult; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Homocysteine; Humans; Levonorgestrel; Lipid Metabolism; Lipoproteins; Nitric Oxide; Norpregnenes | 2002 |
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovarian Follicle; Patient Compliance; Progesterone | 2002 |
Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
Topics: Adipose Tissue; Adolescent; Adult; Alkaline Phosphatase; Anorexia Nervosa; Body Composition; Body Image; Body Weight; Bone Density; Collagen; Collagen Type I; Dehydroepiandrosterone; Energy Intake; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Nutritional Physiological Phenomena; Osteocalcin; Osteoporosis; Peptides | 2002 |
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage | 2002 |
Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial.
Topics: Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Oregon; Patient Satisfaction | 2003 |
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
Topics: Adolescent; Adult; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Levonorgestrel; Nandrolone; Reference Values; Sex Hormone-Binding Globulin; Testosterone; Thyroxine-Binding Proteins; Treatment Outcome | 2003 |
Vitamin D receptor gene polymorphism and bone metabolism during low-dose oral contraceptive use in young women.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Bone Density; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Genotype; Humans; Levonorgestrel; Osteocalcin; Polymorphism, Genetic; Prospective Studies; Receptors, Calcitriol; Reference Values | 2003 |
Adolescents' attitudes and experiences regarding levonorgestrel 100 mcg/ethinyl estradiol 20 mcg.
Topics: Adolescent; Adolescent Behavior; Adolescent Health Services; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; New York City; Ohio; Parent-Child Relations; Patient Compliance; Puerto Rico | 2002 |
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial.
Topics: Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Treatment Outcome; Ultrasonography; Uterine Hemorrhage | 2003 |
Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgens; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Hirsutism; Humans; Levonorgestrel; Middle Aged; Severity of Illness Index; Sex Hormone-Binding Globulin; Treatment Outcome | 2003 |
Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Contraceptives, Oral, Combined; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Nandrolone; Thyroid Hormones; Treatment Outcome | 2003 |
A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome | 2003 |
A multicenter, randomized study of an extended cycle oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Patient Compliance; Pregnancy | 2003 |
Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.
Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Bupropion; Contraceptives, Oral; Cross-Over Studies; Cytochrome P-450 CYP2B6; Desogestrel; Dopamine Uptake Inhibitors; Estradiol; Ethinyl Estradiol; Female; Half-Life; Hormone Replacement Therapy; Humans; Hydroxylation; Levonorgestrel; Metabolic Clearance Rate; Oxidoreductases, N-Demethylating | 2003 |
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Mutation; Protein C; Risk Factors; Thrombosis | 2004 |
An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women.
Topics: Adolescent; Adult; Androstenes; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Thailand | 2004 |
Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism.
Topics: Adolescent; Adult; Cholesterol; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Triglycerides | 2004 |
Effect of hormonal emergency contraception on bleeding patterns.
Topics: Contraceptives, Postcoital, Hormonal; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Interviews as Topic; Levonorgestrel; Menstruation; Menstruation Disturbances; Norethindrone; Pregnancy; Pregnancy, Unwanted; Safe Sex; Time Factors; Treatment Outcome | 2004 |
The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Triglycerides | 2004 |
Lipid profile in women over 35 years old using triphasic combined oral contraceptives.
Topics: Adult; Apoproteins; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Triglycerides | 2004 |
Influence of losigamone on the pharmacokinetics of a combined oral contraceptive in healthy female volunteers.
Topics: Adult; Anticonvulsants; Area Under Curve; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Furans; Humans; Levonorgestrel; Stereoisomerism | 2004 |
Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Ovarian Follicle | 2004 |
The contraceptive vaginal ring (NuvaRing) and hemostasis: a comparative study.
Topics: Administration, Oral; Adolescent; Adult; Blood Coagulation; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Factor VII; Female; Hemostasis; Humans; Levonorgestrel | 2004 |
Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Netherlands; Premenstrual Syndrome; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2004 |
Effect of four oral contraceptives on hemostatic parameters.
Topics: alpha-2-Antiplasmin; Antithrombins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Estradiol; Ethinyl Estradiol; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Homeostasis; Humans; Levonorgestrel; Nandrolone; Peptide Fragments; Plasminogen; Plasminogen Inactivators; Protein C; Prothrombin; Tissue Plasminogen Activator | 2004 |
Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Levonorgestrel; Ovarian Follicle; Ovulation; Progesterone; Vagina | 2004 |
Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Endometrium; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Ovarian Follicle; Ovary; Progesterone; Vagina | 2004 |
Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex).
Topics: Adult; Blood Coagulation Factors; Carbolines; Contraceptives, Oral; Cross-Over Studies; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gastrointestinal Agents; Humans; Levonorgestrel; Luteinizing Hormone; Ovary | 2004 |
Mifepristone versus the Yuzpe regimen (PC4) for emergency contraception.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Mifepristone; Patient Satisfaction; Surveys and Questionnaires; Treatment Outcome | 2004 |
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography | 2004 |
Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Menstrual Cycle; Patient Compliance; Pregnancy; Pregnancy Rate; Uterine Hemorrhage | 2005 |
A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function.
Topics: Adolescent; Adrenal Glands; Adult; Blood Glucose; Carrier Proteins; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; England; Ethinyl Estradiol; Female; Glycated Hemoglobin; Humans; Hydrocortisone; Insulin; Levonorgestrel; Netherlands; Scotland; Thyroid Gland; Thyrotropin; Thyroxine; Treatment Outcome | 2004 |
Effect of multiple-dose dexloxiglumide on the pharmacokinetics of oral contraceptives in healthy women.
Topics: Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Norgestrel; Oximes; Pentanoic Acids; Receptors, Cholecystokinin | 2005 |
A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Topics: Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Denmark; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fatty Acids, Nonesterified; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Prospective Studies; Time Factors; Treatment Outcome; Triglycerides | 2005 |
Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Area Under Curve; Biological Availability; Contraception; Contraceptive Agents, Female; Cross-Over Studies; Emergency Medical Services; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pilot Projects; Radioimmunoassay; Treatment Outcome | 2005 |
Oral contraceptives improve endothelial function in amenorrheic athletes.
Topics: Adolescent; Adult; Amenorrhea; Brachial Artery; Contraceptives, Oral; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Regional Blood Flow; Sports; Vasodilation; Weight-Bearing | 2005 |
Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
Topics: Activated Protein C Resistance; Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Glucosylceramides; Humans; Levonorgestrel; Pilot Projects; Protein C; Protein S; Prothrombin Time; Risk; Sensitivity and Specificity; Venous Thrombosis | 2005 |
A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.
Topics: Adult; Contraception; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Prospective Studies | 2005 |
A trial of contraceptive methods in women with systemic lupus erythematosus.
Topics: Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Lupus Erythematosus, Systemic; Pregnancy; Severity of Illness Index; Single-Blind Method | 2005 |
Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
Topics: Adult; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Patient Satisfaction; Uterine Hemorrhage | 2006 |
Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives.
Topics: Administration, Intravaginal; Adult; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Libido; Menstrual Cycle; Norpregnenes; Prospective Studies; Reproduction; Uterine Hemorrhage | 2006 |
Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins.
Topics: Administration, Cutaneous; Adult; Blood Proteins; Body Mass Index; C-Reactive Protein; Contraceptive Agents; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Receptors, Cell Surface; Serpins; Sex Hormone-Binding Globulin; Thyroxine-Binding Proteins; Transcortin | 2006 |
Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
Topics: Adolescent; Adult; Contraception; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Treatment Outcome | 2006 |
Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength.
Topics: Adult; Androgens; Contraceptives, Oral, Combined; Ethinyl Estradiol; Exercise; Female; Humans; Leg; Levonorgestrel; Muscle Strength; Norgestrel; Progesterone Congeners; Progestins; Sports | 2006 |
Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 micro g/ethinyl estradiol 20 micro g.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Endometrium; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Safety; Treatment Outcome | 2007 |
Influence of avosentan (SPP3OI) on the pharmacokinetics of a second generation oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Hormonal; Cross-Over Studies; Double-Blind Method; Drug Combinations; Endothelin Receptor Antagonists; Ethinyl Estradiol; Exanthema; Facial Injuries; Female; Follicle Stimulating Hormone; Headache; Humans; Levonorgestrel; Luteinizing Hormone; Middle Aged; Molecular Structure; Progesterone; Pyridines; Pyrimidines; Rhinitis; Vomiting | 2006 |
Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol.
Topics: Adult; Blood Pressure; Brachial Artery; Contraceptives, Oral, Combined; Drug Administration Schedule; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Heart Rate; Humans; Levonorgestrel; Nitroglycerin; Progestins; Reference Values; Risk Assessment; Vascular Diseases; Vasodilation; Vasodilator Agents | 2007 |
Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Topics: Adolescent; Adult; Blood Proteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norprogesterones; Sex Hormone-Binding Globulin; Triglycerides | 2007 |
Effects on body weight and body composition of a low-dose oral estroprogestin containing ethinyl estradiol 20 microg plus levonorgestrel 100 microg.
Topics: Blood Glucose; Body Composition; Body Weight; Electric Impedance; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids | 2007 |
Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years.
Topics: Administration, Cutaneous; Adult; Age Factors; Contraceptive Agents; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Pregnancy; Thailand; Time Factors | 2007 |
Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Antifibrinolytic Agents; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Homeostasis; Humans; Levonorgestrel; Middle Aged; Peptide Fragments; Prospective Studies; Protein Precursors; Prothrombin | 2008 |
Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo.
Topics: Adolescent; Adult; Biopsy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Endometrium; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Time Factors | 2008 |
Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Levonorgestrel; Luteinizing Hormone; Ovarian Follicle; Pituitary Gland; Prospective Studies; Ultrasonography | 2008 |
Efficacy of estriol in inhibiting epithelial proliferation in mammary fibroadenoma: randomized clinical trial.
Topics: Adult; Biopsy; Breast Neoplasms; Cell Proliferation; Contraceptives, Oral, Combined; Double-Blind Method; Epithelial Cells; Estriol; Ethinyl Estradiol; Female; Fibroadenoma; Genes, myc; Humans; Immunohistochemistry; Ki-67 Antigen; Levonorgestrel; Mammary Glands, Human; Proliferating Cell Nuclear Antigen; Staining and Labeling; Young Adult | 2007 |
Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteers.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anti-HIV Agents; CCR5 Receptor Antagonists; Contraceptives, Oral; Cyclohexanes; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; HIV Infections; Humans; Lamivudine; Levonorgestrel; Male; Maraviroc; Midazolam; Middle Aged; Statistics as Topic; Triazoles; Zidovudine | 2008 |
Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users.
Topics: Analgesics; Contraceptive Agents, Female; Double-Blind Method; Drug Implants; Estrogens; Ethinyl Estradiol; Female; Humans; Ibuprofen; Levonorgestrel; Metrorrhagia; Placebos; Treatment Outcome | 2008 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
Topics: Adult; Canada; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norethindrone; Norethindrone Acetate; Prospective Studies; Severity of Illness Index | 2009 |
Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen.
Topics: Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovarian Follicle; Ovulation Inhibition; Progesterone; Ultrasonography; Young Adult | 2009 |
Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovulation Inhibition; Progesterone; Tetrahydronaphthalenes; Thiophenes; Young Adult | 2009 |
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Metrorrhagia; Middle Aged; Nandrolone; Patient Satisfaction; Treatment Outcome; Young Adult | 2009 |
Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Metrorrhagia; Middle Aged; Patient Selection; Pregnancy, Unplanned; Statistics, Nonparametric | 2009 |
The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate | 2010 |
Treatment of clomiphene citrate-related ovarian cysts in a prospective randomized study. A single center experience.
Topics: Adult; Analysis of Variance; Body Mass Index; Chi-Square Distribution; Clomiphene; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Infertility, Female; Levonorgestrel; Ovarian Cysts; Prospective Studies; Treatment Outcome | 2009 |
A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran.
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Iran; Levonorgestrel; Metrorrhagia; Nausea; Patient Satisfaction | 2010 |
Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe.
Topics: Contraception, Postcoital; Contraceptives, Oral; Contraceptives, Postcoital; Estrogens; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Humans; Incidence; Iran; Levonorgestrel; Prospective Studies; Surveys and Questionnaires; Treatment Outcome | 2009 |
Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.
Topics: Adolescent; Adult; Androstenes; Body Water; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Quality of Life; Single-Blind Method; Statistics, Nonparametric; Young Adult | 2010 |
An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables.
Topics: Adolescent; Adult; Carbohydrate Metabolism; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Young Adult | 2010 |
Treatment of premature ovarian failure trial: description of an ongoing clinical trial.
Topics: Adolescent; Adult; Bone Density; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Primary Ovarian Insufficiency; Prospective Studies; Treatment Outcome; Young Adult | 2010 |
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Menstrual Cycle; Obesity; Organ Size; Ovarian Follicle; Ovulation Inhibition; Progesterone; Radioimmunoassay; Ultrasonography; Young Adult | 2010 |
A look at the long-term safety of an extended-regimen OC.
Topics: Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Hemoglobins; Humans; Levonorgestrel; Lipids; Medication Adherence; Menstruation | 2010 |
Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels.
Topics: Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Libido; Prospective Studies; Regression Analysis; Sex Hormone-Binding Globulin; Surveys and Questionnaires; Testosterone; Young Adult | 2010 |
Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Ovary; Prospective Studies; Young Adult | 2010 |
A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Treatment Failure; Treatment Outcome | 2011 |
Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding.
Topics: Adolescent; Adult; Anticonvulsants; Area Under Curve; Carbamazepine; Contraceptives, Oral, Hormonal; Cross-Over Studies; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Ovarian Follicle; Ovulation; Progesterone; Steroids; Young Adult | 2011 |
Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. Which one has better affect on acne, hirsutism, and weight change.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Hirsutism; Humans; Levonorgestrel; Weight Gain; Young Adult | 2011 |
Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Megestrol; Norpregnadienes; Placebos; Thrombosis; Treatment Outcome | 2011 |
Treatment with liraglutide--a once-daily GLP-1 analog--does not reduce the bioavailability of ethinyl estradiol/levonorgestrel taken as an oral combination contraceptive drug.
Topics: Aged; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Levonorgestrel; Liraglutide; Middle Aged; Postmenopause | 2011 |
Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use.
Topics: Adult; Bone Remodeling; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Middle Aged; Sex Hormone-Binding Globulin; Triglycerides; Women's Health; Young Adult | 2011 |
The effect of low-dose combined oral contraceptive containing 100 ug levonorgestrel on plasma plasminogen activator inhibitor-1 concentrations.
Topics: Adult; Chi-Square Distribution; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Plasminogen Activator Inhibitor 1 | 2011 |
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Topics: Activated Protein C Resistance; Adolescent; Adult; Antigens; Antithrombin III; Blood Pressure; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Estradiol; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Levonorgestrel; Middle Aged; Nandrolone; Patient Compliance; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Sex Hormone-Binding Globulin; Young Adult | 2011 |
Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteers.
Topics: Adenosine; Adolescent; Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Interactions; Estrogens; Ethinyl Estradiol; Humans; Levonorgestrel; Middle Aged; Ticagrelor | 2011 |
Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Combined; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Linagliptin; Purines; Quinazolines; Young Adult | 2011 |
Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Glucose Tolerance Test; Hematologic Tests; Hemostasis; Humans; Levonorgestrel; Lipids; Middle Aged; Nandrolone; Thyroid Function Tests; Treatment Outcome; Young Adult | 2011 |
Assessment of the activity of an oral contraceptive on the levels of oxidative stress and changes in oxidative stress after co-treatment with two different types of physiological modulators with antioxidant action.
Topics: Adult; Antioxidants; Contraceptives, Oral, Combined; Cross-Over Studies; Dietary Supplements; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Oxidative Stress; Vitamins | 2011 |
Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Feasibility Studies; Female; HIV Seronegativity; HIV Seropositivity; Humans; Lamivudine; Levonorgestrel; Malawi; Nevirapine; Norgestrel; Ovulation Inhibition; Progesterone; Stavudine; Young Adult | 2011 |
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Megestrol; Middle Aged; Norpregnadienes; Sex Hormone-Binding Globulin; Testosterone Congeners; Thyroxine-Binding Globulin; Transcortin; Young Adult | 2011 |
Matched-pairs analysis of ovarian suppression during oral vs. vaginal hormonal contraceptive use.
Topics: Administration, Oral; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Matched-Pair Analysis; Ovarian Follicle; Ovulation; Treatment Outcome; Young Adult | 2011 |
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism.
Topics: Adolescent; Adult; C-Reactive Protein; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Megestrol; Middle Aged; Norpregnadienes; Sex Hormone-Binding Globulin; Triglycerides; Young Adult | 2011 |
A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Contraceptives, Oral, Combined; Double-Blind Method; Doxycycline; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Treatment Outcome | 2012 |
Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Retrospective Studies; Young Adult | 2012 |
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Premenstrual Syndrome; Treatment Outcome; Young Adult | 2012 |
The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Medication Adherence; Obesity; Patient Dropouts; Triglycerides; Young Adult | 2012 |
Predictors of noncompliance in an oral contraceptive clinical trial.
Topics: Adolescent; Adult; Biomarkers; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Educational Status; Ethinyl Estradiol; Female; Hispanic or Latino; Humans; Levonorgestrel; Medication Adherence; Obesity; Ovarian Follicle; Ovulation Inhibition; Patient Dropouts; Poverty; Single-Blind Method; United States; Young Adult | 2012 |
Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Contraceptive Agents, Female; Cross-Over Studies; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 2012 |
The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives.
Topics: Adult; Antithrombin III; Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Humans; Levonorgestrel; Peptide Hydrolases; Protein C; Protein C Inhibitor; Thrombophilia; Young Adult | 2012 |
The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Body Composition; Bone and Bones; Bone Density; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Double-Blind Method; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Progestins; Young Adult | 2012 |
Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women.
Topics: Adolescent; Adult; Chromatography, Liquid; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Midazolam; Obesity; Prospective Studies; Tandem Mass Spectrometry; Young Adult | 2012 |
Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial.
Topics: Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Interactions; Ethinyl Estradiol; Exenatide; Female; Humans; Hypoglycemic Agents; Levonorgestrel; Peptides; Venoms; Young Adult | 2012 |
No clinically relevant drug-drug interactions when dalcetrapib is co-administered with a monophasic oral contraceptive (Microgynon® 30).
Topics: Adult; Amides; Anticholesteremic Agents; Biomarkers; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Interactions; Esters; Ethinyl Estradiol; Female; Follicle Stimulating Hormone, Human; Humans; Levonorgestrel; Luteinizing Hormone; Ovulation Inhibition; Progesterone; Sulfhydryl Compounds; Young Adult | 2012 |
The effect of lersivirine, a next-generation NNRTI, on the pharmacokinetics of midazolam and oral contraceptives in healthy subjects.
Topics: Adolescent; Adult; Biotransformation; Contraceptives, Oral; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Male; Metabolic Clearance Rate; Midazolam; Middle Aged; Nitriles; Pyrazoles; Reverse Transcriptase Inhibitors; Young Adult | 2012 |
Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol.
Topics: Absorptiometry, Photon; Adult; Bone Density; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Megestrol; Norpregnadienes; Progesterone Congeners; Prospective Studies; Young Adult | 2012 |
Using changes in binding globulins to assess oral contraceptive compliance.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral; Educational Status; Ethinyl Estradiol; Ethnicity; Female; Humans; Levonorgestrel; Liver; Patient Compliance; Sex Hormone-Binding Globulin; Thyroxine-Binding Globulin; Transcortin | 2013 |
Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel.
Topics: Administration, Cutaneous; Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Middle Aged; Obesity; Ovary; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 2013 |
Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium.
Topics: Adolescent; Adult; Blood Pressure; Brachial Artery; Brazil; Carotid Artery, Common; Carotid Intima-Media Thickness; Chlormadinone Acetate; Contraceptives, Oral, Combined; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Progestins; Risk; Thromboembolism; Vascular Stiffness; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2013 |
Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exercise.
Topics: Adhesives; Adolescent; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Equipment Failure; Ethinyl Estradiol; Exercise; Female; Hot Temperature; Humans; Humidity; Immersion; Levonorgestrel; Middle Aged; Transdermal Patch; Water | 2013 |
Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch.
Topics: Abdomen; Adult; Buttocks; Cohort Studies; Contraceptive Agents, Female; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Feasibility Studies; Female; Half-Life; Headache; Humans; Incidence; Levonorgestrel; Nausea; Pruritus; Skin Absorption; Thorax; Transdermal Patch; United States; Young Adult | 2013 |
Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
Topics: Acetamides; Adolescent; Adult; Anticonvulsants; Contraceptives, Oral, Combined; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Lacosamide; Levonorgestrel; Progesterone; Young Adult | 2013 |
Effect of empagliflozin on the steady-state pharmacokinetics of ethinylestradiol and levonorgestrel in healthy female volunteers.
Topics: Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Benzhydryl Compounds; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Interactions; Ethinyl Estradiol; Female; Germany; Glucosides; Half-Life; Humans; Hypoglycemic Agents; Levonorgestrel; Metabolic Clearance Rate; Polypharmacy; Young Adult | 2013 |
Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Intention to Treat Analysis; Levonorgestrel; Lost to Follow-Up; Medication Adherence; Menstruation; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Precision Medicine; Severity of Illness Index; United Kingdom; Young Adult | 2013 |
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Topics: Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Substance Withdrawal Syndrome; Young Adult | 2013 |
The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
Topics: Adult; Analysis of Variance; Androstenes; Contraceptives, Oral, Combined; Cross-Over Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Prospective Studies; Testosterone | 2013 |
Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Drug Substitution; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Sexual Dysfunction, Physiological; Young Adult | 2013 |
Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomize
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Administration Schedule; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Norpregnenes; Patient Compliance; Prothrombin Time; Transdermal Patch; Treatment Outcome; Young Adult | 2013 |
Weight and body composition changes during oral contraceptive use in obese and normal weight women.
Topics: Adult; Body Composition; Body Mass Index; Contraceptives, Oral; Dose-Response Relationship, Drug; Electric Impedance; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Obesity; Outcome Assessment, Health Care; Prospective Studies; Time Factors; Weight Gain; Weight Loss; Young Adult | 2014 |
An ethinyl estradiol-levonorgestrel containing oral contraceptive does not alter cytochrome P4502C9 in vivo activity.
Topics: Adolescent; Adult; Aryl Hydrocarbon Hydroxylases; Contraceptives, Oral, Combined; Cytochrome P-450 CYP2C9; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Substrate Specificity; Tolbutamide; Young Adult | 2014 |
Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women.
Topics: Adult; Anticonvulsants; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Interactions; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Progesterone; Pyrrolidinones; Young Adult | 2013 |
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethnicity; Female; Humans; Levonorgestrel; Obesity; Patient Compliance; Pregnancy; Transdermal Patch; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.
Topics: Adolescent; Adult; Carbazoles; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Migraine Disorders; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Tryptamines; Young Adult | 2014 |
Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women.
Topics: Administration, Cutaneous; Aged; Cross-Over Studies; Drug Combinations; Drug Delivery Systems; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Postmenopause; Sex Hormone-Binding Globulin | 2014 |
Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Pregnancy; Treatment Outcome; Young Adult | 2014 |
Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
Topics: Adolescent; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Time Factors; Treatment Outcome; Young Adult | 2014 |
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women.
Topics: Adolescent; Adult; Blood Coagulation; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Humans; Levonorgestrel; Partial Thromboplastin Time; Prothrombin; Young Adult | 2014 |
Use of endogenous cortisol 6β-hydroxylation clearance for phenotyping in vivo CYP3A activity in women after sequential administration of an oral contraceptive (OC) containing ethinylestradiol and levonorgestrel as weak CYP3A inhibitors.
Topics: Adult; Contraceptives, Oral; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Assays; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Hydroxylation; Levonorgestrel; Phenotype; Progesterone | 2014 |
Efficacy of fennel and combined oral contraceptive on depot medroxyprogesterone acetate-induced amenorrhea: a randomized placebo-controlled trial.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Foeniculum; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation; Phytotherapy; Plant Oils; Young Adult | 2014 |
Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Prospective Studies; Young Adult | 2014 |
Effect of oral siponimod (BAF312) on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in healthy female subjects.
Topics: Administration, Oral; Adolescent; Adult; Azetidines; Benzyl Compounds; Contraceptives, Oral; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Ovarian Follicle; Sex Hormone-Binding Globulin | 2014 |
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Obesity; Patient Outcome Assessment; Transdermal Patch; Young Adult | 2015 |
No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.
Topics: Adult; Anti-Anxiety Agents; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endometrium; Estradiol; Ethinyl Estradiol; Female; Herb-Drug Interactions; Humans; Lavandula; Levonorgestrel; Oils, Volatile; Ovarian Follicle; Patient Compliance; Plant Oils; Progesterone; Sex Hormone-Binding Globulin; Young Adult | 2014 |
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
Topics: Adult; Anticoagulants; Area Under Curve; Blood Coagulation; Canagliflozin; Cardiotonic Agents; Contraceptives, Oral, Combined; Cross-Over Studies; Digoxin; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Interactions; Ethinyl Estradiol; Female; Glucosides; Half-Life; Healthy Volunteers; Humans; Hypoglycemic Agents; International Normalized Ratio; Levonorgestrel; Male; Metabolic Clearance Rate; Middle Aged; Polypharmacy; Risk Assessment; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Warfarin; Young Adult | 2015 |
Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.
Topics: Administration, Oral; Adolescent; Adult; Aminoisobutyric Acids; Area Under Curve; Bilirubin; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Leucine; Levonorgestrel; Oligopeptides; Proline; Protease Inhibitors; Quinolines; Thiazoles; Viral Nonstructural Proteins; Young Adult | 2015 |
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menorrhagia; Menstrual Cycle; Metrorrhagia; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; United States; Young Adult | 2015 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovarian Follicle; Ovulation Inhibition; Philadelphia; Progesterone; Time Factors; Washington; Young Adult | 2015 |
Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill.
Topics: Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Patient Compliance; Reproducibility of Results; Self Report; Transdermal Patch; Young Adult | 2015 |
New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study.
Topics: Adhesiveness; Adolescent; Adult; Contraceptives, Oral, Combined; Dermatitis, Contact; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Research Personnel; Transdermal Patch; Young Adult | 2015 |
Effect of pradigastat, a diacylglycerol acyltransferase 1 inhibitor, on the pharmacokinetics of a combination oral contraceptive in healthy female subjects.
Topics: Acetates; Adult; Aminopyridines; Area Under Curve; Contraceptives, Oral, Combined; Diacylglycerol O-Acyltransferase; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Levonorgestrel; Metabolic Clearance Rate; Risk Assessment; Risk Factors; Young Adult | 2015 |
Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial.
Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovary; Ovulation Inhibition; Progesterone; Ultrasonography | 2015 |
Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Excitatory Amino Acid Antagonists; Female; Healthy Volunteers; Humans; Indoles; Levonorgestrel; Metabolic Clearance Rate; Models, Biological; Receptor, Metabotropic Glutamate 5; Young Adult | 2015 |
Pharmacokinetics of Oral Combination Contraceptive Drugs Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Chinese Volunteers.
Topics: Adult; Asian People; China; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Levonorgestrel; Young Adult | 2016 |
Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
Topics: Adolescent; Adult; Alkaline Phosphatase; Androstenes; Aspartate Aminotransferases; Cholesterol, HDL; Cholesterol, LDL; Collagen Type I; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estetrol; Estrogens; Ethinyl Estradiol; Female; gamma-Glutamyltransferase; Growth Hormone; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Levonorgestrel; Lipid Metabolism; Liver; Mineralocorticoid Receptor Antagonists; Osteocalcin; Peptides; Sex Hormone-Binding Globulin; Triglycerides; Young Adult | 2015 |
The effect of combined hormonal contraceptives use on brain reactivity during response inhibition.
Topics: Adult; Brain; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Evoked Potentials; Female; Functional Neuroimaging; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Levonorgestrel; Magnetic Resonance Imaging; Neural Inhibition; Young Adult | 2016 |
Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Endometrium; Estetrol; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Ovarian Follicle; Ovulation; Ovulation Inhibition; Pilot Projects; Pituitary Gland; Progesterone; Ultrasonography; Young Adult | 2015 |
Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects.
Topics: Adolescent; Adult; Aminobutyrates; Angiotensin Receptor Antagonists; Area Under Curve; Biphenyl Compounds; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Male; Metformin; Middle Aged; Omeprazole; Tetrazoles; Valsartan; Young Adult | 2016 |
Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Young Adult | 2016 |
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; India; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; Patient Acceptance of Health Care; Severity of Illness Index | 2016 |
Effect of Extended 30 μg Ethinyl Estradiol with Continuous Low-Dose Ethinyl Estradiol and Cyclic 20 μg Ethinyl Estradiol Oral Contraception on Adolescent Bone Density: A Randomized Trial.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Child; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lumbar Vertebrae | 2016 |
Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Dehydroepiandrosterone; Double-Blind Method; Down-Regulation; Drug Combinations; Endocrine Glands; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Reproducibility of Results; Sex Hormone-Binding Globulin; Solubility; Testosterone; Young Adult | 2017 |
A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
Topics: Adolescent; Adult; Androstenes; Austria; Belgium; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Germany; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Satisfaction; United States; Young Adult | 2016 |
Combined Oral Contraceptives and Sexual Function in Women-a Double-Blind, Randomized, Placebo-Controlled Trial.
Topics: Adolescent; Adult; Arousal; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Lost to Follow-Up; Patient Dropouts; Patient Satisfaction; Pleasure; Psychiatric Status Rating Scales; Severity of Illness Index; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Stress, Psychological; Sweden; Young Adult | 2016 |
Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.
Topics: Adolescent; Adult; Cardiovascular Diseases; Chronic Pain; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Levonorgestrel; Medication Adherence; Middle Aged; Nausea; Patient Satisfaction; Pelvic Pain; Risk; Young Adult | 2016 |
Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.
Topics: Adolescent; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Intra-Abdominal Fat; Levonorgestrel; Metformin; Oligomenorrhea; Ovulation; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones | 2017 |
The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Headache; Humans; Immunologic Factors; Levonorgestrel; Quinolones; Therapeutic Equivalency; Young Adult | 2019 |
The JAK1 Inhibitor Upadacitinib Has No Effect on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol: A Study in Healthy Female Subjects.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Delayed-Action Preparations; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase Inhibitors; Levonorgestrel; Middle Aged; Young Adult | 2019 |
Impact of Adrenal Hormone Supplementation on Bone Geometry in Growing Teens With Anorexia Nervosa.
Topics: Absorptiometry, Photon; Adolescent; Anorexia Nervosa; Bone Density; Child; Dehydroepiandrosterone; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Magnetic Resonance Imaging; Tibia | 2019 |
Extended-cycle versus conventional treatment with a combined oral contraceptive containing ethinylestradiol (30 μg) and levonorgestrel (150 μg) in a randomized controlled trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Treatment Outcome; Young Adult | 2020 |
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome | 2020 |
Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6.
Topics: Adenine; Administration, Oral; Adult; Aged; Aged, 80 and over; Area Under Curve; Bupropion; Contraceptives, Oral; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Drug Interactions; Ethinyl Estradiol; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Levonorgestrel; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Mantle-Cell; Metabolic Clearance Rate; Midazolam; Middle Aged; Piperidines; Waldenstrom Macroglobulinemia | 2020 |
Lack of Drug-Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers.
Topics: Adult; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Janus Kinase 1; Janus Kinase Inhibitors; Levonorgestrel; Middle Aged; Pyridines; Triazoles; Young Adult | 2021 |
Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
Topics: Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Sex Hormone-Binding Globulin | 2021 |
Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects.
Topics: Ethinyl Estradiol; Female; Furosemide; Glucagon-Like Peptides; Healthy Volunteers; Humans; Hypoglycemic Agents; Levonorgestrel; Male; Postmenopause; Rosuvastatin Calcium | 2021 |
A phase 1, open-label, drug-drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily G, Member 2; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Female; Humans; Indoles; Levonorgestrel; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Neoplasm Proteins; Neoplasms; Rosuvastatin Calcium | 2021 |
A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.
Topics: Adult; Contraception; Contraceptives, Oral, Combined; Deoxyadenosines; Drug Interactions; Ethinyl Estradiol; Female; HIV Infections; Humans; Levonorgestrel | 2021 |
Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Estrogens; Ethinyl Estradiol; Female; Fibrin; Humans; Levonorgestrel; Nandrolone; Progestins; Thrombin; Thromboplastin; Young Adult | 2022 |
Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
Topics: Contraceptives, Oral, Combined; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Nandrolone | 2022 |
Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
Topics: Contraceptives, Oral, Combined; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Progestins; Proteome; Proteomics | 2023 |
Lack of Effect of Cenerimod, a Selective S1P
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Immunologic Factors; Levonorgestrel; Male; Propylene Glycols | 2022 |
Extended regimen of a levonorgestrel/ethinyl estradiol transdermal delivery system: Predicted serum hormone levels using a population pharmacokinetic model.
Topics: Contraceptive Agents; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 2022 |
402 other study(ies) available for ethinyl estradiol and levonorgestrel
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Liver adenomatosis with granulomas in two patients on long-term oral contraceptives.
Topics: Adenoma; Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Granuloma; Humans; Levonorgestrel; Liver Neoplasms; Middle Aged; Multiple Endocrine Neoplasia; Norethindrone; Time Factors | 1992 |
Changes in serum levels of SHBG, endogenous ligands and levonorgestrel induced by ethinylestradiol in Norplant users.
Topics: Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Implants; Estradiol; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Metabolic Clearance Rate; Sex Hormone-Binding Globulin; Steroids; Testosterone | 1992 |
The in-vitro mucosal conjugation of ethinyloestradiol and the bioavailability of oral contraceptive steroids in patients with treated and untreated coeliac disease.
Topics: Administration, Oral; Adult; Celiac Disease; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Intestinal Mucosa; Levonorgestrel; Middle Aged | 1992 |
The effect of low-dose oral contraceptives and Norplant on blood pressure and body weight of Nigerian women.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Drug Implants; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Nigeria; Norgestrel; Prospective Studies | 1992 |
Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
Topics: Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Protein Binding; Sex Hormone-Binding Globulin; Time Factors | 1992 |
Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
Topics: Adult; Belgium; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hydrogen; Levonorgestrel; Lipids; Magnetic Resonance Spectroscopy; Middle Aged; Military Personnel; Norethindrone; Norgestrel; Progestins; Protons; Regression Analysis; Water | 1991 |
Pharmacokinetics of levonorgestrel in 18 women after 1 month of treatment with a triphasic oral contraceptive.
Topics: Adolescent; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Radioimmunoassay; Sex Hormone-Binding Globulin | 1991 |
[Effect of levonorgestrel and ethinyl estradiol and their combination on biotransformation reactions].
Topics: Adult; Biotransformation; Caffeine; Contraceptives, Oral, Combined; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dipyrone; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metabolic Clearance Rate | 1991 |
Effects of sex steroids on skin 5 alpha-reductase activity in vitro.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Skin; Steroids | 1991 |
Effects of low-dose oral contraceptives on female whole saliva.
Topics: Adult; Buffers; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Male; Menstrual Cycle; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone Congeners; Saliva; Salivary Proteins and Peptides | 1991 |
Emergency contraception.
Topics: Contraceptives, Postcoital; Emergencies; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Menstrual Cycle; Pregnancy; Referral and Consultation | 1991 |
Effects of oral contraceptive pills on serum lipoproteins and triglycerides.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Regression Analysis; Time Factors; Triglycerides | 1990 |
Persisting cyclical uterine bleeding in patients treated with radical radiation therapy and hormonal replacement for carcinoma of the cervix.
Topics: Adult; Drug Administration Schedule; Endometrium; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Ovary; Uterine Cervical Neoplasms; Uterine Hemorrhage | 1990 |
A model to detect interactions between roxithromycin and oral contraceptives.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Models, Biological; Norgestrel; Roxithromycin | 1990 |
The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea.
Topics: Adult; Contraceptives, Oral, Combined; Dysmenorrhea; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Lynestrenol; Mestranol; Norethindrone; Norgestrel | 1990 |
The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.
Topics: Adolescent; Adult; Carbamazepine; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Phenytoin | 1990 |
Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Gonadotropins; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovary; Periodicity; Placebos | 1990 |
Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Altered growth hormone secretion during oral contraception.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Growth Hormone; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pituitary Gland, Anterior; Progesterone Congeners | 1990 |
Renal and myocardial adrenoceptors in steroid contraceptive-induced hypertension in rats.
Topics: Animals; Binding, Competitive; Blood Pressure; Ethinyl Estradiol; Female; Heart; Hypertension; Iodocyanopindolol; Kidney; Levonorgestrel; Norgestrel; Pindolol; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1990 |
Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
Topics: Adult; Ceruloplasmin; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Sex Hormone-Binding Globulin | 1989 |
Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists.
Topics: Adult; Contraceptives, Oral; Dinoprost; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lypressin; Menstrual Cycle; Norgestrel; Pressure; Uterine Contraction; Uterus | 1989 |
Possible estrogen-induced NMS.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Neuroleptic Malignant Syndrome; Norgestrel; Schizophrenia, Paranoid | 1989 |
[Oral contraceptives and blood diseases are the most common causes of Budd-Chiari syndrome].
Topics: Adult; Anticoagulants; Arteriovenous Shunt, Surgical; Budd-Chiari Syndrome; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Male; Norgestrel; Polycythemia Vera; Radiography | 1989 |
[Initial experiences with a levonorgestrel-ethinyl estradiol combination for interception].
Topics: Adolescent; Adult; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Pregnancy; Progesterone; Prospective Studies | 1989 |
Pulsatile ovarian fossa ectopic and the 'morning after' pill.
Topics: Adult; Contraceptives, Postcoital, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Ovary; Pregnancy; Pregnancy, Ectopic | 1989 |
Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners; Sex Hormone-Binding Globulin; Stereoisomerism | 1987 |
Effect of levonorgestrel and ethinyloestradiol on vasoconstriction in rat isolated vasculature.
Topics: Angiotensin II; Animals; Blood Pressure; Clonidine; Contraceptive Agents, Female; Ethinyl Estradiol; Female; In Vitro Techniques; Levonorgestrel; Norepinephrine; Norgestrel; Phenylephrine; Rats; Rats, Inbred Strains; Splanchnic Circulation; Vasoconstriction | 1988 |
[Lipid metabolism in hormonal contraception].
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Levonorgestrel; Lipid Metabolism; Norethindrone; Norgestrel; Time Factors | 1985 |
Endometrial morphology during a normophasic and a triphasic regimen: a comparison.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 1986 |
Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Life Style; Menstrual Cycle; Norgestrel; Norpregnenes | 1987 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
[Impetigo herpetiformis].
Topics: Adult; Biopsy; Contraceptives, Oral, Combined; Cysts; Dermatitis Herpetiformis; Drug Eruptions; Ethinyl Estradiol; Etretinate; Female; HLA Antigens; HLA-C Antigens; Humans; Impetigo; Levonorgestrel; Norgestrel; Prednisolone; Pregnancy; Pregnancy Complications, Infectious; Skin; Splenic Rupture | 1988 |
Trace elements during 2 years' oral contraception with low-estrogen preparations.
Topics: Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Desogestrel; Ethinyl Estradiol; Female; Humans; Iron; Levonorgestrel; Norgestrel; Norpregnenes; Trace Elements; Zinc | 1988 |
Progestagen-dependent effect on some plasma proteins during oral contraception.
Topics: Blood Proteins; Ceruloplasmin; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pregnancy Proteins; Progesterone Congeners; Sex Hormone-Binding Globulin; Transcortin | 1988 |
Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.
Topics: Adolescent; Adult; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Norpregnenes; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners | 1988 |
Effects of the contraceptive pill on sedative responses to clonidine and apomorphine in normal women.
Topics: Adult; Apomorphine; Arousal; Blood Pressure; Brain; Clonidine; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Interactions; Ethinyl Estradiol; Female; Growth Hormone; Humans; Levonorgestrel; Norgestrel; Receptors, Adrenergic, alpha; Receptors, Dopamine | 1985 |
Chronic steroid contraceptive treatment decreases renal alpha-adrenoceptor levels in the rat.
Topics: Animals; Ethinyl Estradiol; Female; Hypertension, Renal; Kidney; Levonorgestrel; Norgestrel; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1986 |
Liver-cell adenoma. Case report.
Topics: Adult; Carcinoma, Hepatocellular; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Liver Neoplasms; Norgestrel; Radionuclide Imaging | 1986 |
Influence of pregnancy, oophorectomy and contraceptive steroids on gall bladder concentrating function and hepatic bile flow in the cat.
Topics: Absorption; Animals; Bile; Body Water; Cats; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Gallbladder; Levonorgestrel; Norethindrone; Norgestrel; Ovariectomy; Pregnancy; Pregnancy, Animal; Prolactin; Stereoisomerism | 1986 |
The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids.
Topics: Adolescent; Adult; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Valproic Acid | 1986 |
Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
Topics: Adult; Antacids; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Time Factors | 1986 |
A prospective study of the metabolic effects of a low dose combined oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Prospective Studies | 1986 |
Oral contraception, 1986. Currently available formulations.
Topics: Canada; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Combinations; Drug Compounding; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; France; Humans; Levonorgestrel; Norethindrone; Norgestrel; Stereoisomerism; United States | 1986 |
Contraceptive steroid concentrations in women with early active schistosomiasis: lack of effect of antischistosomal drugs.
Topics: Adolescent; Adult; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Praziquantel; Schistosomiasis; Schistosomicides; Trichlorfon | 1986 |
Evaluation of a new triphasic oral contraceptive in private practice.
Topics: Blood Glucose; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Menstrual Cycle; Norgestrel; Private Practice | 1986 |
Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1987 |
One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.
Topics: Adult; Antipyrine; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metabolic Clearance Rate; Microsomes, Liver; Norgestrel; Triglycerides | 1987 |
Effect of the hormonal contraception on serum reverse triiodothyronine levels.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Stimulation, Chemical; Thyroid Hormones; Thyroxine-Binding Proteins; Triiodothyronine, Reverse | 1987 |
Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems.
Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Levonorgestrel; Lynestrenol; Norgestrel; Plasminogen; Proteins; Sex Hormone-Binding Globulin; Tissue Plasminogen Activator; von Willebrand Factor | 1987 |
[Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dietary Carbohydrates; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel | 1987 |
Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.
Topics: Acetaminophen; Adult; Contraceptives, Oral, Hormonal; Drug Interactions; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel | 1987 |
Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes.
Topics: Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1987 |
Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
Topics: Adult; Biological Availability; Cystic Fibrosis; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Stereoisomerism | 1987 |
Chinical experience with levonorgestrel and ethinyl estradiol in Beijing.
Topics: Adult; China; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel | 1987 |
Direct measurements of enterohepatic circulation of bile acids in the cat. Influence of contraceptive steroids and oophorectomy.
Topics: Animals; Bile Acids and Salts; Cats; Contraceptives, Oral, Combined; Enterohepatic Circulation; Ethinyl Estradiol; Female; Levonorgestrel; Norgestrel; Ovariectomy | 1987 |
Progestogen potency in oral contraceptive pills.
Topics: Breast; Cholesterol, HDL; Contraceptives, Oral, Combined; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Phasic approach to oral contraceptives.
Topics: Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norethindrone; Norgestrel; Progesterone | 1987 |
Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel; Smoking | 1988 |
Chorea associated with oral contraception.
Topics: Adolescent; Adult; Chorea; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 1987 |
Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
Topics: Adolescent; Adult; Arginine Vasopressin; Contraceptives, Oral, Combined; Dinoprost; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Prostaglandins F | 1987 |
The effect of oral contraceptive pills on levels of oxytocin in plasma and on cognitive functions.
Topics: Adult; Cognition; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Oxytocin; Prolactin; Psychological Tests | 1987 |
Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives.
Topics: Adult; Chemical and Drug Induced Liver Injury; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Liver Cirrhosis; Lynestrenol; Norgestrel; Peliosis Hepatis; Radiography; Time Factors | 1988 |
Effect of addition oral contraceptives in chicks diet.
Topics: Adipose Tissue; Animal Feed; Animals; Blood Glucose; Blood Proteins; Chickens; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Levonorgestrel; Liver; Norgestrel; Organ Size; Weight Gain | 1988 |
Automated stability-indicating high-performance liquid chromatographic assay for ethinyl estradiol and (levo)norgestrel tablets.
Topics: Automation; Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Drug Stability; Ethinyl Estradiol; Levonorgestrel; Norgestrel; Reproducibility of Results; Solutions; Tablets | 1987 |
The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.
Topics: Adult; Castration; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norgestrel; Norpregnenes | 1985 |
Vasomotor symptoms and estrogen-progestogen therapy.
Topics: Adult; Climacteric; Contraceptives, Oral, Combined; Estradiol; Estriol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progestins; Vasomotor System | 1985 |
Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol.
Topics: Animals; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Levonorgestrel; Lipids; Norgestrel; Rats | 1985 |
The effect of progestins on the mitotic activity of uterine fibromyomas.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Leiomyoma; Levonorgestrel; Medroxyprogesterone; Middle Aged; Mitosis; Norethindrone; Norgestrel; Uterine Neoplasms; Uterus | 1985 |
Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Levonorgestrel; Lipids; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1985 |
Effect of two different combinations of ethinyl estradiol and levonorgestrel on hepatic functions.
Topics: Animals; Drug Interactions; Ethinyl Estradiol; Female; Levonorgestrel; Liver; Norgestrel; Rats; Rats, Inbred Strains; Stereoisomerism | 1985 |
Measurement of ethynylestradiol and levonorgestrel incorporated into sustained release contraceptive formulations.
Topics: Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Combinations; Ethinyl Estradiol; Levonorgestrel; Norgestrel; Silicone Elastomers; Stereoisomerism | 1985 |
Examination of the effect of Anteovin tablet on the endometrium.
Topics: Adult; Drug Combinations; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 1985 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Longitudinal Studies; Luteinizing Hormone; Lynestrenol; Norgestrel; Norpregnenes; Pituitary Gland | 1982 |
Effects of two oral contraceptive combinations, 0.125 mg desogestrel + 0.050 mg ethinylestradiol and 0.125 mg levonorgestrel + 0.050 mg ethinylestradiol on the adrenal function of healthy female volunteers.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Metyrapone; Norgestrel; Norpregnenes; Progestins; Random Allocation | 1982 |
[Therapeutic trend in acne associated with the menstrual cycle].
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel | 1983 |
Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Norpregnenes; Progesterone; Prolactin; Random Allocation; Serum Globulins; Sex Hormone-Binding Globulin; Transcortin | 1983 |
Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
Topics: Adult; Biological Availability; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Radioimmunoassay; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1984 |
Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins; Arteriosclerosis; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Middle Aged; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1984 |
Changes in relative fatty acid composition of serum lecithin and cholesterol ester after treatment with two gonane progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Castration; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Norpregnenes; Phosphatidylcholines; Progesterone Congeners; Stereoisomerism; Uterine Cervical Neoplasms | 1984 |
The morning after: novel hormonal approaches to postcoital interception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Gestrinone; Humans; Levonorgestrel; Luteolytic Agents; Male; Norgestrel; Receptors, Progesterone | 1983 |
Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
Topics: Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Genital Neoplasms, Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism | 1983 |
Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
Topics: Body Weight; Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism | 1983 |
A new ultra-low-dose combination oral contraceptive.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Stereoisomerism | 1983 |
Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth.
Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation; Nausea; Norgestrel; Uterine Hemorrhage | 1983 |
Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
Topics: Adult; Contraceptives, Oral, Combined; Endometrium; Estradiol; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel; Ovary; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone; Vagina | 1983 |
The effect of cotrimoxazole on oral contraceptive steroids in women.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Case of ectopic pregnancy after postcoital contraception with ethinyloestradiol-levonorgestrel.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy, Tubal | 1983 |
[Residual ovarian function after minidoses of estroprogestative agents].
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Gonadotropins, Pituitary; Humans; Levonorgestrel; Norgestrel; Ovary | 1983 |
Plasma lipoproteins and fatty acid composition after "minipill".
Topics: Adult; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipoproteins; Lipoproteins, HDL; Norgestrel; Triglycerides | 1983 |
Prolactin plasma levels and oral contraceptives at low dosage.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Prolactin; Smoking | 1983 |
The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
Topics: Adult; Blood Coagulation Factors; Blood Glucose; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Time Factors; Triglycerides | 1983 |
[Hemolytic-uremic syndrome caused by estrogen-progestagen combined oral contraceptives].
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hemolytic-Uremic Syndrome; Humans; Levonorgestrel; Norgestrel | 1984 |
Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
Topics: Adult; Androgens; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estrogens; Ethinyl Estradiol; Female; Gonadotropins, Pituitary; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Ovary; Ovulation; Plasma; Progesterone | 1984 |
Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation; Patient Compliance; Progesterone | 1984 |
[Postcoital contraception with steroid hormones].
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Danazol; Embryo Implantation; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Norpregnadienes; Pregnancy; Risk | 1984 |
Vitamin metabolism and the effects of multivitamin supplementation in oral contraceptive users.
Topics: Adult; Avitaminosis; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Risk; Thailand; Vitamins | 1984 |
Growth and sexual development before and after sex steroid therapy in patients with thalassemia major.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Growth; Humans; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Progesterone; Puberty; Sexual Maturation; Thalassemia | 1984 |
Pharmacokinetics of oral contraceptive steroids following the administration of the antimalarial drugs primaquine and chloroquine.
Topics: Adult; Chloroquine; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Primaquine | 1984 |
Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Topics: Adult; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel | 1984 |
Changes in urinary homocysteine following synthetic steroidal estrogen and progestogen administration to rats.
Topics: Animals; Chromatography, Thin Layer; Drug Interactions; Ethinyl Estradiol; Female; Homocysteine; Kinetics; Levonorgestrel; Norgestrel; Rats; Rats, Inbred Strains; Stereoisomerism | 1984 |
[Experimental use of the new generation of Tri-Step contraceptive agents in 20 treated cases].
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 1984 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I-Use effectiveness. An international comparative trial.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Statistics as Topic; Vagina | 1981 |
The in vitro metabolism of ethinyloestradiol, mestranol and levonorgestrel by human jejunal mucosa.
Topics: Adult; Ethinyl Estradiol; Female; Humans; Intestinal Mucosa; Jejunum; Levonorgestrel; Male; Mestranol; Middle Aged; Norgestrel | 1981 |
Elevated prolactin levels in oral contraceptive pill-related hypertension.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Norgestrel; Prolactin | 1981 |
The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette.
Topics: Adult; Biological Availability; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Radioimmunoassay | 1981 |
Zinc and copper nutriture of women taking oral contraceptive agents.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Copper; Ethinyl Estradiol; Female; Hair; Humans; Levonorgestrel; Norgestrel; Stereoisomerism; Time Factors; Zinc | 1981 |
The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activity.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Erythrocytes; Ethinyl Estradiol; Female; Glutathione Peroxidase; Humans; Levonorgestrel; Norgestrel; Peroxidases; Pyridoxal; Riboflavin; Selenium; Time Factors | 1981 |
[Triquilar/Trinordiol. A new pill with 3 sequences].
Topics: Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel | 1981 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III-Menstrual patterns. An international comparative trial.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel; Vagina | 1981 |
Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. I. Carbohydrate metabolism and liver function.
Topics: Blood Glucose; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Liver; Liver Function Tests; Norgestrel; Prospective Studies; Vagina | 1981 |
Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Norgestrel; Prospective Studies; Vagina | 1981 |
The effect of a contraceptive vaginal ring and oral contraceptives on the vaginal flora.
Topics: Adult; Candida; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Levonorgestrel; Neisseria gonorrhoeae; Norgestrel; Vagina | 1981 |
Serum bile acids during biphasic contraceptive treatment with ethinyl estradiol and norgestrel.
Topics: Adolescent; Adult; Bile Acids and Salts; Cholic Acid; Cholic Acids; Contraceptives, Oral; Contraceptives, Oral, Combined; Deoxycholic Acid; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Liver Function Tests; Norgestrel; Stereoisomerism | 1982 |
Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Longitudinal Studies; Norgestrel | 1982 |
Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Synthetic; England; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Prospective Studies | 1982 |
Low dosage oral contraception in women with previous gestational diabetes.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Prospective Studies | 1982 |
Ultrastructure of cervical mucus and sperm penetration during use of a triphasic oral contraceptive.
Topics: Cervix Mucus; Contraceptives, Oral; Contraceptives, Oral, Sequential; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Male; Microscopy, Electron, Scanning; Norgestrel; Sperm Motility | 1982 |
The effects of ampicillin on oral contraceptive steroids in women.
Topics: Adult; Ampicillin; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Norethindrone; Norgestrel; Progesterone; Time Factors | 1982 |
Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill.
Topics: Adult; Brain Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Hypertension, Malignant; Levonorgestrel; Norethindrone; Norgestrel | 1982 |
Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
Topics: Adult; Blood Pressure; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Norethindrone; Norgestrel | 1982 |
Ovulation suppression in women following vaginal administration of oral contraceptive tablets.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Levonorgestrel; Norgestrel; Ovulation; Progesterone; Vagina | 1982 |
Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovary; Ovulation; Random Allocation; Sex Hormone-Binding Globulin | 1982 |
Hormone replacement therapy and sexuality in women.
Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hysterectomy; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Sexual Behavior | 1982 |
The effect of ethinyl estradiol 20 mcg and levonorgestrel 250 mcg on the pituitary-ovarian function during normal tablet-taking and when tablets are missed.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Gonadotropins, Pituitary; Humans; Levonorgestrel; Menstruation; Norgestrel; Ovary; Pituitary Gland; Progesterone | 1982 |
Serial detection of plasma-factor XIII levels during the ovulatory cycle and estroprogestative contraception.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor XIII; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Norgestrel; Ovulation | 1982 |
[Clinical evaluation of 1,668 cycles of triphasic oral contraception (Trigynon). Multicentric Belgian study].
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel | 1982 |
Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Glycoproteins; Humans; Immunoassay; Levonorgestrel; Menstruation; Norgestrel; Proteins | 1982 |
Hormonal consequences of "missing the pill".
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Progesterone; Progesterone Congeners; Progesterone-Binding Globulin; Time Factors | 1982 |
Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys.
Topics: Animals; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptives, Oral, Hormonal; Diet, Atherogenic; Ethinyl Estradiol; Female; Levonorgestrel; Macaca fascicularis; Premenopause; Social Dominance | 1995 |
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Progestins; Risk Factors; Smoking; Thromboembolism; Time Factors | 1995 |
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Thromboembolism | 1995 |
Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Carrier Proteins; Complement System Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy Proteins; Protease Inhibitors; Serum Albumin; Sex Hormone-Binding Globulin; Steroids; Transcortin | 1993 |
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors | 1995 |
[Extrauterine pregnancy after hormonal postcoital contraception].
Topics: Adult; Contraceptives, Postcoital, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Laparoscopy; Levonorgestrel; Pregnancy; Pregnancy, Tubal; Rupture, Spontaneous | 1995 |
Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
Topics: Adolescent; Body Weight; Case-Control Studies; Chi-Square Distribution; Child; Condoms; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Norgestrel; Regression Analysis | 1995 |
After the morning after and the morning after that.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Time Factors | 1995 |
Cardiac and neurologic complications in malignant hypertension due to oral contraceptive use.
Topics: Acute Kidney Injury; Adult; Antihypertensive Agents; Cerebral Hemorrhage; Dexamethasone; Ethinyl Estradiol; Female; Headache; Hemianopsia; Humans; Hypertension, Malignant; Hypertrophy, Left Ventricular; Levonorgestrel; Seizures | 1994 |
Effect of contraceptive steroid and enalapril treatment of systolic blood pressure and plasma renin-angiotensin in the rat.
Topics: Angiotensin II; Animals; Blood Pressure; Contraceptives, Oral; Drug Combinations; Enalapril; Ethinyl Estradiol; Female; Levonorgestrel; Rats; Rats, Sprague-Dawley; Renin; Systole | 1994 |
[The clinico-morphological and cytological characteristics of the ecto- and endocervix with the use of the oral contraceptive triregol].
Topics: Adolescent; Adult; Biopsy; Cervix Uteri; Colposcopy; Contraceptives, Oral, Combined; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Histocytochemistry; Humans; Levonorgestrel; Time Factors; Uterine Cervical Erosion; Vaginal Smears | 1993 |
The effect of contraceptive steroids on hepatic cholesterol metabolism in female rats (I).
Topics: Acetoacetates; Acetyl-CoA C-Acetyltransferase; Animals; Cholesterol; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Hydroxymethylglutaryl-CoA Synthase; Levonorgestrel; Liver; Norethindrone; Norethindrone Acetate; Rats | 1993 |
Ischemic stroke in congenital (type II C) defective antithrombin III.
Topics: Adult; Antithrombin III Deficiency; Brain Ischemia; Ethinyl Estradiol; Female; Heterozygote; Humans; Levonorgestrel; Risk Factors | 1993 |
Youssef's syndrome: an appraisal of hormonal treatment.
Topics: Adult; Cesarean Section; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fistula; Humans; Levonorgestrel; Pregnancy; Syndrome; Urinary Bladder Fistula; Uterine Diseases | 1994 |
Promoting effects of ethinyl estradiol on development of renal proliferative lesions induced by N-nitrosobis (2-oxopropyl)amine in female Syrian golden hamsters.
Topics: Adenoma; Animals; Carcinogens; Cricetinae; Drug Interactions; Ethinyl Estradiol; Female; Kidney; Kidney Neoplasms; Levonorgestrel; Mesocricetus; Nitrosamines; Wilms Tumor | 1994 |
Clotting factors after emergency contraception.
Topics: Administration, Oral; Adolescent; Adult; Antithrombin III; Contraceptives, Oral, Combined; Contraindications; Emergencies; Ethinyl Estradiol; Factor VII; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Risk Factors; Thromboembolism; Time Factors | 1993 |
The effect of contraceptive steroids on plasma lipoprotein metabolism in female rats (II).
Topics: Animals; Apolipoproteins; Cholesterol; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Levonorgestrel; Lipids; Lipoproteins; Norethindrone; Norethindrone Acetate; Phospholipids; Rats; Triglycerides | 1993 |
[Risk of an unwanted pregnancy after a single unprotected coitus; observations on the current hormonal postcoital contraceptive methods].
Topics: Contraceptives, Postcoital, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Risk | 1993 |
Contraceptive steroids increase erythrocyte lipid peroxidation in female rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Erythrocyte Membrane; Ethinyl Estradiol; Female; Levonorgestrel; Lipid Peroxidation; Norethindrone; Rats; Rats, Inbred Strains | 1993 |
Enlarged follicles in women using oral contraceptives.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Ovarian Follicle; Ovary; Progestins; Ultrasonography | 1995 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events.
Topics: Adolescent; Adult; Androgen Antagonists; Antibodies; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Immunoenzyme Techniques; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes; Progesterone Congeners; Thrombophlebitis | 1995 |
Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
Topics: Adult; Amino Acids; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle | 1996 |
Effect of 17 alpha-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth muscles.
Topics: Aorta; Calcium; Calcium Channels; Calcium Radioisotopes; Cells, Cultured; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel; Muscle, Smooth, Vascular; Norpregnenes; Progesterone Congeners | 1996 |
Ethinyl oestradiol plus dl-norgestrel or levonorgestrel in the Yuzpe method for post-coital contraception: results of an observational study.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Nausea; Norgestrel; Vomiting | 1996 |
Simultaneous determination of ethinylestradiol and levonorgestrel in oral contraceptives by derivative spectrophotometry.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Estradiol Congeners; Ethinyl Estradiol; Levonorgestrel; Progesterone Congeners; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry | 1997 |
Sequential danazol/leuprolide acetate therapy for ovarian suppression in an in vitro fertilization patient unresponsive to leuprolide acetate.
Topics: Adult; Contraceptives, Oral; Danazol; Embryo Transfer; Estradiol; Estrogen Antagonists; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Leuprolide; Levonorgestrel; Luteinizing Hormone; Ovulation Induction; Ultrasonography | 1997 |
The effect of oral contraceptive agents on the basal metabolic rate of young women.
Topics: Adult; Anthropometry; Basal Metabolism; Blood Pressure; Body Composition; Calorimetry, Indirect; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Pulse; Stimulation, Chemical; Systole | 1997 |
Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Biomarkers; Bone and Bones; Bone Density; Calcium; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Levonorgestrel; Macaca fascicularis; Osteocalcin; Prospective Studies; Time Factors | 1997 |
Marked gender differences in ambulatory morning growth hormone values in young adults.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Fasting; Female; Human Growth Hormone; Humans; Levonorgestrel; Male; Prospective Studies; Sex Factors | 1998 |
Elevated serum prolactin level with high-dose estrogen contraceptive pills.
Topics: Adult; Age Distribution; Chemistry, Pharmaceutical; Contraceptives, Oral, Hormonal; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hyperprolactinemia; Incidence; Levonorgestrel; Parity; Progesterone Congeners; Time Factors | 1998 |
Effects of ethinylestradiol and levonorgestrel on morphology, ultrastructure and histoenzymatic activity of rat kidney.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Ca(2+) Mg(2+)-ATPase; Contraceptives, Oral, Synthetic; Epithelial Cells; Estradiol Congeners; Ethinyl Estradiol; Female; Glucose-6-Phosphatase; Histocytochemistry; Kidney; L-Lactate Dehydrogenase; Levonorgestrel; Microscopy, Electron; NADPH-Ferrihemoprotein Reductase; Progesterone Congeners; Rats; Rats, Wistar; Succinate Dehydrogenase | 1998 |
Emergency contraception.
Topics: Contraceptives, Postcoital; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 1998 |
From the Food and Drug Administration.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptives, Postcoital; Cyclopropanes; Drug Approval; Ethinyl Estradiol; Humans; Levonorgestrel; Oxazines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration | 1998 |
Emergency contraception approved in the US.
Topics: Contraceptives, Postcoital; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel; United States; United States Food and Drug Administration | 1998 |
Self-administering emergency hormonal contraception.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Emergency Medical Services; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Prospective Studies; Randomized Controlled Trials as Topic; Scotland; Self Administration | 1998 |
Calcium and phosphorus in milk of Brazilian mothers using oral contraceptives.
Topics: Adolescent; Adult; Calcium; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lactation; Levonorgestrel; Milk, Human; Norethindrone; Phosphorus; Regression Analysis | 1998 |
International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Progesterone Congeners | 1999 |
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Odds Ratio; Risk Factors; Smoking; United Kingdom; Venous Thrombosis | 1999 |
Large observational trial of a new low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 100 micrograms levonorgestrel (Miranova) in Germany.
Topics: Adolescent; Adult; Aged; Child; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Patient Satisfaction; Pregnancy | 1999 |
Safety and effectiveness of hormonal postcoital contraception: a prospective study.
Topics: Adolescent; Adult; Child; Coitus; Contraception; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Drug Combinations; Emergency Service, Hospital; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Prospective Studies; Spain; Treatment Outcome | 1999 |
The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.
Topics: Adult; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Hemostasis; Humans; Levonorgestrel; Plasminogen; Protein S | 1999 |
The role of matching menstrual data with hormonal measurements in evaluating effectiveness of postcoital contraception.
Topics: Contraceptives, Postcoital, Hormonal; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Pregnancy; Progesterone; Prospective Studies | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Bladder endometriosis: conservative management.
Topics: Adult; Aged; Cystoscopy; Endometriosis; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Progesterone Congeners; Urinary Bladder Diseases | 2000 |
Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys.
Topics: Animals; Contraceptives, Oral, Combined; Coronary Artery Disease; Disease Models, Animal; Drug Administration Schedule; Estradiol Congeners; Ethinyl Estradiol; Female; Levonorgestrel; Lipoproteins; Macaca fascicularis; Progesterone Congeners; Random Allocation | 2000 |
Renewed interest in haemostasis changes induced by oral contraceptives (OCs)
Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Hemostasis; Humans; Levonorgestrel; Partial Thromboplastin Time; Randomized Controlled Trials as Topic; Thrombophilia; Venous Thrombosis | 2000 |
The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Chloride; Chlormadinone Acetate; Cyclic AMP; Cyclic GMP; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; In Vitro Techniques; Jugular Veins; Levonorgestrel; Male; Norpregnenes; Potassium Chloride; Progesterone Congeners; Protein Kinase C; Rabbits; Rolipram; Tetradecanoylphorbol Acetate; Thionucleotides; Vasodilation | 2000 |
Emergency contraception.
Topics: Coitus; Contraception; Contraceptives, Oral, Combined; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; History, 20th Century; Humans; Levonorgestrel; United States | 2000 |
[Acute abdominal pain in a 19-year-old patient taking oral contraceptives].
Topics: Abdomen, Acute; Adult; Chylomicrons; Contraceptives, Oral, Sequential; Diagnosis, Differential; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoprotein Lipase; Pancreatitis | 2000 |
Pregnancy in premature ovarian failure: a possible role of estrogen plus progesterone treatment.
Topics: Adult; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Primary Ovarian Insufficiency; Progesterone Congeners | 2000 |
[Emergency hormonal contraception in France in 2000].
Topics: Contraceptives, Postcoital; Estradiol Congeners; Ethinyl Estradiol; Female; France; Humans; Levonorgestrel; Progesterone Congeners | 2000 |
Faculty of Family Planning and Reproductive Health Care. Royal College of Obstetricians and Gynaecologists. Guidance April 2000. Emergency contraception: recommendations for clinical practice.
Topics: Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Pregnancy | 2000 |
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over.
Topics: Adult; Analysis of Variance; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein S; Risk; Venous Thrombosis | 2001 |
Fine structure of prolactin cell of female albino rat as affected by some antifertility drugs--a comparative electron microscopic study.
Topics: Animals; Contraceptive Agents; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Levonorgestrel; Microscopy, Electron; Norethindrone; Pituitary Gland; Progesterone; Prolactin; Rats; Rats, Wistar; Tamoxifen | 2001 |
Levonorgestrel: new preparation. Emergency contraceptive.
Topics: Contraceptive Agents, Female; Drug Therapy, Combination; Ethinyl Estradiol; Female; France; Humans; Levonorgestrel; Randomized Controlled Trials as Topic; Treatment Outcome | 2000 |
Young women requesting emergency contraception are, despite contraceptive counseling, a high risk group for new unintended pregnancies.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Synthetic; Counseling; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Risk Factors; Sweden; Time Factors; Treatment Outcome | 2001 |
Influence of two low-dose oral contraceptives on pulsatile gonadotropin secretion.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Levonorgestrel; Menstrual Cycle; Ovary; Progesterone; Reference Values | 2001 |
Oral contraceptives and the risk of myocardial infarction.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Logistic Models; Middle Aged; Myocardial Infarction; Norpregnenes; Odds Ratio; Point Mutation; Prothrombin; Risk Factors; Smoking | 2001 |
From the Food and Drug Administration.
Topics: Administration, Cutaneous; Adult; Child; Contraceptive Agents, Female; Dermatologic Agents; Ethinyl Estradiol; Female; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Humans; Isotretinoin; Levonorgestrel; Male; Prostheses and Implants; Risk Management; United States; United States Food and Drug Administration | 2002 |
Ortho Evra--a contraceptive patch.
Topics: Contraceptive Agents; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Oximes | 2002 |
Determination of steroid hormones in oral contraceptives by high-performance liquid chromatography.
Topics: Calibration; Chromatography, High Pressure Liquid; Contraceptives, Oral; Estradiol Congeners; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Progesterone Congeners | 2002 |
A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Liver; Progesterone Congeners; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 2002 |
A clinico-pathological study of Neogynon as a new oral contraceptive steroid.
Topics: Africa; Africa, Northern; Biology; Birth Rate; Central Nervous System; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Developing Countries; Economics; Egypt; Endometrium; Ethinyl Estradiol; Family Planning Services; Fertility; Genitalia; Genitalia, Female; Histology; Lactation; Levonorgestrel; Middle East; Parity; Patient Acceptance of Health Care; Physiology; Population; Population Dynamics; Pregnancy; Research; Social Class; Socioeconomic Factors; Urogenital System; Uterus | 1976 |
Effect of oral contraception by progesterone pill on lipids and glucose metabolism.
Topics: Biology; Carbohydrates; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Diagnosis; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Glucose Tolerance Test; Levonorgestrel; Lipids; Lynestrenol; Mestranol; Metabolism; Metrorrhagia; Parity; Physiology; Reproductive Control Agents; Research | 1983 |
[Postcoital contraception].
Topics: Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Delivery of Health Care; Developed Countries; Ethinyl Estradiol; Europe; Evaluation Studies as Topic; Family Planning Services; Germany, West; Health; Health Planning; Health Services; Health Services Administration; Hormones; Levonorgestrel; Medicine; Norgestrel; Patient Acceptance of Health Care; Population; Population Dynamics; Program Evaluation; Reproductive Control Agents; Time Factors | 1984 |
[A comparative clinical study of the effects of three types of low-dose estrogen/progestogen oral contraceptives].
Topics: Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Endocrine System; Ethinyl Estradiol; Family Planning Services; Hormones; Levonorgestrel; Menstrual Cycle; Menstruation; Norethindrone; Physiology; Reproduction; Reproductive Control Agents; Research | 1987 |
Post coital contraception.
Topics: Biology; Birth Rate; Breast; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Developed Countries; Digestive System; Disease; Embryo Implantation; Embryonic Development; Endocrine System; Ethics; Ethinyl Estradiol; Europe; Family Planning Services; Fertility; Hormones; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Nausea; Netherlands; Parity; Pelvic Inflammatory Disease; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy, Ectopic; Reproduction; Signs and Symptoms; Vomiting | 1986 |
Three triphasic oral contraceptives now available in U.S.
Topics: Americas; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Developing Countries; Endocrine System; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Hormones; Levonorgestrel; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproductive Control Agents; Sexual Behavior; Signs and Symptoms; United States | 1985 |
[Progestins and arterial disease].
Topics: Age Factors; Behavior; Biology; Blood; Blood Coagulation; Carbohydrates; Cardiovascular System; Cause of Death; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Demography; Disease; Endocrine System; Ethinyl Estradiol; Family Planning Services; Glucose; Hormones; Levonorgestrel; Lipids; Metabolism; Mortality; Norethindrone; Organic Chemicals; Physiology; Population; Population Characteristics; Reproductive Control Agents; Smoking; Social Behavior; Vascular Diseases | 1985 |
[Post-coital contraception].
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Diethylstilbestrol; Disease; Endocrine System; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Intrauterine Devices; Levonorgestrel; Norgestrel; Physiology; Pregnancy Complications; Pregnancy, Ectopic; Reproductive Control Agents | 1985 |
[Influence of progestins on adverse effects of oral contraceptives].
Topics: Biology; Carbohydrates; Chemical Phenomena; Chemistry; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Disease; Endocrine System; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Hormone Antagonists; Hormones; Levonorgestrel; Lipids; Lynestrenol; Metabolism; Norethindrone; Norethynodrel; Norgestrel; Organic Chemicals; Physiology; Reproductive Control Agents | 1985 |
[Preclinical research and development of norethisterone].
Topics: Animals, Laboratory; Biology; Cervix Mucus; Cervix Uteri; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Economics; Endocrine System; Ethinyl Estradiol; Family Planning Services; Genitalia; Genitalia, Female; Hormones; In Vitro Techniques; Levonorgestrel; Medroxyprogesterone Acetate; Membrane Proteins; Norethindrone; Ovulation; Physiology; Proteins; Reproduction; Reproductive Control Agents; Research; Technology; Urogenital System; Uterus | 1985 |
Post-coital contraception.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Developed Countries; Endocrine System; Endometrium; Ethinyl Estradiol; Europe; Family Planning Services; Hormone Antagonists; Hormones; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Netherlands; Physiology; Progesterone; Progestins; Uterus | 1988 |
Vaginal rings for contraception: endocrine parameters.
Topics: Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Endocrine Glands; Endocrine System; Estradiol; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins | 1992 |
Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
Topics: Americas; Biology; Blood; Blood Pressure; Body Weight; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developing Countries; Diagnosis; Disease; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Latin America; Levonorgestrel; Lipids; Menstrual Cycle; Menstruation; Metrorrhagia; Mexico; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Signs and Symptoms | 1992 |
First emergency contraceptive product hits U.S. market shelves.
Topics: Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Developed Countries; Ethinyl Estradiol; Family Planning Services; Government Agencies; Health Services Accessibility; Levonorgestrel; North America; Organizations; United States; United States Food and Drug Administration; United States Public Health Service | 1998 |
Berlex introduces new 20 mcg birth control pill.
Topics: Americas; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Ethinyl Estradiol; Family Planning Services; Legislation as Topic; Levonorgestrel; North America; United States | 1998 |
[Minidril and Adepal. 2 minidose pills: an easy prescription for the doctor, without incidents or risks for the woman].
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Ethinyl Estradiol; Family Planning Services; Health Planning; Levonorgestrel; Patient Acceptance of Health Care; Reproductive Control Agents | 1978 |
Study of rigevidon for oral contraception in a family planning clinic in Kota Bahru, Kelantan.
Topics: Asia; Asia, Southeastern; Birth Rate; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Demography; Developing Countries; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Fertility; Health Planning; Levonorgestrel; Malaysia; Patient Acceptance of Health Care; Population; Population Dynamics; Pregnancy Rate | 1990 |
Effects of the triphasic oral contraceptive on lipid and lipoprotein metabolism.
Topics: Africa; Africa South of the Sahara; Africa, Eastern; Ambulatory Care Facilities; Biology; Blood; Blood Pressure; Cholesterol; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delivery of Health Care; Developing Countries; Diagnosis; Ethinyl Estradiol; Family Planning Services; Follow-Up Studies; Health; Health Facilities; Health Planning; Kenya; Levonorgestrel; Lipids; Patient Acceptance of Health Care; Patient Dropouts; Physiology; Research | 1991 |
Oral contraceptives.
Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases | 1987 |
Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases | 1991 |
The choice of the dose of oestrogen in a combined oral contraceptive.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Mestranol; Norethindrone | 1978 |
Norgestrel, increased lipids: fact or "marketing monster"?
Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases | 1989 |
Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation.
Topics: Belgium; Biology; Blood; Blood Pressure; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Data Collection; Developed Countries; Ethinyl Estradiol; Europe; Family Planning Services; Incidence; Levonorgestrel; Menstrual Cycle; Menstruation; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Research Design | 1990 |
Coagulation profile in women on low-dose oral contraceptive pills.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Desogestrel; Developing Countries; Ethinyl Estradiol; Family Planning Services; Human Experimentation; Levonorgestrel; Malaysia; Physiology; Research | 1990 |
Current perspectives on emergency contraception.
Topics: Contraception Behavior; Contraceptives, Postcoital; Drug Prescriptions; Emergencies; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Hong Kong; Humans; Intrauterine Devices; Levonorgestrel; Mifepristone; Nonprescription Drugs; Patient Education as Topic; Pregnancy; Pregnancy, Unwanted; Self Administration | 2002 |
Differences in the use of combined oral contraceptives amongst women with and without acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Prescriptions; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Polycystic Ovary Syndrome | 2003 |
The use of low dose oral contraceptives for the management of acne.
Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral; Ethinyl Estradiol; Humans; Levonorgestrel | 2002 |
False risk attribution results in misleading assessment of the relationship between suppression of ovulation and the effectiveness of the Yuzpe regimen for emergency contraception.
Topics: Contraceptives, Postcoital; Data Interpretation, Statistical; Ethinyl Estradiol; False Negative Reactions; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Levonorgestrel; Luteinizing Hormone; Ovarian Follicle; Ovary; Ovulation; Risk Factors | 2003 |
Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Contraceptives, Oral, Synthetic; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Levonorgestrel; Norpregnenes; Progestins; Rabbits | 2003 |
[Medication of the month. Lowette, a contraceptive for treating acne in young women].
Topics: Acne Vulgaris; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 2003 |
Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis.
Topics: Adolescent; Adult; Amino Acid Substitution; Combined Modality Therapy; Conjunctivitis; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cushing Syndrome; DNA Mutational Analysis; Ethinyl Estradiol; Exons; Female; Genes, Recessive; Genotype; Humans; Hypophysectomy; Introns; Levonorgestrel; Mutation, Missense; Pedigree; Plasminogen; Point Mutation; RNA Splice Sites; von Willebrand Diseases | 2003 |
Oral contraception and cyclic changes in premenstrual and menstrual experiences.
Topics: Abdominal Pain; Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Premenstrual Syndrome; Prospective Studies | 2003 |
Preparation and characterization of injectable microspheres of contraceptive hormones.
Topics: Contraceptives, Oral, Synthetic; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Levonorgestrel; Microspheres; Polyesters | 2003 |
Serum lipid and lipoprotein changes induced by preparations containing low-dose ethinylestradiol plus levonorgestrel.
Topics: Adult; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Triglycerides | 2003 |
Morphological and functional study of the cochlea after administration of estrogen and progesterone in the guinea pig.
Topics: Animals; Case-Control Studies; Cochlea; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Levonorgestrel; Progesterone; Temporal Bone | 2001 |
Endogenous estradiol metabolism during treatment with oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Levonorgestrel; Nandrolone; Norethindrone; Premenopause; Randomized Controlled Trials as Topic | 2004 |
Hospital-based program for increasing the availability of emergency contraception: simulating nonprescription access.
Topics: Administration, Oral; Adolescent; Adult; Contraceptives, Postcoital; Drug Combinations; Drug Utilization Review; Emergencies; Ethinyl Estradiol; Female; Health Services Accessibility; Hospitals, Teaching; Humans; Levonorgestrel; Nonprescription Drugs; Pharmacy Service, Hospital; Time Factors; United States | 2004 |
Emergency contraception: the right to full disclosure.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Nonprescription Drugs; Patient Education as Topic; United States | 2004 |
Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
Topics: Absorptiometry, Photon; Adolescent; Adolescent Health Services; Body Mass Index; Bone Demineralization, Pathologic; Bone Density; Bone Development; Cohort Studies; Confidence Intervals; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Ethinyl Estradiol; Female; Femur Neck; Health Education; Humans; Levonorgestrel; Lumbar Vertebrae; Medroxyprogesterone Acetate; Odds Ratio; Prospective Studies; Risk Factors; Time Factors; United States | 2004 |
Bone density and contraception in adolescent girls.
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Case-Control Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Osteogenesis; Time Factors | 2004 |
Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive.
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Case-Control Studies; Contraceptives, Oral; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Prospective Studies; Time Factors | 2004 |
Effects of low dose oral contraceptives on serum total cholesterol, TAG, HDL-C & LDL-C levels in contraceptive users.
Topics: Adult; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Prospective Studies; Triglycerides | 2005 |
Interactions between aqueous Hypericum perforatum extracts and drugs: in vitro studies.
Topics: Chromatography, High Pressure Liquid; Drug Interactions; Ethinyl Estradiol; Humans; Hypericum; Levonorgestrel; Phytotherapy; Plant Extracts | 2004 |
Influence of ethinyl estradiol on C1s inhibitor: a new etiopathogenetic mechanism of angioedema. Case report.
Topics: Adult; Angioedema; Autoantibodies; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Complement Inactivator Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dermatitis, Allergic Contact; Diabetes Mellitus, Type 2; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Serpins | 2005 |
Comparison of vaginal and oral administration of emergency contraception.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Cross-Over Studies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Prospective Studies; Vagina | 2005 |
Glycemic status in women using combined oral contraceptive pill.
Topics: Adolescent; Adult; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Prospective Studies | 2005 |
Characterization of polymeric poly(epsilon-caprolactone) injectable implant delivery system for the controlled delivery of contraceptive steroids.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Contraceptives, Oral, Combined; Cytokines; Drug Implants; Ethinyl Estradiol; Female; Inflammation; Injections, Intramuscular; Levonorgestrel; Materials Testing; Microscopy, Electron, Scanning; Microspheres; Polyesters; Rats; Rats, Wistar | 2006 |
Pharmacokinetic interaction of solifenacin with an oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women: a double-blind, placebo-controlled study.
Topics: Adult; Area Under Curve; Contraceptives, Oral; Cross-Over Studies; Double-Blind Method; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Metabolic Clearance Rate; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; White People | 2005 |
The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.
Topics: Adolescent; Adult; Anticonvulsants; Contraceptives, Oral, Combined; Drug Interactions; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Lamotrigine; Levonorgestrel; Luteinizing Hormone; Middle Aged; Ovulation; Sex Hormone-Binding Globulin; Triazines | 2006 |
Study of temperature-responsibility on the surfaces of a thermo-responsive polymer modified stationary phase.
Topics: Acrylic Resins; Chromatography, High Pressure Liquid; Contraceptives, Oral, Combined; Dexamethasone; Ethinyl Estradiol; Humans; Hydrocortisone; Levonorgestrel; Molecular Conformation; Prednisolone; Steroids; Surface Properties; Temperature; Testosterone | 2006 |
Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Treatment Outcome | 2006 |
What is the seminal exposition among women requiring emergency contraception? A prospective, observational comparative study.
Topics: Adolescent; Adult; Case-Control Studies; Contraception, Postcoital; Contraceptive Agents, Female; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Prospective Studies; Semen; Sperm Count; Unsafe Sex; Vagina | 2007 |
Mechanism of action of emergency contraceptive pills.
Topics: Animals; Contraceptives, Postcoital; Embryo Implantation; Ethinyl Estradiol; Female; Fertilization; Levonorgestrel; Ovulation; Pregnancy | 2006 |
Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Chromatography, High Pressure Liquid; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Stability; Ethinyl Estradiol; Female; Immunohistochemistry; Injections, Intramuscular; Lactic Acid; Levonorgestrel; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar | 2006 |
Reproductive hormone effects on strength of the rat anterior cruciate ligament.
Topics: Animals; Anterior Cruciate Ligament; Biomechanical Phenomena; Estradiol; Ethinyl Estradiol; Female; Levonorgestrel; Progesterone; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2007 |
A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry.
Topics: Automation; Chromatography, Liquid; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Humans; Levonorgestrel; Norethindrone; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2007 |
High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel.
Topics: Chromatography, High Pressure Liquid; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2007 |
Cerebral venous thrombosis associated with repeated use of emergency contraception.
Topics: Anticoagulants; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Factor VIII; Female; Humans; Intracranial Thrombosis; Levonorgestrel; Middle Aged; Venous Thrombosis | 2007 |
Clinical management of an unusual case of gingival enlargement.
Topics: Adult; Contraceptives, Oral, Synthetic; Dental Plaque; Dental Scaling; Ethinyl Estradiol; Female; Gingival Overgrowth; Humans; Levonorgestrel; Oral Hygiene | 2007 |
Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro.
Topics: Basic Helix-Loop-Helix Transcription Factors; Benzhydryl Compounds; Cell Proliferation; Cell Survival; Cells, Cultured; DDT; Dibutyl Phthalate; Dose-Response Relationship, Drug; Endocrine Disruptors; Endometrium; Endothelial Cells; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Phenols; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Progesterone; Progestins; Proliferating Cell Nuclear Antigen; Receptors, Aryl Hydrocarbon | 2007 |
[Hepatic lesions and prolonged use of oral contraceptive].
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Peliosis Hepatis | 2007 |
Ectopic pregnancy following emergency contraception with ethinyloestradiol-levonorgestrel: a case report.
Topics: Adult; Condoms; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2007 |
[Lybrel and menstrual cessation].
Topics: Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 2007 |
Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Fertility; Follow-Up Studies; Humans; Hypothalamo-Hypophyseal System; Levonorgestrel; Menstruation; Middle Aged; Ovary; Pregnancy; Regression Analysis; Time Factors | 2008 |
Fluctuations in brain concentrations of neurosteroids are not associated to changes in gephyrin levels.
Topics: Administration, Oral; Animals; Brain; Carrier Proteins; Cerebral Cortex; Estradiol; Estrogens; Estrus; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hippocampus; Levonorgestrel; Male; Membrane Proteins; Neural Inhibition; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; RNA, Messenger; Synapses; Synaptic Membranes; Synaptic Transmission | 2007 |
Development of a novel immunoassay for the assessment of plasma Gas6 concentrations and their variation with hormonal status.
Topics: Adolescent; Adult; Biomarkers; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Intercellular Signaling Peptides and Proteins; Levonorgestrel; Male; Plasma; Reference Values; Sensitivity and Specificity; Sex Factors | 2007 |
Study of low-density lipoprotein receptor regulation by oral (steroid) contraceptives: desogestrel, levonorgestrel and ethinyl estradiol in JEG-3 cell line and placental tissue.
Topics: Cell Line, Tumor; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Humans; Levonorgestrel; Placenta; Receptors, LDL; Up-Regulation | 2007 |
Serum HDL-cholesterol in women using low dose oral contraceptives.
Topics: Adult; Age Factors; Cholesterol, HDL; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Ischemia; Prospective Studies; Risk Factors; Venous Thromboembolism | 2007 |
Modelling costs and outcomes of expanded availability of emergency contraceptive use in British Columbia.
Topics: British Columbia; Contraceptives, Postcoital; Cost Savings; Decision Support Techniques; Decision Trees; Drug Utilization; Ethinyl Estradiol; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Levonorgestrel; Norgestrel; Outcome Assessment, Health Care; Pharmaceutical Services; Practice Patterns, Physicians'; Pregnancy; Pregnancy, Unwanted | 2007 |
By the way, doctor. Some of my friends are excited about the new oral contraceptive that eliminates periods. But it worries me. Does anyone know what happens when you stop menstruating for a long time? It just seems unnatural.
Topics: Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation | 2007 |
Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Child; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Ethinyl Estradiol; Female; Femur Neck; Humans; Injections, Intramuscular; Levonorgestrel; Lumbar Vertebrae; Medroxyprogesterone Acetate; Midwestern United States; Prospective Studies; Time Factors | 2008 |
Endogenous and exogenous female sex hormones and renal electrolyte handling: effects of an acute sodium load on plasma volume at rest.
Topics: Adult; Arginine Vasopressin; Bicycling; Body Water; Contraceptives, Oral, Hormonal; Electrolytes; Ethinyl Estradiol; Female; Follicular Phase; Gonadal Steroid Hormones; Hormones; Humans; Kidney; Levonorgestrel; Luteal Phase; Models, Statistical; Osmotic Pressure; Plasma Volume; Progestins; Rest; Sodium | 2008 |
Return to fertility after cessation of a continuous oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fertility; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Prospective Studies | 2009 |
Menorrhagia and severe menstrual pain related to the use of adalimumab in a psoriatic.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Contraceptives, Oral, Combined; Drug Combinations; Drug Labeling; Dysmenorrhea; Etanercept; Ethinyl Estradiol; Female; Humans; Immunoglobulin G; Immunologic Factors; Levonorgestrel; Menorrhagia; Obesity, Morbid; Product Surveillance, Postmarketing; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha; United Kingdom; United States | 2008 |
Risk factors of cardiovascular disease among the oral contraceptive users in Kermanshah City of Iran.
Topics: Adult; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Iran; Levonorgestrel; Prevalence; Risk Factors | 2008 |
Migrainous cerebral infarction after postcoital contraception.
Topics: Adult; Contraception, Postcoital; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Magnetic Resonance Imaging; Stroke | 2009 |
Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
Topics: Adolescent; Ambulatory Care Facilities; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Levonorgestrel; Medication Adherence; Norethindrone; Patient Satisfaction; Prospective Studies; Young Adult | 2009 |
Toxic epidermal necrolysis secondary to emergency contraceptive pills.
Topics: Adult; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Stevens-Johnson Syndrome | 2009 |
Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Metrorrhagia; Retrospective Studies; Young Adult | 2009 |
[Emergency contraception ].
Topics: Adolescent; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Mifepristone; Norgestrel; Time Factors | 2008 |
[Back up contraception].
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Time Factors | 2008 |
Characterization of new types of stationary phases for fast liquid chromatographic applications.
Topics: Chemistry, Pharmaceutical; Chromatography; Chromatography, Liquid; Equipment Design; Ethinyl Estradiol; Kinetics; Levonorgestrel; Particle Size; Reproducibility of Results; Software; Tablets; Temperature | 2009 |
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Levonorgestrel; Luteinizing Hormone; Obesity; Young Adult | 2009 |
Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.
Topics: Adolescent; Adult; Case-Control Studies; Confidence Intervals; Contraceptives, Oral; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norgestrel; Odds Ratio; Product Surveillance, Postmarketing; United States; Venous Thromboembolism | 2010 |
Antimullerian hormone and obesity: insights in oral contraceptive users.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Body Mass Index; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Levonorgestrel; Luteinizing Hormone; Obesity; Regression Analysis | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Concurrent branch retinal vein occlusion and cerebral venous thrombosis from oral contraceptive pill use.
Topics: Adult; Cerebral Veins; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Magnetic Resonance Angiography; Ophthalmoscopy; Phlebography; Retinal Vein Occlusion; Venous Thrombosis; Visual Acuity | 2010 |
Effects of two different low-dose oral contraceptives on plasma homocysteine levels.
Topics: Adolescent; Adult; Contraceptives, Oral; Cross-Sectional Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Homocysteine; Humans; Levonorgestrel; Young Adult | 2011 |
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Logistic Models; Middle Aged; Mineralocorticoid Receptor Antagonists; Nandrolone; Risk Factors; Venous Thromboembolism; Young Adult | 2010 |
Drug release and adhesive properties of crospovidone-containing matrix patches based on polyisobutene and acrylic adhesives.
Topics: Acrylates; Adhesives; Administration, Cutaneous; Chemistry, Pharmaceutical; Diffusion; Dosage Forms; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Male; Povidone; Skin; Skin Absorption; Solubility | 2010 |
Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
Topics: Adolescent; Adult; Amenorrhea; Canada; Clinical Trials, Phase III as Topic; Contraceptives, Oral, Combined; Dosage Forms; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Menorrhagia; Metrorrhagia; Middle Aged; Multicenter Studies as Topic; Patient Satisfaction; Young Adult | 2010 |
BMI, pharmacokinetics, and OCP failure.
Topics: Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 2010 |
Combined oral contraceptives and body weight: do oral contraceptives cause weight gain? A primate model.
Topics: Animals; Basal Metabolism; Body Composition; Body Weight; Contraceptives, Oral, Combined; Energy Intake; Ethinyl Estradiol; Female; Levonorgestrel; Macaca mulatta; Obesity | 2011 |
Influence of adsorbents in transdermal matrix patches on the release and the physical state of ethinyl estradiol and levonorgestrel.
Topics: Administration, Cutaneous; Adsorption; Contraceptive Agents, Female; Crystallization; Delayed-Action Preparations; Drug Compounding; Estrogens; Ethinyl Estradiol; Humans; Levonorgestrel; Molecular Weight; Particle Size; Povidone; Solubility; Transdermal Patch; Water | 2011 |
Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogen.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Longitudinal Studies; Middle Aged; Young Adult | 2011 |
Adolescents' experiences using the contraceptive patch versus pills.
Topics: Adolescent; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Menstruation; Norgestrel; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Transdermal Patch; Young Adult | 2011 |
Oral contraceptives and the risk of gallbladder disease: a comparative safety study.
Topics: Adult; Androstenes; Cholecystectomy; Confidence Intervals; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Gallbladder Diseases; Humans; Levonorgestrel; Progestins; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors | 2011 |
Progestins possess poor anti-estrogenic activity on murine hepatic coagulation gene transcription despite evident anti-estrogenic activity on uterine tissue.
Topics: Animals; Blood Coagulation; Contraceptives, Oral; Desogestrel; Estrogen Antagonists; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Mice; Mice, Inbred C57BL; Receptors, Estrogen; Receptors, Progesterone; Transcription, Genetic; Uterus | 2011 |
Effects of human contraceptive on reproduction and offspring in Chrysomya megacephala.
Topics: Animal Structures; Animals; Contraceptive Agents; Diptera; Ethinyl Estradiol; Female; Levonorgestrel; Male; Reproduction | 2011 |
Risk of blood clots higher for oral contraceptives with certain progestins.
Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism | 2011 |
The association between drospirenone and hyperkalemia: a comparative-safety study.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Levonorgestrel; Logistic Models; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spironolactone | 2011 |
Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers.
Topics: Adiponectin; Adult; Cholesterol; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Lipids; Lipoproteins; Young Adult | 2012 |
Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone/EE vs. a second-generation oral contraceptive containing levonorgestrel/EE.
Topics: Angiotensinogen; Blood Coagulation Factors; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Discriminant Analysis; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norprogesterones; Risk; Sex Hormone-Binding Globulin; Thrombosis; Triglycerides | 2012 |
Ethinylestradiol and levonorgestrel preparations on the Belgian market: a comparative study.
Topics: Belgium; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Levonorgestrel; Reproducibility of Results; Solubility; Spectrophotometry, Ultraviolet; Tablets, Enteric-Coated | 2012 |
Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women; cross-sectional study.
Topics: Adolescent; Adult; Androstenes; Brazil; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; E-Selectin; Ethinyl Estradiol; Female; Humans; Intercellular Adhesion Molecule-1; Levonorgestrel; Vascular Cell Adhesion Molecule-1 | 2012 |
Long-term administration with levonorgestrel decreases allopregnanolone levels and alters GABA(A) receptor subunit expression and anxiety-like behavior.
Topics: Animals; Anxiety; Blotting, Western; Cerebral Cortex; Ethinyl Estradiol; Female; Hippocampus; Levonorgestrel; Maze Learning; Pregnanolone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2012 |
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Topics: Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Levonorgestrel; Propylene Glycols; Sphingosine | 2012 |
The influence of emergency contraception on post-traumatic stress symptoms following sexual assault.
Topics: Adolescent; Adult; Analysis of Variance; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Forensic Nursing; Humans; Levonorgestrel; Rape; Stress Disorders, Post-Traumatic; Young Adult | 2012 |
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.
Topics: Adolescent; Adult; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Progesterone; Prospective Studies | 2013 |
Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives.
Topics: Adult; Autonomic Nervous System; Blood Pressure; Brazil; Cardiovascular Diseases; Contraceptives, Oral, Combined; Desogestrel; Estrogen Receptor alpha; Estrogens; Ethinyl Estradiol; Female; Genetic Association Studies; Heart Rate; Humans; Introns; Levonorgestrel; Norpregnenes; Polymorphism, Single Nucleotide; Progestins; Risk Factors | 2013 |
Emergency contraception: no. 280 (replaces No. 131, August 2003).
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Drug Combinations; Ethinyl Estradiol; Female; Health Services Accessibility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Pregnancy, Unplanned | 2013 |
Newer non-oral hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Implants; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Safety; Treatment Outcome | 2013 |
Emergency contraception.
Topics: China; Contraception, Postcoital; Contraceptive Agents; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; European Union; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Norpregnadienes; Ovulation; Pregnancy; Pregnancy, Ectopic; Receptors, Progesterone; Time Factors | 2013 |
Women's experiences with tailored use of a combined oral contraceptive: a qualitative study.
Topics: Adolescent; Adult; Contraception; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Randomized Controlled Trials as Topic | 2013 |
Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral; Databases, Factual; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Proportional Hazards Models; Risk; Time Factors; United States; Venous Thromboembolism; Young Adult | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
Aesthetic and incentive salience of cute infant faces: studies of observer sex, oral contraception and menstrual cycle.
Topics: Analysis of Variance; Beauty; Contraceptives, Oral; Cross-Sectional Studies; Ethinyl Estradiol; Face; Facial Expression; Female; Humans; Infant; Judgment; Levonorgestrel; Male; Menstrual Cycle; Photic Stimulation; Visual Perception; Young Adult | 2013 |
The effect of low-dose combined oral contraceptive pills on brachial artery endothelial function and common carotid artery intima-media thickness.
Topics: Adult; Atherosclerosis; Blood Pressure; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; Contraceptives, Oral, Combined; Drug Combinations; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Young Adult | 2014 |
Quartette: an ascending-dose, extended-cycle oral contraceptive.
Topics: Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Approval; Drug Interactions; Ethinyl Estradiol; Humans; Levonorgestrel; United States; United States Food and Drug Administration | 2013 |
Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill is not the second largest RCT.
Topics: Contraception Behavior; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Precision Medicine | 2013 |
Response to Dr. Szarewski.
Topics: Contraception Behavior; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Precision Medicine | 2013 |
Use of simulated patients to evaluate combined oral contraceptive dispensing practices of community pharmacists.
Topics: Adult; Brazil; Clinical Competence; Contraception; Contraceptives, Oral, Combined; Counseling; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Male; Patient Simulation; Pharmacists | 2013 |
A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens.
Topics: Adolescent; Adult; Biological Availability; Computer Simulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Middle Aged; Models, Biological; Nonlinear Dynamics; Young Adult | 2014 |
Recurrent peritoneal inclusion cysts successfully treated with oral contraceptives: a report of two cases.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cysts; Drug Combinations; Ethinyl Estradiol; Female; Gynecologic Surgical Procedures; Humans; Levonorgestrel; Middle Aged; Peritoneal Diseases; Recurrence; Sclerotherapy; Tissue Adhesions | 2014 |
Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats.
Topics: Agonistic Behavior; Anhedonia; Animals; Cerebral Cortex; Contraceptives, Oral, Hormonal; Depression; Drug Combinations; Ethinyl Estradiol; Female; Levonorgestrel; Maze Learning; Motivation; Pregnanolone; Rats; Rats, Sprague-Dawley; Sexual Behavior, Animal; Social Behavior; Swimming | 2014 |
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy | 2014 |
In reply.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy | 2014 |
Endometrial cancer in a woman with 46,XY pure gonadal dysgenesis.
Topics: Adult; Drug Combinations; Endometrial Neoplasms; Ethinyl Estradiol; Female; Gonadal Dysgenesis, 46,XY; Hormone Replacement Therapy; Hormones; Humans; Incidental Findings; Levonorgestrel; Ovariectomy; Treatment Outcome | 2015 |
Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel.
Topics: Aged; Area Under Curve; Blood Glucose; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Glucagon-Like Peptides; Glycated Hemoglobin; Half-Life; Humans; Hypoglycemic Agents; Levonorgestrel; Metabolic Clearance Rate; Middle Aged; Postmenopause | 2015 |
Estimating systemic exposure to ethinyl estradiol from an oral contraceptive.
Topics: Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Young Adult | 2015 |
A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) model.
Topics: Animals; Contraceptives, Oral, Combined; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; HIV Infections; Levonorgestrel; Macaca nemestrina; Menstrual Cycle; Mucous Membrane; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Vagina | 2015 |
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.
Topics: Adiponectin; Adipose Tissue; Adult; Androstenes; Anthropometry; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Egypt; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Norpregnenes; Resistin; Risk Factors | 2015 |
Recurrent transaminitis induced by oral contraceptives during HIV infection.
Topics: Alanine Transaminase; Anti-HIV Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Contraceptives, Oral; Ethinyl Estradiol; Female; HIV Infections; Humans; Levonorgestrel; Middle Aged | 2015 |
Oral contraceptive use and saliva diurnal pattern of metabolic steroid hormones in young healthy women.
Topics: Circadian Rhythm; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Menstrual Cycle; Saliva; Testosterone; Young Adult | 2015 |
Comparative study of the effects of combined oral contraceptives in hemostatic variables: an observational preliminary study.
Topics: Adolescent; Adult; Androstenes; Biomarkers; Contraceptives, Oral, Combined; Cross-Sectional Studies; Ethinyl Estradiol; Factor VII; Factor XII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Levonorgestrel; Partial Thromboplastin Time; Protein C; Protein S; Prothrombin Time; Young Adult | 2015 |
Mixture effects of levonorgestrel and ethinylestradiol: estrogenic biomarkers and hormone receptor mRNA expression during sexual programming.
Topics: Animals; Biomarkers; Drug Synergism; Embryo, Nonmammalian; Estrogens; Ethinyl Estradiol; Female; Gene Expression Regulation, Developmental; Gonads; Levonorgestrel; Liver; Male; Receptors, Androgen; Receptors, Progesterone; Sex Ratio; Vitellogenins; Water Pollutants, Chemical; Xenopus | 2015 |
Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
Topics: Contraception Behavior; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Medication Adherence; Patient Satisfaction; Pregnancy; United States | 2016 |
Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system.
Topics: Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Humans; Levonorgestrel; Norgestrel; Oximes | 2015 |
Ethinyl estradiol and levonorgestrel alter cognition and anxiety in rats concurrent with a decrease in tyrosine hydroxylase expression in the locus coeruleus and brain-derived neurotrophic factor expression in the hippocampus.
Topics: Animals; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition; Ethinyl Estradiol; Female; Hippocampus; Learning; Levonorgestrel; Locus Coeruleus; Memory; Rats; Tyrosine 3-Monooxygenase | 2015 |
The effect of oral contraception on macroprolactin levels in women with macroprolactinemia: A pilot study.
Topics: Adult; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pilot Projects; Premenopause; Prevalence; Prolactin; Young Adult | 2015 |
Clotting factor changes during the first cycle of oral contraceptive use.
Topics: Adult; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Humans; Levonorgestrel; Pilot Projects; Protein C; Sex Hormone-Binding Globulin; Transcortin; Young Adult | 2016 |
From single chemicals to mixtures--reproductive effects of levonorgestrel and ethinylestradiol on the fathead minnow.
Topics: Animals; Biological Assay; Cyprinidae; Ethinyl Estradiol; Female; Levonorgestrel; Male; Reproduction; Water Pollutants, Chemical | 2015 |
Concentrations of levonorgestrel and ethinylestradiol in wastewater effluents: Is the progestin also cause for concern?
Topics: Ethinyl Estradiol; Levonorgestrel; Limit of Detection; Models, Theoretical; Progestins; Queensland; Wastewater; Water Pollutants, Chemical; Water Purification | 2016 |
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
Topics: Adult; Androstenes; Cardiovascular Diseases; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Mineralocorticoid Receptor Antagonists; Patient Reported Outcome Measures; Pharmacovigilance; Progestins; Proportional Hazards Models; Risk Factors | 2016 |
Population-based evaluation of the effectiveness of two regimens for emergency contraception.
Topics: Adolescent; Adult; British Columbia; Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Multivariate Analysis; Pregnancy; Pregnancy Rate; Retrospective Studies; Young Adult | 2016 |
Autoimmune progesterone dermatitis: Case report with history of urticaria, petechiae and palpable pinpoint purpura triggered by medical abortion.
Topics: Abortion, Induced; Adult; Autoimmune Diseases; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Dermatitis; Ethinyl Estradiol; Female; Humans; IgA Vasculitis; Levonorgestrel; Progesterone; Purpura; Urticaria | 2016 |
Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study.
Topics: Adolescent; Adult; Chemokine CCL2; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intercellular Adhesion Molecule-1; Levonorgestrel; Pilot Projects; Polycystic Ovary Syndrome; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
Additive effects of levonorgestrel and ethinylestradiol on brain aromatase (cyp19a1b) in zebrafish specific in vitro and in vivo bioassays.
Topics: Animals; Animals, Genetically Modified; Aromatase; Biological Assay; Brain; Cell Line; Drug Interactions; Embryo, Nonmammalian; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Ethinyl Estradiol; Genes, Reporter; Green Fluorescent Proteins; Humans; Levonorgestrel; Luciferases; Progestins; Zebrafish; Zebrafish Proteins | 2016 |
Estimating systemic exposure to levonorgestrel from an oral contraceptive.
Topics: Adolescent; Adult; Area Under Curve; Contraceptive Agents, Female; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Progestins; Sex Hormone-Binding Globulin; Transcortin; Young Adult | 2017 |
Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.
Topics: Administration, Oral; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone, Human; Healthy Volunteers; HIV Integrase Inhibitors; Humans; Levonorgestrel; Luteinizing Hormone; Progesterone; Pyridones; Young Adult | 2017 |
Endogenous thrombin potential changes during the first cycle of oral contraceptive use.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Venous Thromboembolism | 2017 |
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.
Topics: Adolescent; Adult; Aged; Amides; Antiviral Agents; Benzofurans; Carbamates; Contraceptives, Oral, Combined; Cyclopropanes; Drug Interactions; Ethinyl Estradiol; Female; Hepacivirus; Humans; Imidazoles; Levonorgestrel; Middle Aged; Quinoxalines; Sulfonamides; Young Adult | 2017 |
The levonorgestrel-releasing intrauterine device potentiates stress reactivity.
Topics: Adrenocorticotropic Hormone; Adult; Contraceptive Agents, Female; Cross-Sectional Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Intrauterine Devices; Levonorgestrel; Pituitary-Adrenal System; Saliva; Young Adult | 2017 |
Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent.
Topics: Animals; Anti-Inflammatory Agents; Blood Viscosity; Contraceptives, Oral; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fibrinolytic Agents; Glucocorticoids; Insulin Resistance; Levonorgestrel; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley | 2017 |
Combined oral contraceptive and nitric oxide synthesis inhibition synergistically causes cardiac hypertrophy and exacerbates insulin resistance in female rats.
Topics: Animals; Blood Pressure; C-Reactive Protein; Cardiomegaly; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Insulin Resistance; Levonorgestrel; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plasminogen Activator Inhibitor 1; Rats, Wistar; Uric Acid | 2017 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Phototoxic reaction to a combined oral contraceptive (levonorgestrel/ethinylestradiol).
Topics: Adult; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Photosensitizing Agents; Skin; Spectrophotometry; Ultraviolet Rays | 2017 |
Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.
Topics: Administration, Oral; Aldosterone; Animals; Biomarkers; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Glycogen Synthase Kinase 3; Heart; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Levonorgestrel; Myocardium; Nicotine; Nicotinic Agonists; Plasminogen Activator Inhibitor 1; Prediabetic State; Random Allocation; Rats, Wistar | 2018 |
Hypercupremia secondary to oral contraceptives: report of 2 cases.
Topics: Ceruloplasmin; Contraceptives, Oral; Copper; Crohn Disease; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Malnutrition; Oligonucleotides; Polycystic Ovary Syndrome; Spectrophotometry, Atomic; Young Adult; Zinc | 2017 |
Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain?
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Pelvic Pain; Progestins; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2018 |
Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Eating; Estradiol; Estrogens; Ethinyl Estradiol; Fasting; Female; Glycogen Synthase Kinase 3; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Levonorgestrel; Mineralocorticoids; Obesity; Rats; Rats, Wistar; Triglycerides | 2018 |
Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique
Topics: Adult; Contraceptives, Oral, Synthetic; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Incidence; Intention to Treat Analysis; Intestinal Diseases; Italy; Levonorgestrel; Metrorrhagia; Norethindrone; Norethindrone Acetate; Ovarian Diseases; Pain Measurement; Patient Dropouts; Patient Preference; Pelvic Pain; Prospective Studies; Vaginal Diseases | 2018 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |
Hormonal contraception and breast cancer.
Topics: Breast Neoplasms; Cohort Studies; Contraception; Ethinyl Estradiol; Humans; Levonorgestrel | 2018 |
Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
Topics: Animals; Contraception; Contraceptive Agents, Female; Ethinyl Estradiol; Female; HIV Infections; Interleukin-10; Levonorgestrel; Macaca nemestrina; Medroxyprogesterone Acetate; Mucous Membrane; Progestins; Risk Factors; Vagina | 2018 |
Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: A prospective cohort study.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Levonorgestrel; Luteinizing Hormone; Norpregnadienes; Ovarian Follicle; Ovulation; Progesterone; Prospective Studies; Ultrasonography | 2018 |
Hormonal contraception and breast cancer.
Topics: Breast Neoplasms; Cohort Studies; Contraception; Ethinyl Estradiol; Humans; Levonorgestrel | 2018 |
Oral ethinylestradiol-levonorgestrel attenuates cardiac glycogen and triglyceride accumulation in high fructose female rats by suppressing pyruvate dehydrogenase kinase-4.
Topics: Administration, Oral; Animals; Drug Combinations; Ethinyl Estradiol; Female; Fructose; Glycogen; Levonorgestrel; Myocardium; Protein Kinases; Rats, Wistar; Triglycerides | 2019 |
Sodium acetate improves disrupted glucoregulation and hepatic triglyceride content in insulin-resistant female rats: involvement of adenosine deaminase and dipeptidyl peptidase-4 activities.
Topics: Adenosine Deaminase; Animals; Dipeptidyl Peptidase 4; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Insulin Resistance; Levonorgestrel; Liver; Rats, Wistar; Sodium Acetate; Triglycerides; Uric Acid; Xanthine Oxidase | 2019 |
Ethinylestradiol and Levonorgestrel as Active Agents in Normal Skin, and Pathological Conditions Induced by UVB Exposure: In Vitro and In Ovo Assessments.
Topics: Animals; Apoptosis; Cell Line; Cell Line, Tumor; Contraceptive Agents; Ethinyl Estradiol; Fibroblasts; Humans; Keratinocytes; Levonorgestrel; Melanocytes; Melanoma; Mice; Skin; Ultraviolet Rays | 2018 |
Short article: Hormone therapy for severe gastrointestinal bleeding due to multiple angiodysplastic lesions.
Topics: Aged; Aged, 80 and over; Anemia; Angiodysplasia; Blood Transfusion; Drug Combinations; Ethinyl Estradiol; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Length of Stay; Levonorgestrel; Male; Patient Admission; Recurrence; Severity of Illness Index; Time Factors; Treatment Outcome | 2019 |
Involvement of glucocorticoid and mineralocorticoid receptors in lipid accumulation and depressed G6PD activity in the livers of rats treated with postpartum oral estrogen-progestin.
Topics: Animals; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Glucose; Glucosephosphate Dehydrogenase; Levonorgestrel; Lipid Metabolism; Liver; Mifepristone; Mineralocorticoid Receptor Antagonists; Pregnancy; Progestins; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2019 |
Hepatotoxicity induced by a second-generation combined oral contraceptive: case report and review of the literature.
Topics: Chemical and Drug Induced Liver Injury; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Young Adult | 2019 |
A fractured arm and forgotten contraceptive implant.
Topics: Accidental Falls; Adult; Contraceptive Agents, Female; Device Removal; Drug Combinations; Drug Implants; Ethinyl Estradiol; Female; Foreign-Body Migration; Humans; Humeral Fractures; Levonorgestrel; Ultrasonography, Interventional | 2019 |
Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study.
Topics: Adult; Body Mass Index; Coagulation Protein Disorders; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; India; Inflammation; Insulin; Insulin Resistance; Levonorgestrel; Metformin; Polycystic Ovary Syndrome; Risk Factors; Waist-Hip Ratio; Young Adult | 2019 |
Oral ethinylestradiol-levonorgestrel normalizes fructose-induced hepatic lipid accumulation and glycogen depletion in female rats.
Topics: Administration, Oral; Animals; Antioxidants; Blood Glucose; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fructose; Glucosephosphate Dehydrogenase; Glycogen; Hyperinsulinism; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Lipid Peroxidation; Liver; Protein Kinases; Rats; Rats, Wistar; Uric Acid | 2019 |
Removal of the endocrine disruptors ethinyl estradiol, bisphenol A, and levonorgestrel by subsurface constructed wetlands.
Topics: Benzhydryl Compounds; Cyperus; Eichhornia; Endocrine Disruptors; Ethinyl Estradiol; Levonorgestrel; Phenols; Waste Disposal, Fluid; Water Pollutants, Chemical; Wetlands | 2019 |
Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone.
Topics: Androstenes; Animals; Blood Glucose; Body Weight; Contraceptives, Oral; Corticosterone; Drug Combinations; Ethinyl Estradiol; Female; Insulin; Insulin-Secreting Cells; Levonorgestrel; Rats | 2019 |
Comments on: "A Systematic Review and Meta‑analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive".
Topics: Contraceptives, Oral; Drug-Related Side Effects and Adverse Reactions; Emergency Service, Hospital; Ethinyl Estradiol; Female; Humans; Levonorgestrel | 2020 |
Insulin resistance and depressed cardiac G6PD activity induced by glucocorticoid exposure during pregnancy are attenuated by maternal estrogen-progestin therapy.
Topics: Animals; Contraceptives, Oral, Combined; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Glucocorticoids; Glucosephosphate Dehydrogenase; Insulin Resistance; Levonorgestrel; Maternal-Fetal Exchange; Myocardium; Pregnancy; Progestins; Rats, Wistar | 2020 |
Evaluation of the Potential Pharmacokinetic Interactions Between Vixotrigine and an Oral Contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Phenyl Ethers; Proline; Young Adult | 2020 |
Risk of sexual dysfunction with progestin-based contraceptives in women of child-bearing age.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Progestins; Sexual Dysfunction, Physiological; Young Adult | 2021 |
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
Topics: Adult; Alkynes; Benzoxazines; Body Mass Index; Carbamazepine; Clarithromycin; Computer Simulation; Contraceptives, Oral, Combined; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Itraconazole; Levonorgestrel; Models, Biological; Obesity; Rifampin; Sex Hormone-Binding Globulin | 2021 |
Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery.
Topics: Brazil; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Gastric Bypass; Humans; Levonorgestrel; Male | 2021 |
Discussing pregnancy prevention with bariatric surgery patients.
Topics: Bariatric Surgery; Ethinyl Estradiol; Female; Gastric Bypass; Humans; Levonorgestrel; Obesity, Morbid; Pregnancy | 2021 |
Author response to ethinyl estradiol and levonorgestrel Phase 3 data clarification.
Topics: Ethinyl Estradiol; Humans; Levonorgestrel | 2021 |
Ethinyl estradiol and levonorgestrel patch phase 3 data clarification.
Topics: Ethinyl Estradiol; Humans; Levonorgestrel | 2021 |
Association between the use of hormonal contraceptives and risk of cholecystectomy in women of reproductive age.
Topics: Adolescent; Adult; Age Factors; Body Mass Index; Cholecystectomy; Comorbidity; Contraceptive Agents, Hormonal; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Long-Acting Reversible Contraception; Medroxyprogesterone Acetate; Middle Aged; Retrospective Studies; Young Adult | 2021 |
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Topics: Antifibrinolytic Agents; Contraceptive Agents, Hormonal; Endometrial Ablation Techniques; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Tranexamic Acid; Uterine Artery Embolization; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms; Watchful Waiting | 2021 |
Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Signal Transduction; Triple Negative Breast Neoplasms | 2021 |
Lack of pharmacokinetic interaction between the HIV-1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women.
Topics: Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; HIV-1; Humans; Levonorgestrel; Luteinizing Hormone; Progesterone; Transaminases | 2022 |
Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Megestrol; Norpregnadienes; Pregnancy; Pregnancy, Unplanned | 2021 |
A Drug-Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Microgynon (Ethinylestradiol and Levonorgestrel) in Female Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.
Topics: Antineoplastic Agents; Area Under Curve; Contraceptive Agents, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Europe; Female; Humans; Indoles; Levonorgestrel; Lung Diseases, Interstitial; Middle Aged; Scleroderma, Systemic; United States | 2022 |
Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
Topics: Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Nurses; Progestins; Prospective Studies | 2022 |
Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers.
Topics: Drug Interactions; Ethinyl Estradiol; Female; Humans; Imidazoles; Levonorgestrel; Pyrimidines; Volunteers | 2022 |
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.
Topics: Contraceptives, Oral, Combined; Estetrol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Thrombin | 2022 |
Effects of oral contraceptives on spatial cognition depend on pharmacological properties and phase of the contraceptive cycle.
Topics: Cognition; Contraceptives, Oral; Estranes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Progesterone Congeners; Progestins | 2022 |
Combined effects of the contraceptive hormones, ethinyl estradiol and levonorgestrel, on the use of place and response memory in gonadally-intact female rats.
Topics: Animals; Contraceptives, Oral; Control Groups; Estrous Cycle; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Rats | 2023 |
Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach.
Topics: Chromatography, High Pressure Liquid; Contraceptive Agents; Drug Stability; Ethinyl Estradiol; Humans; Levonorgestrel; Reproducibility of Results | 2023 |